Bis(hetero)aryl thioether oxadiazines as antifungal compounds
Novel bis(hetero)arylthioether oxadiazine derivatives address the need for effective, low-toxicity, and selective fungicides by providing enhanced control of phytopathogenic fungi, including resistance prevention.
Patent Information
- Application Number
- JP2024532326
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-30
- Filing Date
- 2022-11-29
- Publication Date
- 2024-11-26
AI Technical Summary
There is a need for new compounds that are effective against a wide range of phytopathogenic microorganisms such as fungi, have low toxicity, are highly selective, and can be used at low application rates while preventing the emergence of resistance.
Development of bis(hetero)arylthioether oxadiazine derivatives, which are novel compounds designed to control phytopathogenic fungi, with specific structural variations allowing for varied substituents and functional groups to enhance efficacy and selectivity.
The bis(hetero)arylthioether oxadiazine derivatives provide effective control of phytopathogenic fungi with low toxicity and potential resistance prevention, offering advantages over existing compounds in terms of selectivity and application rates.
Smart Images

Figure 2024543953000001 
Figure 2024543953000002 
Figure 2024543953000003
Abstract
Description
[Technical Field]
[0001] The present invention relates to bis(hetero)aryl thioether oxadiazine derivatives and their use for controlling plant pathogenic microorganisms, such as plant pathogenic fungi, as well as to processes and intermediates for preparing these compounds. [Background technology]
[0002] Up to now, many crop protection agents have been developed to combat or prevent the spread of microorganisms.However, there is still a need to develop new compounds, in order to provide compounds that are effective against a wide range of plant pathogenic microorganisms such as fungi, have low toxicity, have high selectivity, or can be used at low application rates, and at the same time enable effective pest control.It is also desirable to have new compounds to prevent the emergence of resistance.
[0003] The present invention provides novel compounds for controlling plant pathogenic microorganisms, such as fungi, which have advantages over known compounds and compositions in at least some of their aspects.
[0004] Heterocyclyl-substituted pyridazines as antifungal agents are disclosed in WO 2020 / 127780. WO 2021 / 245083, WO 2021 / 249995, WO 2021 / 245087 and WO 2021 / 255071 claim further heterocyclyl-substituted compounds as antifungal agents. DISCLOSURE OF THE INVENTION
[0005] Compounds of formula (I) The present invention relates to a compound of formula (I): [ka]
[0006] The compound of formula (I) A 2are O, S, C(=O), S(=O), S(=O)2, NR 1 Or CR 2A R R2B and R 1 is hydrogen, C1-C6 alkyl, C3-C8 cycloalkyl or formyl, The C1-C6 alkyl is optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; and the C3-C8 cycloalkyl is optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; R 2A and R 2B is hydrogen, C1-C6 alkyl or C3-C8 cycloalkyl, The C1-C6 alkyl is optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; and the C3-C8 cycloalkyl is optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; or R 2A and R 2B together with the carbon atoms to which they are attached form a C3-C8 cycloalkyl ring or a 3- to 7-membered heterocyclyl ring; m is 0, 1, or 2; R 3 and R 4 are independently hydrogen, halogen, cyano, hydroxyl, formyl, carboxyl, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylcarbonyl, C1-C6 alkylcarbonyloxy, C1-C6 alkoxycarbonyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C8 cycloalkyl, C6-C 14 aryl, 5- to 14-membered heteroaryl, 3- to 14-membered heterocyclyl, or —O—Si(C1-C6 alkyl)3; C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylcarbonyl, C1-C6 alkylcarbonyloxy, C1-C6 alkoxycarbonyl, C2-C6 alkenyl, C2-C6 alkynyl and -O-Si(C1-C6 alkyl)3 are optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; and C3-C8 cycloalkyl, C6-C 14The aryl, 5- to 14-membered heteroaryl, and 3- to 14-membered heterocyclyl are optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3, and 3- to 7-membered heterocyclyl; or R 3 and R 4 together with the carbon atoms to which they are attached form a carbonyl, methylidene, C3-C8 cycloalkyl ring, or 3- to 7-membered heterocyclyl ring; the C3-C8 cycloalkyl ring and the 3- to 7-membered heterocyclyl ring are optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; R 5 is hydrogen, hydroxyl, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylcarbonyloxy, C1-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C3-C8 cycloalkyl or -O-Si(C1-C6 alkyl)3; C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylcarbonyloxy, C1-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl and -O-Si(C1-C6 alkyl)3 are optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; and the C3-C8 cycloalkyl is optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; or R 3 and R 5 Or R 4 and R 5 together with the carbon atoms to which they are attached form a C3-C8 cycloalkyl ring, T is hydrogen, hydroxyl, C1-C6 alkyl, C1-C6 alkoxy, -C(=O)R 9 , -C(=O)(OR 10 ), -C(=O)N(R 11 )2, -S(=O)R 12 , -S(=O)2R 13 Or -S(=O)2N(R 14 )2, R 9 and R 10 are independently C1-C6 alkyl, C1-C6 haloalkyl, C3-C8 cycloalkyl, or C2-C6 alkenyl; R 11 , R 12 , R 13and R 14 are independently hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C8 cycloalkyl, or C2-C6 alkenyl; L is a direct bond, carbonyl, C1-C6 alkylene, C2-C6 alkenylene, C2-C6 alkynylene, -C(=O)-C1-C6 alkylene, -C1-C6 alkylene-C(=O)-, -NR L1 -, -NR L2 (C=O)-, -C(=O)NR L3 -, -NR L4 S(=O)2-, -S(=O)2NR L5 -, -C(=NOR L6 )-, -C(=NN(R L7 )2)-, -C(=NR L8 )-or the expression:
[0007] [ka]
[0008] is the basis of The C1-C6 alkylene, C2-C6 alkenylene, C2-C6 alkynylene, -C(=O)-C1-C6 alkylene and -C1-C6 alkylene-C(=O)- are each independently selected from the group consisting of 1 to 3 substituents L SA and optionally substituted by ## is the point of attachment to the heterocyclyl moiety; ### is R 6 It is the connection point with L 1 is a direct bond or C1-C6 alkylene, L 2 is a direct bond or C1-C6 alkylene, E is C3-C8 cycloalkyl, C3-C8 cycloalkenyl, or 3- to 7-membered heterocyclyl; The C3-C8 cycloalkyl, C3-C8 cycloalkenyl and 3- to 7-membered heterocyclyl are then optionally substituted with 1 to 3 substituents L SC and optionally substituted by and RL1 , R L2 , R L3 , and R L4 are independently hydrogen or C1-C6 alkyl, R L5 , R L6 , R L7 and R L8 are independently hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C8 cycloalkyl, or C2-C6 alkenyl; L SA are independently halogen, cyano, hydroxyl, carboxyl, methylidene, halomethylidene, C1-C6 alkoxy, C1-C6 haloalkoxy, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C1-C6 alkoxycarbonyl, -O-Si(C1-C6 alkyl)3 or 3- to 7-membered heterocyclyl; and / or Two substituents L attached to the same carbon atom SA together with the carbon atoms to which they are attached form a C3-C8 cycloalkyl ring or a 3- to 7-membered heterocyclyl ring; L SC are independently halogen, cyano, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; and / or Two L's SC the substituents, together with the carbon atoms to which they are attached, form a C3-C8 cycloalkyl ring; R 6 is C3~C 12 Carbocyclyl, C6-C 14 Aryl, 3- to 14-membered heterocyclyl, 5- to 14-membered heteroaryl, C3-C 12 Carbocyclyloxy, C6-C 14Aryloxy, 5- to 14-membered heteroaryloxy, 3- to 14-membered heterocyclyloxy, C3-C 12 Carbocyclylsulfanyl, C6-C 14 Arylsulfanyl, 5- to 14-membered heteroarylsulfanyl, 3- to 14-membered heterocyclylsulfanyl, C3-C 12 Carbocyclylsulfinyl, C6-C 14 Arylsulfinyl, 5- to 14-membered heteroarylsulfinyl, 3- to 14-membered heterocyclylsulfinyl, C3-C 12 Carbocyclylsulfonyl, C6-C 14 arylsulfonyl, 5- to 14-membered heteroarylsulfonyl, 3- to 14-membered heterocyclylsulfonyl, C1-C3 alkoxy, C1-C3 haloalkoxy, C1-C3 alkylsulfanyl, C1-C3 alkylsulfinyl or C1-C3 alkylsulfonyl; C1-C3 alkoxy, C1-C3 haloalkoxy, C1-C3 alkylsulfanyl, C1-C3 alkylsulfinyl and C1-C3 alkylsulfonyl are each an alkyl group selected from the group consisting of C3-C 12 Carbocyclyl, C6-C 14 substituted by one substituent selected from the group consisting of aryl, 3- to 14-membered heterocyclyl, and 5- to 14-membered heteroaryl; Said C3~C 12 Carbocyclyl, C6-C 14 Aryl, 3- to 14-membered heterocyclyl and 5- to 14-membered heteroaryl are then 1 to 4R 6S may be substituted by a substituent, C3~C 12 Carbocyclyl, C6-C 14 Aryl, 3- to 14-membered heterocyclyl, 5- to 14-membered heteroaryl, C3-C 12 Carbocyclyloxy, C6-C 14 Aryloxy, 5- to 14-membered heteroaryloxy, 3- to 14-membered heterocyclyloxy, C3-C 12 Carbocyclylsulfanyl, C6-C 14Arylsulfanyl, 5- to 14-membered heteroarylsulfanyl, 3- to 14-membered heterocyclylsulfanyl, C3-C 12 Carbocyclylsulfinyl, C6-C 14 Arylsulfinyl, 5- to 14-membered heteroarylsulfinyl, 3- to 14-membered heterocyclylsulfinyl, C3-C 12 Carbocyclylsulfonyl, C6-C 14 Arylsulfonyl, 5- to 14-membered heteroarylsulfonyl, and 3- to 14-membered heterocyclylsulfonyl are 1 to 4R 6S may be substituted by a substituent, R 6S is halogen, cyano, isocyano, nitro, hydroxyl, mercapto, pentafluorosulfanyl, oxo, methylidene, halomethylidene, formyl, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C2-C6 alkynyloxy, C2-C6 Haloalkynyloxy, C1-C6 alkylsulfanyl, C1-C6 haloalkylsulfanyl, C3-C8 cycloalkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C3-C8 cycloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, C3-C8 cycloalkylsulfonyl, C3-C8 cycloalkyl, C3-C8 cycloalkyloxy, C3-C8 cycloalkenyl, C6-C 14 Aryl, 5- or 6-membered heteroaryl, 3- to 7-membered heterocyclyl, -N(R 15 )2, -O(C=O)R 16 , -C(=O)R 16 , -C(=O)(OR 17 ), -C(=O)N(R 18 )2, -S(=O)2N(R 19 )2, —O—Si(C1-C6 alkyl)3, and —Si(C1-C6 alkyl)3; C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C2-C6 alkynyloxy, C2-C6 haloalkynyloxy, C1-C6 alkylsulfanyl, C1-C6 haloalkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl -Si(C1-C6 alkyl)3, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, -O-Si(C1-C6 alkyl)3 and -Si(C1-C6 alkyl)3 are optionally further substituted by 1 to 3 substituents independently selected from the group consisting of cyano, hydroxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, -O-Si(C1-C6 alkyl)3, -Si(C1-C6 alkyl)3, C3-C8 cycloalkyl, C3-C8 halocycloalkyl and 3- to 7-membered heterocyclyl; or two C1-C6 alkyl substituents attached to the same carbon atom together with the carbon atoms to which they are attached form a C3-C8 cycloalkyl ring; and C3-C8 cycloalkylsulfanyl, C3-C8 cycloalkylsulfinyl, C3-C8 cycloalkylsulfonyl, C3-C8 cycloalkyl, C3-C8 cycloalkyloxy, C3-C8 cycloalkenyl, C6-C 14 The aryl, 5- or 6-membered heteroaryl, and 3- to 7-membered heterocyclyl may be further substituted by 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C1-C6 haloalkoxycarbonyl, C2-C6 alkenyl, C3-C8 cycloalkenyl, and C3-C8 halocycloalkyl; and R 15are independently hydrogen, C1-C6 alkyl, or C3-C8 cycloalkyl; The C1-C6 alkyl is in turn optionally substituted with 1 to 3 substituents independently selected from the group consisting of halogen, cyano, hydroxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, -O-Si(C1-C6 alkyl)3, -Si(C1-C6 alkyl)3, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, and 3- to 7-membered heterocyclyl; and The C3-C8 cycloalkyl is in turn optionally substituted by 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C1-C6 haloalkoxycarbonyl, C2-C6 alkynyl, C3-C8 cycloalkyl, and C3-C8 halocycloalkyl; R 16 , R 17 , R 18 and R 19 are independently hydrogen, C1-C6 alkyl, or C1-C6 cycloalkyl; The C1-C6 alkyl and C1-C6 haloalkyl may in turn be substituted by 1 to 3 substituents independently selected from the group consisting of cyano, hydroxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, -O-Si(C1-C6 alkyl)3, -Si(C1-C6 alkyl)3, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, and 3- to 7-membered heterocyclyl; Ring Y has the formula (II-a), (II-b), (II-c), (II-d), (II-e), (II-f), (II-g), (II-h), (II-i), (II-j), (II-k), (II-l), (II-m), (II-n), (II- o), (II-p), (II-q), (II-r), (II-s), (II-t), (II-u), (II-v), (II-w), (II-x), (II-y), (II-z), (II-aa), (II-ab) or (II-ac):
[0009] [ka] JPEG2024543953000004.jpg171127
[0010] is a group of the formula * is the group -S(O) p -Q is the connection point, # is the point of attachment to another heterocycle, A 1 is CR 8 Or N, R 8 is hydrogen, halogen, cyano or C1-C4 alkyl, G is O, S or NR 7L and R 7L is hydrogen, C1-C4 alkyl, C1-C4 haloalkyl or C3-C8 cycloalkyl; q is 0, 1, 2, 3, or 4; x1 is 1 or 2, x2 is 0, 1 or 2, R 7A , R 7B , R 7C , R 7D , R 7E , R 7F and R 7Gare independently hydrogen, hydroxyl, halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy or C3-C8 cycloalkyl; R 7H is hydrogen, C1-C4 alkyl or C1-C4 haloalkyl, R 7K is methylidene, halomethylidene, halogen, hydroxyl, oxo, C1-C4 alkyl, C1-C6 haloalkyl or C3-C6 cycloalkyl; or 2 Substituent R 7K together with the carbon atoms to which they are attached form a C3-C8 cycloalkyl ring, R 7L is hydrogen, halogen, cyano, isocyano, hydroxyl, mercapto, nitro, amino, formyl, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 hydroxyalkyl, C1-C6 alkylcarbonyl, C1-C6 haloalkylcarbonyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C2-C6 alkynyloxy, C2-C6 haloalkynyloxy, C1-C6 alkylsulfanyl, C1-C6 haloalkylsulfanyl, C3-C8 cycloalkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C3-C8 cycloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, C3-C8 cycloalkylsulfonyl, C3-C8 cycloalkyl, C3-C6 cycloalkenyl, C6-C 14 Aryl, 5- or 6-membered heteroaryl, 3- to 7-membered heterocyclyl, C3-C8 cycloalkoxy, C6-C 14 Aryloxy, 5- or 6-membered heteroaryloxy, 3- to 7-membered heterocyclyloxy, -O-Si(C1-C6 alkyl)3, -Si(C1-C6 alkyl)3, -N(R 20 )2, -C(=NR 21 )R22 , -NR 23 C(=O)R 24 , -C(=O)(OR 25 ), -C(=O)N(R 26 )2, -S(=O)2N(R 27 )2 or -S(=O)(=NR 28 )R 29 and C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 hydroxyalkyl, C1-C6 alkylcarbonyl, C1-C6 haloalkylcarbonyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C2-C6 alkynyloxy, C2-C6 haloalkynyloxy, C1-C6 alkylsulfanyl, C1-C6 haloalkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl and C1-C6 haloalkylsulfonyl are each 1-3R 7Sa may be substituted by a substituent, C3-C8 cycloalkylsulfanyl, C3-C8 cycloalkylsulfinyl, C3-C8 cycloalkylsulfonyl, C3-C8 cycloalkyl, C3-C6 cycloalkenyl, C6-C 14 Aryl, 5- or 6-membered heteroaryl, 3- to 7-membered heterocyclyl, C3-C8 cycloalkoxy, C6-C 14 Aryloxy, 5- or 6-membered heteroaryloxy, and 3- to 7-membered heterocyclyloxy are 1 to 3R 7Sc may be substituted by a substituent, and R 20 is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C6-C 14 aryl, 5- or 6-membered heteroaryl, or 3- to 7-membered heterocyclyl; C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl and C2-C6 haloalkynyl are each independently selected from the group consisting of 1 to 3 substituents R 7Sa and optionally substituted by and C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C6-C 14 Aryl, 5- or 6-membered heteroaryl and 3- to 7-membered heterocyclyl may be substituted with 1 to 3 substituents R 7Sc and optionally substituted by R 21 and R 22 are independently hydrogen, hydroxyl, amino, cyano, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, mono(C1-C6 alkyl)amino or di(C1-C6 alkyl)amino; C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, mono(C1-C6 alkyl)amino or di(C1-C6 alkyl)amino is 1-3R 7Sa may be substituted by a substituent, R 23 , R 24 , R 25 , R 26 , R 27 , R 28 and R 29 are independently hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, and C3-C8 cycloalkyl; C1-C6 alkyl and C1-C6 haloalkyl are 1-3R 7Sa may be substituted by a substituent, and C3-C8 cycloalkyl is 1-3R 7Sc may be substituted by a substituent, R 7Saare independently selected from cyano, hydroxyl, carboxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C1-C6 alkoxycarbonyl, -O-Si(C1-C6 alkyl)3, -Si(C1-C6 alkyl)3, C6-C 14 aryl or 3- to 7-membered heterocyclyl; R 7Sc are independently halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, halomethylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 or 3- to 7-membered heterocyclyl; or 2R bonded to the same carbon atom 7Sc the C1-C6 alkyl substituents taken together form a C3-C8 cycloalkyl; R 7M is hydrogen, halogen, cyano, isocyano, amino, nitro, hydroxyl, mercapto, carboxyl, C1-C6 alkoxycarbonyl, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 hydroxyalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C2-C6 alkenyl peroxy, C2-C6 haloalkenyloxy, C2-C6 alkynyloxy, C2-C6 haloalkynyloxy, C1-C6 alkylsulfanyl, C1-C6 haloalkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, C3-C8 cycloalkyl, C3-C8 cycloalkenyl, C6-C 14 Aryl, 3- to 14-membered heterocyclyl, 5- to 14-membered heteroaryl, C3-C8 cycloalkoxy, C6-C 14Aryloxy, 3- to 14-membered heterocyclyloxy, 5- to 14-membered heteroaryloxy, -O-Si(C1-C6 alkyl)3, -Si(C1-C6 alkyl)3, -N(R 30 )2, -SR 31 , -S(=O)R 31 or -S(=O)2R 31 and The C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 hydroxyalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C2-C6 alkynyloxy, C2-C6 haloalkynyloxy, C1-C6 alkylsulfanyl, C1-C6 haloalkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, -O-Si(C1-C6 alkyl)3 and -Si(C1-C6 alkyl)3 are each independently 1 to 3R 8Sa may be substituted by a substituent, The C3 to C8 cycloalkyl, C3 to C6 cycloalkenyl, C6 to C 14 Aryl, 3- to 14-membered heterocyclyl, 5- to 14-membered heteroaryl, C3-C8 cycloalkoxy, C6-C 14 Aryloxy, 3- to 14-membered heterocyclyloxy, and 5- to 14-membered heteroaryloxy are 1 to 3R 8Sc may be substituted by a substituent, and R 30 are independently hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C6-C 14 aryl, 5- to 14-membered heteroaryl, or 3- to 7-membered heterocyclyl; The C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl and C2-C6 haloalkynyl are then each independently selected from the group consisting of 1 to 3R 8Sa may be substituted by a substituent, The C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C6-C 14 Aryl, 5- to 14-membered heteroaryl and 3- to 7-membered heterocyclyl are then 1 to 3R 8Sc may be substituted by a substituent, R 31 is C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C6-C 14 aryl, 5- to 14-membered heteroaryl, or 3- to 7-membered heterocyclyl; The C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl and C2-C6 haloalkynyl are then each independently selected from the group consisting of 1 to 3R 8Sa may be substituted by a substituent, The C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C6-C 14 Aryl, 5- to 14-membered heteroaryl and 3- to 7-membered heterocyclyl are then 1 to 3R 8Sc may be substituted by a substituent, and R 8Saare independently cyano, amino, nitro, hydroxyl, formyl, carboxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxy-C1-C6 alkoxy, C1-C6 alkoxycarbonyl, C1-C6 haloalkoxycarbonyl, C1-C6 alkylcarbonyl, C1-C6 haloalkylcarbonyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C1-C6 alkylsulfanyl, C1-C6 haloalkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, -O-Si(C1-C6 alkyl)3, -Si(C1-C6 alkyl)3, 3- to 7-membered heterocyclyl, and -N(R 32 )2 independently selected from the group consisting of: The 3- to 7-membered heterocyclyl may in turn be substituted by 1 to 3 substituents independently selected from the group C1 to C6 alkyl, R 32 are independently hydrogen, formyl, C1-C6 alkyl, C1-C6 haloalkyl, C3-C8 cycloalkyl or C1-C6 alkylcarbonyl; R 8Sc is independently selected from the group consisting of halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C1-C6 haloalkoxycarbonyl, C2-C6 alkenyl, C1-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, —O—Si(C1-C6 alkyl)3, and 3- to 7-membered heterocyclyl; The 3- to 7-membered heterocyclyl may in turn be substituted by 1 to 3 substituents independently selected from the group C1 to C6 alkyl, or 2nd Round 8ScThe substituents, together with the carbon atoms to which they are attached, may form a C3-C8 cycloalkyl ring or a 3- to 7-membered heterocyclyl ring; The 3- to 7-membered heterocyclyl ring may in turn be substituted with 1 to 3 substituents independently selected from the group C1 to C6 alkyl, p is 0, 1 or 2; Q is C6~C 14 Aryl, C3-C 12 carbocyclyl, 3- to 14-membered heterocyclyl, or 5- to 14-membered heteroaryl; C6~C 14 Aryl, C3-C 12 Carbocyclyl, 3- to 14-membered heterocyclyl or 5- to 14-membered heteroaryl may be substituted with 1 to 5 substituents Q S and optionally substituted by Q S is halogen, cyano, isocyano, nitro, hydroxyl, mercapto, formyl, carboxyl, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkylcarbonyl, C1-C6 haloalkylcarbonyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C1-C6 haloalkoxycarbonyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 Haloalkynyl, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C1-C6 alkylsulfanyl, C1-C6 haloalkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, C3-C8 cycloalkyl, C3-C8 cycloalkyloxy, C3-C6 cycloalkenyl, 3-membered to 7-membered heterocyclyl, C6-C 14 Aryl, 5- to 14-membered heteroaryl, -O-Si(C1-C6 alkyl)3, -Si(C1-C6 alkyl)3, -OC(=O)R 33 , -NR 34 C(=O)R 35 , -C(=O)N(R 36 )2, C(=S)R 37 , -C(=S)N(R38 )2, -C(=NR 39 )R 40 , -C(=NOR 41 )R 42 and -N(R 43 )2 independently selected from the group consisting of: The C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkylcarbonyl, C1-C6 haloalkylcarbonyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxy-C1-C6 alkyl, C1-C6 alkoxycarbonyl, C1-C6 haloalkoxycarbonyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C1-C6 alkylsulfanyl, C1-C6 haloalkylsulfanyl, C1-C6 alkylsulfinyl -Si(C1-C6 alkyl)3 and -Si(C1-C6 alkyl)3 are in turn optionally substituted by 1 to 3 substituents independently selected from the group consisting of cyano, amino, nitro, hydroxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C1-C6 haloalkoxycarbonyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; and The C3-C8 cycloalkyl, C3-C8 cycloalkoxy, C3-C6 cycloalkenyl, 3- to 7-membered heterocyclyl and 5- to 14-membered heteroaryl are each optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C1-C6 haloalkoxycarbonyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C2-C6 alkenyl and 3- to 7-membered heterocyclyl; The C3-C8 cycloalkyl, C3-C8 halocycloalkyl and 3- to 7-membered heterocyclyl may be further substituted by two substituents which, together with the carbon atoms to which they are attached, form a C3-C8 cycloalkyl; and R 33 , R 34 , R 35 , R 36 , R 37 , R 38 , R 39 , R 40 , R 41 and R 42 are independently hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, or C1-C6 alkoxy; The C1-C6 alkyl, C1-C6 haloalkyl and C1-C6 alkoxy may in turn be selected by 1 to 3 substituents independently selected from the group consisting of cyano, amino, nitro, hydroxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C1-C6 haloalkoxycarbonyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; and R 43 is hydrogen, hydroxyl, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl or C3-C8 cycloalkyl; The C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C2-C6 alkenyl and C2-C6 haloalkenyl may in turn be selected from the group consisting of cyano, amino, nitro, hydroxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C1-C6 haloalkoxycarbonyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; and The C3-C8 cycloalkyl is optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C1-C6 haloalkoxycarbonyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C2-C6 alkenyl, and 3- to 7-membered heterocyclyl; The C3-C8 cycloalkyl, C3-C8 halocycloalkyl and 3- to 7-membered heterocyclyl may be further substituted by two substituents which, together with the carbon atoms to which they are attached, form a C3-C8 cycloalkyl; or 2Q bonded to the same carbon atom S The substituents, together with the carbon atoms to which they are attached, form a C3-C8 cycloalkyl ring; The present invention relates to compounds, as well as N-oxides, salts, hydrates, and hydrates of the salts and N-oxides thereof.
[0011] The present invention further relates to a composition comprising at least one compound of formula (I) as defined herein and at least one agriculturally suitable adjuvant.
[0012] The present invention also relates to the use of a compound of formula (I) as defined herein or a composition as defined herein for controlling phytopathogenic fungi.
[0013] The present invention further relates to a method for controlling plant pathogenic fungi, comprising the step of applying to plants, plant parts, seeds, fruits or the soil in which the plants in need of treatment grow at least one compound of formula (I) as defined herein or a composition as defined herein.
[0014] The present invention also relates to processes and intermediates for preparing compounds of formula (I).
[0015] Unless otherwise stated, the following definitions apply to substituents and radicals used throughout the specification and claims. As used herein, the term "halogen" refers to a fluorine, chlorine, bromine, or iodine atom.
[0016] As used herein, the term "methylidene" refers to a CH2 group connected to a carbon atom via a double bond.
[0017] As used herein, the term "halomethylidene" refers to a CX2 group connected to a carbon atom via a double bond, where X is a halogen.
[0018] As used herein, the term "oxo" refers to an oxygen atom attached to a carbon or sulfur atom through a double bond.
[0019] As used herein, the term "formyl" refers to -CH(=O).
[0020] As used herein, the term "C1-C6 alkyl" refers to a saturated, branched, or straight hydrocarbon chain having 1, 2, 3, 4, 5, or 6 carbon atoms. Examples of C1-C6 alkyl include, but are not limited to, methyl, ethyl, propyl (n-propyl), 1-methylethyl (iso-propyl), butyl (n-butyl), 1-methylpropyl (sec-butyl), 2-methylpropyl (iso-butyl), 1,1-dimethylethyl (tert-butyl), pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, and 1-ethyl-2-methylpropyl. In particular, the hydrocarbon chain has 1, 2, 3 or 4 carbon atoms ("C1-C4 alkyl"), for example methyl, ethyl, propyl, iso-propyl, butyl, sec-butyl, iso-butyl or tert-butyl.
[0021] As used herein, the term "C1-C6 haloalkyl" refers to a C1-C6 alkyl group as defined above, in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different. Examples of C1-C6 haloalkyl include, but are not limited to, chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl, and 1,1,1-trifluoroprop-2-yl. Preferred are fluoromethyl, difluoromethyl, trifluoromethyl, fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl and 1,1,1-trifluoroprop-2-yl.
[0022] As used herein, the term "C1-C6 fluoroalkyl" refers to a C1-C6 alkyl group as defined above, in which one or more hydrogen atoms are replaced by one or more fluorine atoms, which may be the same or different. Examples of C1-C6 fluoroalkyl include, but are not limited to, monofluoromethyl, difluoromethyl, trifluoromethyl, 1-fluoroethyl, 1,1-difluoroethyl, 2,2-difluoroethyl, and 2,2,2-trifluoroethyl.
[0023] As used herein, the term "C1-C6 alkylene" refers to a divalent C1-C6 alkyl group, as defined herein. Examples of C1-C6 alkylene include, but are not limited to, methylene, 1,2-ethylene, 1,1-ethylene, 1,3-propylene, 1,2-propylene, 2,2-propylene, 1,4-butylene, 1,3-butylene, 1,2-butylene, 1,5-pentylene, and 1,6-hexylene.
[0024] As used herein, the terms "C3-C8 cycloalkyl" and "C3-C8 cycloalkyl ring" refer to a saturated monocyclic hydrocarbon ring containing 3, 4, 5, 6, 7, or 8 carbon atoms. Examples of C3-C8 cycloalkyl include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl. In particular, said cycloalkyl has 3 to 6 carbon atoms.
[0025] As used herein, the term "C3-C8 halocycloalkyl" refers to a saturated hydrocarbon ring system in which all ring members, varying from 3 to 8, are carbon atoms and in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.
[0026] As used herein, the term "C2-C6 alkenyl" refers to an unsaturated branched or straight hydrocarbon chain having 2, 3, 4, 5, or 6 carbon atoms and comprising at least one double bond. Examples of C2-C6 alkenyl include ethenyl (or "vinyl"), prop-2-en-1-yl (or "allyl"), prop-1-en-1-yl, but-3-enyl, but-2-enyl, but-1-enyl, pent-4-enyl, pent-3-enyl, pent-2-enyl, pent-1-enyl, hex-5-enyl, hex-4-enyl, hex-3-enyl, hex-2-enyl, hex-1-enyl, prop-1-en-2- ... or "isopropenyl") group, 2-methylprop-2-enyl group, 1-methylprop-2-enyl group, 2-methylprop-1-enyl group, 1-methylprop-1-enyl group, 3-methylbut-3-enyl group, 2-methylbut-3-enyl group, 1-methylbut-3-enyl group, 3-methylbut-2-enyl group, 2-methylbut-2-enyl group, 1-methylbut-2-enyl group, 3-methylbut-1-enyl group, 2-methylbut-1-enyl group, 1-methylbut-1-enyl group, 1,1-dimethylprop-2-enyl group, 1-ethylprop-1-enyl group, 1-propylvinyl group, 1-isopropylvinyl group, 4-methylpent-4-enyl group, 3-methylpent-4-enyl group, 2-methylpent-4-enyl group, 1-methylpent-4-enyl group, 4-methylpent-3-enyl group, 3-methylpent-3-enyl group, 2-methylpent-3-enyl group, 1-methylpent pent-3-enyl group, 4-methylpent-2-enyl group, 3-methylpent-2-enyl group, 2-methylpent-2-enyl group, 1-methylpent-2-enyl group, 4-methylpent-1-enyl group, 3-methylpent-1-enyl group, 2-methylpent-1-enyl group, 1-methylpent-1-enyl group, 3-ethylbut-3-enyl group, 2-ethylbut-3-enyl group, 1-ethylbut-3 -enyl group, 3-ethylbut-2-enyl group, 2-ethylbut-2-enyl group, 1-ethylbut-2-enyl group, 3-ethylbut-1-enyl group, 2-ethylbut-1-enyl group, 1-ethylbut-1-enyl group, 2-propylprop-2-enyl group, 1-propylprop-2-enyl group, 2-isopropylprop-2-enyl group, 1-isopropylprop-2-enyl group, 2-propylprop Examples of the alkyl group include, but are not limited to, 1-prop-1-enyl, 1-propylprop-1-enyl, 2-isopropylprop-1-enyl, 1-isopropylprop-1-enyl, 3,3-dimethylprop-1-enyl, 1-(1,1-dimethylethyl)ethenyl, buta-1,3-dienyl, penta-1,4-dienyl, hexa-1,5-dienyl, or methylhexadienyl.
[0027] As used herein, the term "C2-C6 alkynyl" refers to a branched or straight hydrocarbon chain having 2, 3, 4, 5, or 6 carbon atoms and comprising at least one triple bond. Examples of C2-C6 alkynyl include ethynyl, prop-1-ynyl, prop-2-ynyl (or "propargyl"), but-1-ynyl, but-2-ynyl, but-3-ynyl, pent-1-ynyl, pent-2-ynyl, pent-3-ynyl, pent-4-ynyl, hex-1-ynyl, hex-2-ynyl, hex-3-ynyl, hex-4-ynyl, hex-5-ynyl, 1-methylprop-2-ynyl, 2-methylbut-3-ynyl, 1-methylbut-3-ynyl, 1-methylbut-2-ynyl, 3-methylbut-1-ynyl, 1-ethylprop-2-ynyl, 3-methylpent-4-ynyl, 2-methylpent-5-ynyl, 1-methylprop-2-ynyl, 2 ...but-2-ynyl, 1-methylbut-3-ynyl, 1-methylbut-2-ynyl, 3-methylpent-4-ynyl, 2-methylpent-5-ynyl, 1-methylbut-2-ynyl, 1-methylpent-5-ynyl, 1-methylbut-2-ynyl, 1-methylpent-5-ynyl, 1-methylpent-5-ynyl, 1-methylpent-5-ynyl, 1-methylpent-5-ynyl, 1-methylpent- Examples of such alkyl groups include, but are not limited to, ethylpent-4-ynyl, 1-methylpent-4-ynyl, 2-methylpent-3-ynyl, 1-methylpent-3-ynyl, 4-methylpent-2-ynyl, 1-methylpent-2-ynyl, 4-methylpent-1-ynyl, 3-methylpent-1-ynyl, 2-ethylbut-3-ynyl, 1-ethylbut-3-ynyl, 1-ethylbut-2-ynyl, 1-propylprop-2-ynyl, 1-isopropylprop-2-ynyl, 2,2-dimethylbut-3-ynyl, 1,1-dimethylbut-3-ynyl, 1,1-dimethylbut-2-ynyl, and 3,3-dimethylbut-1-ynyl.
[0028] As used herein, the term "C2-C6 haloalkenyl" refers to a C2-C6 alkenyl group as defined above, in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.
[0029] As used herein, the term "C2-C6 haloalkynyl" refers to a C2-C6 alkynyl group as defined above, in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.
[0030] As used herein, the term "C2-C6 alkenylene" refers to a divalent C2-C6 alkenyl group, as defined herein. Examples of C2-C6 alkenylene include, but are not limited to, ethenylene, 1,3-propenylene, butenylene, pentenylene, and hexenylene.
[0031] As used herein, the term "C2-C6 alkynylene" refers to a divalent C2-C6 alkynyl group, as defined herein. Examples of C2-C6 alkynylene include, but are not limited to, ethynylene, 1,3-propynylene, butynylene, pentynylene, hexynylene, and the like.
[0032] As used herein, the term "C1-C6 alkoxy" refers to a group of the formula (C1-C6 alkyl)-O-, where the term "C1-C6 alkyl" is as defined herein. Examples of C1-C6 alkoxy include methoxy, ethoxy, n-propoxy, 1-methylethoxy, n-butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, n-pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, n-hexyloxy, 1-methylpentoxy, and 2-methylpentoxy. , 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy, and 1-ethyl-2-methylpropoxy. This also applies to alkoxy, e.g., alkoxyalkyl, alkoxyalkoxy, as part of a compound substituent, unless otherwise defined.
[0033] As used herein, the term "C1-C6 haloalkoxy" refers to a C1-C6 alkoxy group as defined above, in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different. Examples of C1-C6 haloalkoxy include, but are not limited to, chloromethoxy, bromomethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 1-chloroethoxy, 1-bromoethoxy, 1-fluoroethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy, and 1,1,1-trifluoroprop-2-oxy.
[0034] As used herein, the term "C1-C6 hydroxyalkyl" refers to a C1-C6 alkyl group as defined above, in which at least one hydrogen atom is replaced by a hydroxyl group. Examples of C1-C6 hydroxyalkyl include, but are not limited to, hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl, 1,2-dihydroxyethyl, 3-hydroxypropyl, 2-hydroxypropyl, 1-hydroxypropyl, 1-hydroxypropan-2-yl, 2-hydroxypropan-2-yl, 2,3-dihydroxypropyl, and 1,3-dihydroxypropan-2-yl.
[0035] As used herein, the term "C3-C8 cycloalkoxy" refers to a monocyclic saturated cycloalkoxy radical having 3 to 8, preferably 3 to 6, carbon ring members, such as (but not limited to) cyclopropyloxy, cyclobutyloxy, cyclopentyloxy, and cyclohexyloxy. This also applies to cycloalkoxy as part of a compound substituent, e.g., cycloalkoxyalkyl, unless otherwise defined.
[0036] As used herein, the term "C2-C6 alkenyloxy" refers to the formula (C2-C6 alkenyl)-O-, where the term "C1-C6 alkenyl" is as defined herein. Examples of C2-C6 alkenyl include ethenyloxy (or "vinyloxy"), prop-2-en-1-yloxy (or "allyl"), prop-1-en-1-yloxy, but-3-enyloxy, but-2-enyloxy, but-1-enyloxy, pent-4-enyloxy, pent-3-enyloxy, pent-2-enyloxy, pent-1-enyloxy, hex-5-enyloxy, hex-4-enyloxy, hex-3-enyloxy, hex-2-enyloxy, hex-1-enyloxy, prop-1-en-2-yl, Oxy (or "isopropenyloxy"), 2-methylprop-2-enyloxy, 1-methylprop-2-enyloxy, 2-methylprop-1-enyloxy, 1-methylprop-1-enyloxy, 3-methylbut-3-enyloxy, 2-methylbut-3-enyloxy, 1-methylbut-3-enyloxy, 3-methylbut-2-enyloxy, 2-methylbut-2-enyloxy, 1-methylbut-2-enyloxy, 3-methylbut-1-enyloxy, 2-methylbut-1-enyloxy, 1-methylbut-1-enyloxy, 1,1-dimethylprop-2-enyloxy, 1-ethylprop-1-enyloxy, 1-propylvinyloxy, 1-isopropylvinyloxy, 4-methylpent-4-enyloxy, 3-methylpent-4-enyloxy, 2-methylpent-4-enyloxy, 1-methylpent-4-enyloxy, 4-methylpent-3-enyloxy, 3-methylpent-3-enyloxy, 2-methylpent-3-enyloxy, 1-methylpent but-3-enyloxy, 4-methylpent-2-enyloxy, 3-methylpent-2-enyloxy, 2-methylpent-2-enyloxy, 1-methylpent-2-enyloxy, 4-methylpent-1-enyloxy, 3-methylpent-1-enyloxy, 2-methylpent-1-enyloxy, 1-methylpent-1-enyloxy, 3-ethylbut-3-enyloxy, 2-ethylbut-3-enyloxy, 1-ethylbut-3 -enyloxy, 3-ethylbut-2-enyloxy, 2-ethylbut-2-enyloxy, 1-ethylbut-2-enyloxy, 3-ethylbut-1-enyloxy, 2-ethylbut-1-enyloxy, 1-ethylbut-1-enyloxy, 2-propylprop-2-enyloxy, 1-propylprop-2-enyloxy, 2-isopropylprop-2-enyloxy, 1-isopropylprop-2-enyloxy, 2-propylprop Examples of the alkoxy group include, but are not limited to, 1-prop-1-enyloxy, 1-propylprop-1-enyloxy, 2-isopropylprop-1-enyloxy, 1-isopropylprop-1-enyloxy, 3,3-dimethylprop-1-enyloxy, 1-(1,1-dimethylethyl)ethenyloxy, buta-1,3-dienyloxy, penta-1,4-dienyloxy, hexa-1,5-dienyloxy, or methylhexadienyloxy groups.
[0037] As used herein, the term "C-C haloalkenyloxy" refers to a (C-C alkenyl)-O- group as defined above in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.
[0038] As used herein, the term "C2-C6 haloalkynyloxy" refers to a (C2-C6 alkynyl)-O- group as defined above in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.
[0039] As used herein, the term "C1-C6 alkylsulfanyl" refers to a saturated straight or branched chain group of formula (C1-C6 alkyl)-S-, where the term "C1-C6 alkyl" is as defined herein. Examples of C1-C6 alkylsulfanyl include, but are not limited to, methylsulfanyl, ethylsulfanyl, propylsulfanyl, isopropylsulfanyl, butylsulfanyl, sec-butylsulfanyl, isobutylsulfanyl, tert-butylsulfanyl, pentylsulfanyl, isopentylsulfanyl, and hexylsulfanyl.
[0040] As used herein, the term "C1-C6 haloalkylsulfanyl" refers to C1-C6 alkylsulfanyl as defined above, in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.
[0041] As used herein, the term "C3-C8 cycloalkylsulfanyl" refers to a saturated monovalent monocyclic hydrocarbon ring containing 3, 4, 5, 6, 7, or 8 carbon atoms and attached to a backbone via a sulfur atom. Examples of monocyclic C3-C8 cycloalkylsulfanyl include, but are not limited to, cyclopropylsulfanyl, cyclobutylsulfanyl, cyclopentylsulfanyl, cyclohexylsulfanyl, cycloheptylsulfanyl, or cyclooctylsulfanyl.
[0042] As used herein, the term "C1-C6 alkylsulfinyl" represents a saturated straight or branched chain group of formula (C1-C6 alkyl)-S(=O)-, where the term "C1-C6 alkyl" is as defined herein. Examples of C1-C6 alkylsulfinyl include saturated straight or branched chain alkylsulfinyl radicals having 1 to 8, preferably 1 to 6, and more preferably 1 to 4 carbon atoms, such as (but not limited to), methylsulfinyl, ethylsulfinyl, propylsulfinyl, 1-methylethylsulfinyl, butylsulfinyl, 1-methylpropylsulfinyl, 2-methylpropylsulfinyl, 1,1-dimethylethylsulfinyl, pentylsulfinyl, 1-methylbutylsulfinyl, 2-methylbutylsulfinyl, 3-methylbutylsulfinyl, 2,2-dimethylpropylsulfinyl, 1-ethylpropylsulfinyl, 1,1-dimethylpropylsulfinyl, 1,2-dimethylpropylsulfinyl, hexyl ... C1-C6 alkylsulfinyl such as silsulfinyl, 1-methylpentylsulfinyl, 2-methylpentylsulfinyl, 3-methylpentylsulfinyl, 4-methylpentylsulfinyl, 1,1-dimethylbutylsulfinyl, 1,2-dimethylbutylsulfinyl, 1,3-dimethylbutylsulfinyl, 2,2-dimethylbutylsulfinyl, 2,3-dimethylbutylsulfinyl, 3,3-dimethylbutylsulfinyl, 1-ethylbutylsulfinyl, 2-ethylbutylsulfinyl, 1,1,2-trimethylpropylsulfinyl, 1,2,2-trimethylpropylsulfinyl, 1-ethyl-1-methylpropylsulfinyl and 1-ethyl-2-methylpropylsulfinyl.
[0043] As used herein, the term "C1-C6 haloalkylsulfinyl" refers to a C1-C6 alkylsulfinyl as defined above, in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.
[0044] As used herein, the term "C3-C8 cycloalkylsulfinyl" refers to a saturated monovalent monocyclic hydrocarbon ring containing 3, 4, 5, 6, 7, or 8 carbon atoms and attached to a backbone via an -S(=O)- group. Examples of monocyclic C3-C8 cycloalkylsulfinyl include, but are not limited to, cyclopropylsulfinyl, cyclobutylsulfinyl, cyclopentylsulfinyl, cyclohexylsulfinyl, cycloheptylsulfinyl, or cyclooctylsulfinyl.
[0045] As used herein, the term "C1-C6 alkylsulfonyl" refers to a saturated straight or branched chain group of the formula (C1-C6 alkyl)-S(=O)2-, where "C1-C6 alkyl" is as defined herein. Examples of C1-C6 alkylsulfonyl include methylsulfonyl, ethylsulfonyl, propylsulfonyl, 1-methylethylsulfonyl, butylsulfonyl, 1-methylpropylsulfonyl, 2-methylpropylsulfonyl, 1,1-dimethylethylsulfonyl, pentylsulfonyl, 1-methylbutylsulfonyl, 2-methylbutylsulfonyl, 3-methylbutylsulfonyl, 2,2-dimethylpropylsulfonyl, 1-ethylpropylsulfonyl, 1,1-dimethylpropylsulfonyl, 1,2-dimethylpropylsulfonyl, hexylsulfonyl, 1-methylpentylsulfonyl, 2-methylpentylsulfonyl, 1 ... butylsulfonyl, 3-methylpentylsulfonyl, 4-methylpentylsulfonyl, 1,1-dimethylbutylsulfonyl, 1,2-dimethylbutylsulfonyl, 1,3-dimethylbutylsulfonyl, 2,2-dimethylbutylsulfonyl, 2,3-dimethylbutylsulfonyl, 3,3-dimethylbutylsulfonyl, 1-ethylbutylsulfonyl, 2-ethylbutylsulfonyl, 1,1,2-trimethylpropylsulfonyl, 1,2,2-trimethylpropylsulfonyl, 1-ethyl-1-methylpropylsulfonyl and 1-ethyl-2-methylpropylsulfonyl.
[0046] As used herein, the term "C1-C6 haloalkylsulfonyl" refers to C1-C6 alkylsulfonyl as defined above, in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.
[0047] As used herein, the term "C3-C8 cycloalkylsulfonyl" refers to a saturated monovalent monocyclic hydrocarbon ring containing 3, 4, 5, 6, 7, or 8 carbon atoms and attached to a backbone via an -S(=O)2- group. Examples of monocyclic C3-C8 cycloalkylsulfonyl include, but are not limited to, cyclopropylsulfonyl, cyclobutylsulfonyl, cyclopentylsulfonyl, cyclohexylsulfonyl, cycloheptylsulfonyl, or cyclooctylsulfonyl.
[0048] As used herein, the term "C1-C6 alkylcarbonyl" refers to a saturated straight or branched chain group of formula (C1-C6 alkyl)-C(=O)-, where the term "C1-C6 alkyl" is as defined herein.
[0049] As used herein, the term "C1-C6 haloalkylcarbonyl" refers to a C1-C6 alkylcarbonyl as defined above in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.
[0050] As used herein, the term "C1-C6 alkylcarbonyloxy" refers to a saturated straight or branched chain group of formula (C1-C6 alkyl)-C(=O)-, where the term "C1-C6 alkyl" is as defined herein.
[0051] As used herein, the term "C1-C6 alkoxycarbonyl" refers to a saturated straight or branched chain group of formula (C1-C6 alkoxy)-C(=O)-, where the term "C1-C6 alkoxy" is as defined herein.
[0052] As used herein, the term "C1-C6 haloalkoxycarbonyl" refers to a C1-C6 alkoxycarbonyl as defined above in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.
[0053] As used herein, the term "mono-(C1-C6 alkyl)amino" refers to an amino radical having one C1-C6 alkyl group, as defined herein. Examples of mono-(C1-C6 alkyl)amino include, but are not limited to, N-methylamino, N-ethylamino, N-isopropylamino, Nn-propylamino, N-isopropylamino, and N-tert-butylamino.
[0054] As used herein, the term "di-(C1-C6)alkylamino" refers to an amino radical having two independently selected C1-C6 alkyl groups, as defined herein. Examples of C1-C6-dialkylamino include, but are not limited to, N,N-dimethylamino, N,N-diethylamino, N,N-diisopropylamino, N-ethyl-N-methylamino, N-methyl-Nn-propylamino, N-isopropyl-Nn-propylamino, and N-tert-butyl-N-methylamino.
[0055] As used herein, the term "C3-C 12 "Carbocyclyl" refers to a saturated or partially unsaturated hydrocarbon ring system, of which all ring members, varying from 3 to 12, are carbon atoms. The ring system may be monocyclic or polycyclic (fused, spiro, or bridged). C3-C 12 Carbocyclyl: C3-C 12 Cycloalkyl (monocyclic or bicyclic), C3-C 12Examples include, but are not limited to, cycloalkenyl (monocyclic or bicyclic), bicyclic systems comprising an aryl (e.g., phenyl) fused to a monocyclic C3-C8 cycloalkyl (e.g., tetrahydronaphthalenyl, indanyl, 3-bicyclo[4.2.0]octa-1,3,5-trienyl), bicyclic systems comprising an aryl (e.g., phenyl) fused to a monocyclic C3-C8 cycloalkenyl (e.g., indenyl, dihydronaphthalenyl), and tricyclic systems comprising a cyclopropyl connected by one carbon atom to a bicyclic system comprising an aryl (e.g., phenyl) fused to a C3-C8 cycloalkyl or C3-C8 cycloalkenyl. 12 The carbocyclyl can be attached to the parent molecular moiety through any carbon atom.
[0056] As used herein, the term "C3-C 12 "Cycloalkenyl" refers to an unsaturated monovalent monocyclic or bicyclic hydrocarbon ring containing 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 carbon atoms and 1 or 2 double bonds. Examples of monocyclic C3-C8 cycloalkenyl groups include, but are not limited to, cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, and cyclooctenyl groups. Bicyclic C6-C8 12 Examples of cycloalkenyl groups include, but are not limited to, 3-bicyclo[4.2.0]octa-1,3,5-trienyl, bicyclo[2.2.1]hept-2-enyl, or bicyclo[2.2.2]oct-2-enyl.
[0057] As used herein, the term "C6-C 14 "Aryl" refers to an aromatic hydrocarbon ring system in which all of the ring members, varying from 6 to 14, preferably 6 to 10, are carbon atoms. The ring system may be monocyclic or fused polycyclic (e.g., bicyclic or tricyclic). Examples of aryl include, but are not limited to, phenyl, azulenyl, and naphthyl.
[0058] As used herein, the term "3- to 14-membered heterocyclyl" refers to a saturated or partially unsaturated 3-, 4-, 5-, 6-, 7-, 8-, 9-, 10-, 11-, 12-, 13-, or 14-membered ring system comprising 1 to 4 heteroatoms independently selected from the group consisting of oxygen, nitrogen, and sulfur. If the ring system contains more than one oxygen atom, they are not immediately adjacent. Heterocycles include, but are not limited to, 3- to 7-membered monocyclic heterocycles and 8- to 14-membered polycyclic (e.g., bicyclic or tricyclic) heterocycles. The 3- to 14-membered heterocycle can be attached to the parent molecular moiety through any carbon or nitrogen atom contained within the heterocycle. Examples of saturated heterocycles include three-membered rings such as oxiranyl and aziridinyl, four-membered rings such as azetidinyl, oxetanyl, and thietanyl, five-membered rings such as tetrahydrofuranyl, 1,3-dioxolanyl, tetrahydrothienyl, pyrrolidinyl, pyrazolidinyl, imidazolidinyl, triazolidinyl, isoxazolidinyl, oxazolidinyl, oxadiazolidinyl, thiazolidinyl, isothiazolidinyl, and thiadiazolidinyl, piperidinyl, hexahydropyridazinyl, hexahydropyrimidinyl, and the like. Examples of unsaturated heterocycles include, but are not limited to, 6-membered rings such as dihydrofuranyl, 1,3-dioxolyl, dihydrothienyl, pyrrolinyl, dihydroimidazolyl, dihydropyrazolyl, isoxazolinyl, dihydrooxazolyl, and dihydrothiazolyl, or 6-membered rings such as pyranyl, thiopyranyl, thiazinyl, and thiadiazinyl.A bicyclic heterocycle may consist of a monocyclic heteroaryl as defined herein fused to a monocyclic C-C cycloalkyl, a monocyclic C-C cycloalkenyl, or a monocyclic heterocycle, or may consist of a monocyclic heterocycle fused to either an aryl (e.g., phenyl), a C-C cycloalkyl, a C-C cycloalkenyl, or a monocyclic heterocycle. When two monocyclic heterocycles or one monocyclic heterocycle and one monocyclic heteroaryl comprising a nitrogen atom are fused, the nitrogen atom may be in a bridgehead position (e.g., 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydroimidazo[1,2-a]pyridinyl). A tricyclic heterocycle may consist of a monocyclic cycloalkyl attached via one common atom to a bicyclic heterocycle.
[0059] As used herein, the terms "3- to 7-membered heterocyclyl" and "3- to 7-membered heterocyclyl ring" refer to a saturated 3-, 4-, 5-, 6-, or 7-membered ring system comprising one, two, or three heteroatoms independently selected from the group consisting of oxygen, nitrogen, and sulfur. Examples include oxiranyl, aziridinyl, azetidinyl, oxetanyl, thietanyl, tetrahydrofuranyl, 1,3-dioxolanyl, tetrahydrothienyl, pyrrolidinyl, pyrazolidinyl, imidazolidinyl, triazolidinyl, isoxazolidinyl, oxazolidinyl, oxadiazolidinyl, thiazolidinyl, isothiazolidinyl, thiadiazolidinyl, piperidinyl, hexahydropyridazinyl, hexahydropyrimidinyl, piperazinyl, hexahydropyridazinyl, hexahydropyrimid ... Preferred 3- to 7-membered heterocyclyls include, but are not limited to, 1,2-oxazinanyl, 1,3-dioxolanyl, 1,4-dioxolan ...
[0060] As used herein, the term "5- to 14-membered heteroaryl" refers to an aromatic ring system containing 1 to 4 heteroatoms independently selected from the group consisting of oxygen, nitrogen, and sulfur. If the ring system contains more than one oxygen atom, they are not immediately adjacent. Aromatic heterocycles include 5- or 6-membered monocyclic heteroaryls and 7- to 14-membered polycyclic (e.g., bicyclic or tricyclic) heteroaryls. The 5- to 14-membered heteroaryls can be attached to the parent molecular moiety through any carbon or nitrogen atom contained within the heterocycle.
[0061] As used herein, the term "5- or 6-membered heteroaryl" refers to a 5- or 6-membered aromatic monocyclic ring system containing 1, 2, 3, or 4 heteroatoms independently selected from the group consisting of oxygen, nitrogen, and sulfur. Examples of 5-membered monocyclic heteroaryls include, but are not limited to, furyl (furanyl), thienyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl, tetrazolyl, isoxazolyl, oxazolyl, oxadiazolyl, oxatriazolyl, isothiazolyl, thiazolyl, thiadiazolyl, and thiatriazolyl. Examples of 6-membered monocyclic heteroaryls include, but are not limited to, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, and tetrazinyl.
[0062] As used herein, the term "7- to 14-membered heteroaryl" refers to a 7-, 8-, 9-, 10-, 11-, 12-, 13-, or 14-membered aromatic polycyclic (e.g., bicyclic or tricyclic) ring system containing 1, 2, or 3 heteroatoms independently selected from the group consisting of oxygen, nitrogen, and sulfur. As defined herein, a bicyclic heteroaryl can consist of a monocyclic heteroaryl fused to an aryl (e.g., phenyl) or monocyclic heteroaryl. Examples of bicyclic heteroaryls include, but are not limited to, 9-membered rings such as indolyl, indolizinyl, isoindolyl, benzimidazolyl, imidazopyridinyl, indazolyl, benzotriazolyl, purinyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, and benzisoxazolyl, or 10-membered rings such as quinolinyl, isoquinolinyl, cinnolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, naphthyridinyl, pteridinal, and benzodioxinyl. In a 9- or 10-membered bicyclic heteroaryl comprising two fused 5- or 6-membered monocyclic heteroaryls, the nitrogen atom may be in a bridgehead position (e.g., imidazo[1,2-a]pyridinyl, [1,2,4]triazolo[4,3-a]pyridinyl, imidazo[1,2-a]pyridinyl, imidazo[2,1-b]oxazolyl, furo[2,3-d]isoxazolyl). Examples of tricyclic aromatic heterocycles include, but are not limited to, carbazolyl, acridinyl, and phenazinyl.
[0063] As used herein, the term "C3-C 12 carbocyclyloxy, C3-C8 cycloalkoxy, C6-C 14 "aryloxy," "5- to 14-membered heteroaryloxy," and "3- to 14-membered heterocyclyloxy" are each a C3-C6 alkyl group as defined herein. 12 Carbocyclyl group, C3-C8 cycloalkyl group, C6-C 14 represents a group of formula -OR, which is an aryl group, a 5- to 14-membered heteroaryl group, or a 3- to 14-membered heterocyclyl group.
[0064] As used herein, the term "C3-C 12 Carbocyclylsulfanyl, C6-C 14 "5- to 14-membered heteroarylsulfanyl," "5- to 14-membered heteroarylsulfanyl," and "3- to 14-membered heterocyclylsulfanyl" are each a C3-C6 alkyl group as defined herein. 12 Carbocyclyl, C6-C 14 represents a group of formula -SR, which is an aryl, 5- to 14-membered heteroaryl, or 3- to 14-membered heterocyclyl group.
[0065] As used herein, the term "C3-C 12 Carbocyclylsulfinyl, C6-C 14 "5- to 14-membered heteroarylsulfinyl," "5- to 14-membered heteroarylsulfinyl," and "3- to 14-membered heterocyclylsulfinyl" are each defined as a C3-C6 alkyl group, as defined herein. 12 Carbocyclyl, C6-C 14 represents a group of the formula -(S=O)-R, which is an aryl, 5- to 14-membered heteroaryl, or 3- to 14-membered heterocyclyl group.
[0066] As used herein, the term "C3-C 12 Carbocyclylsulfonyl, C6-C 14 "arylsulfonyl," "5- to 14-membered heteroarylsulfonyl," and "3- to 14-membered heterocyclylsulfonyl" are each a C3-C6 alkyl group as defined herein. 12 Carbocyclyl, C6-C 14 represents a group of the formula -(S=O)2-R, which is an aryl, 5- to 14-membered heteroaryl, or 3- to 14-membered heterocyclyl group.
[0067] As used herein, the term "leaving group" shall be understood to mean a group that is displaced from a compound in a substitution or elimination reaction, e.g., a halogen atom, a trifluoromethanesulfonate ("triflate") group, an alkoxy, a methanesulfonate, or a p-toluenesulfonate.
[0068] Compounds resulting from combinations that violate the laws of nature and would therefore be excluded by a person skilled in the art based on their specialized knowledge are not encompassed herein, for example, ring structures having three or more adjacent oxygen atoms are excluded.
[0069] Compounds of formula (I) may suitably be in their free form, in the form of a salt, an N-oxide or in the form of a solvate (eg a hydrate).
[0070] Depending on the nature of the substituents, the compound of formula (I) can exist in different stereoisomeric forms.These stereoisomers are, for example, enantiomers, diastereomers, atropisomers, or geometric isomers.Therefore, the present invention encompasses both pure stereoisomers and any mixtures of these isomers.If a compound can exist in equilibrium in two or more tautomeric forms, a reference to a compound by describing one tautomer is considered to include all tautomeric forms.
[0071] Any of the compounds of the present invention can also exist in one or more geometric isomeric forms, depending on the number of double bonds in the compound. Geometric isomers, depending on the nature of the substituents on the double bond or ring, can exist in cis (=Z-) or trans (=E-) form. Thus, the present invention equally relates to all geometric isomers and all possible mixtures in all ratios.
[0072] Depending on the nature of the substituents, the compounds of formula (I) may exist in the form of the free compounds and / or their salts, such as pesticidal active salts.
[0073] Pesticide active salts include acid addition salts of inorganic and organic acids and salts of conventional bases. Examples of inorganic acids are hydrohalic acids such as hydrogen fluoride, hydrogen chloride, hydrogen bromide, and hydrogen iodide, sulfuric acid, phosphoric acid, nitric acid, and acid salts such as sodium bisulfate and potassium bisulfate. Useful organic acids include, for example, formic acid, alkanoic acids (carbonic acid, acetic acid, trifluoroacetic acid, trichloroacetic acid, and propionic acid), glycolic acid, thiocyanic acid, lactic acid, succinic acid, citric acid, benzoic acid, cinnamic acid, oxalic acid, saturated or mono- or di-unsaturated fatty acids having 6 to 20 carbon atoms, alkyl sulfate monoesters, alkyl sulfonic acids (sulfonic acids having a linear or branched alkyl group having 1 to 20 carbon atoms), aryl sulfonic acids or aryl disulfonic acids (phenyl sulfonates having one or two sulfonic acid groups). and naphthyl), alkylphosphonic acids (phosphonic acids with linear or branched alkyl radicals having 1 to 20 carbon atoms), and arylphosphonic or aryldiphosphonic acids (aromatic radicals such as phenyl and naphthyl with one or two phosphonic acid radicals) (the alkyl and aryl groups may have further substituents, e.g., p-toluenesulfonic acid, salicylic acid, p-aminosalicylic acid, 2-phenoxybenzoic acid, 2-acetoxybenzoic acid, etc.).
[0074] Solvates of the compounds of the invention or their salts are stoichiometric compositions of the compound and a solvent.
[0075] The compounds of the present invention may exist in multiple crystalline and / or amorphous forms. Crystalline forms include unsolvated crystalline forms, solvates, and hydrates.
[0076] Preferably, the present invention relates to a compound of formula (I), wherein: A 2 are O, C(=O), NR 1 Or CR 2A R R2B and R 1is hydrogen, C1-C4 alkyl or formyl, R 2A and R 2B is hydrogen, C1-C4 alkyl or C3-C6 cycloalkyl, m is 0, 1, or 2; R 3 and R 4 are independently hydrogen, fluoro, chloro, C1-C4 alkyl, C1-C4 alkylcarbonyl, C1-C4 alkylcarbonyloxy, C2-C4 alkenyl, C2-C4 alkynyl or C3-C4 cycloalkyl; C1-C4 alkyl, C1-C4 alkylcarbonyl, C1-C4 alkylcarbonyloxy, C2-C4 alkenyl and C2-C4 alkynyl are optionally substituted by 1 or 2 substituents independently selected from the group consisting of fluoro, chloro, hydroxyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C3-C6 cycloalkyl and C3-C6 halocycloalkyl; and C3-C6 cycloalkyl is optionally substituted by 1 or 2 substituents independently selected from the group consisting of fluoro, chloro, hydroxyl, oxo, methylidene, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C3-C6 cycloalkyl and C3-C6 halocycloalkyl; R 5 is hydrogen or C1-C4 alkyl, T is hydrogen or C1-C4 alkyl; L is a direct bond, a C1-C6 alkylene, or a group of the formula:
[0077] [ka]
[0078] is a group of the formula The C1-C6 alkylene may be substituted with 1 to 3 substituents L SA and optionally substituted by ## is the point of attachment to the heterocyclyl moiety; ### is R 6 It is the connection point with L 1 is a direct bond or C1-C6 alkylene, L 2 is a direct bond or C1-C6 alkylene, E is a C3-C8 cycloalkyl or a 3- to 7-membered heterocyclyl; The C3-C8 cycloalkyl and 3- to 7-membered heterocyclyl are then each selected from 1 to 3 substituents L SC and optionally substituted by and L SA are independently fluoro, chloro, hydroxyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C3-C6 cycloalkyl or C3-C6 halocycloalkyl; or Two substituents L attached to the same carbon atom SA together with the carbon atoms to which they are attached form a C3-C6 cycloalkyl ring or a 3- to 7-membered heterocyclyl ring; L SC are independently fluoro, chloro, hydroxyl, oxo, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C3-C6 cycloalkyl and C3-C6 halocycloalkyl; R 6 is C5~C 10 Carbocyclyl, phenyl, naphthyl, 5- to 10-membered heterocyclyl, 5- to 10-membered heteroaryl, C5-C 10 Carbocyclyloxy, phenoxy, naphthyloxy, 5- to 10-membered heteroaryloxy, 5- to 10-membered heterocyclyloxy, C5-C 10 carbocyclylsulfanyl, phenylsulfanyl, naphthylsulfanyl, 5- to 10-membered heteroarylsulfanyl, 5- to 10-membered heterocyclylsulfanyl, C1-C3 alkoxy or C1-C3 haloalkoxy; C1-C3 alkoxy and C1-C3 haloalkoxy are C5-C 10 substituted by one substituent selected from the group consisting of carbocyclyl, phenyl, naphthyl, 5- to 10-membered heterocyclyl, and 5- to 10-membered heteroaryl; Said C5~C 10 Carbocyclyl, phenyl, naphthyl, 5- to 10-membered heterocyclyl and 5- to 10-membered heteroaryl are then 1 to 3R 6S may be substituted by a substituent, C5~C 10 Carbocyclyl, phenyl, naphthyl, 5- to 10-membered heterocyclyl, 5- to 10-membered heteroaryl, C5-C 10 Carbocyclyloxy, phenoxy, naphthyloxy, 5- to 10-membered heteroaryloxy, 5- to 10-membered heterocyclyloxy, C5-C 10 Carbocyclylsulfanyl, phenylsulfanyl, naphthylsulfanyl, 5- to 10-membered heteroarylsulfanyl and 5- to 10-membered heterocyclylsulfanyl are 1-3R 6S may be substituted by a substituent, R 6S is halogen, cyano, hydroxyl, mercapto, pentafluorosulfanyl, oxo, methylidene, halomethylidene, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C1-C4 alkylsulfanyl, C1-C4 haloalkylsulfanyl, C3-C6 cycloalkylsulfanyl, C3-C6 cycloalkyl, C3-C6 cycloalkyloxy, phenyl, 5- or 6-membered heteroaryl, 3- to 7-membered heterocyclyl, -C(=O)R 16 , -C(=O)(OR 17 ) and -C(=O)N(R 18 )2 independently selected from the group consisting of: C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C1-C4 alkylsulfanyl and C1-C4 haloalkylsulfanyl are optionally further substituted by 1 to 3 substituents independently selected from the group consisting of hydroxyl, C1-C4 alkoxy, C1-C4 haloalkoxy, -Si(C1-C6 alkyl)3, C3-C6 cycloalkyl and C3-C6 halocycloalkyl; and C3-C6 cycloalkylsulfanyl, C3-C6 cycloalkyl, C3-C6 cycloalkyloxy, phenyl, 5- or 6-membered heteroaryl and 3- to 7-membered heterocyclyl are optionally further substituted by 1 to 4 substituents independently selected from the group consisting of fluoro, chloro, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy and C1-C4 haloalkoxy; and R 16 , R 17 and R 18 are independently hydrogen, C1-C4 alkyl, or C1-C4 haloalkyl; The C1-C4 alkyl and C1-C4 haloalkyl may in turn be substituted with 1 to 3 substituents independently selected from the group consisting of hydroxyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C3-C6 cycloalkyl, and C3-C6 halocycloalkyl; Ring Y is represented by formula (II-a), (II-b), (II-g), (II-h), (II-i), (II-r), (II-s), (II-u), (II-v), (II-ab) or (II-ac):
[0079] [ka]
[0080] is a group of the formula * is the group -S(O) p-Q is the connection point, # is the point of attachment to another heterocycle, A 1 is CR 8 Or N, R 8 is hydrogen or methyl, G is O, S or NR 7L and R 7L is hydrogen, q is 0, 1 or 2; x1 is 1 or 2, x2 is 0, 1 or 2, R 7A is hydrogen, R 7B is hydrogen, fluoro, methyl or methoxy, R 7C is hydrogen, fluoro, methyl or methoxy, R 7D is hydrogen, R 7E is hydrogen, R 7F is hydrogen, R 7K is hydroxyl or methyl, R 7L is hydrogen, halogen, cyano, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 hydroxyalkyl, C1-C4 alkylcarbonyl, C1-C4 haloalkylcarbonyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C1-C4 alkylsulfanyl, C1-C4 haloalkylsulfanyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C3-C6 cycloalkyl, phenyl, 5- or 6-membered heteroaryl, 3- to 7-membered heterocyclyl, -N(R 20 )2, -C(=NR 21 )R 22 , -C(=O)(OR 25) or -C(=O)N(R 26 )2, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 hydroxyalkyl, C1-C4 alkylcarbonyl, C1-C4 haloalkylcarbonyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C1-C4 alkylsulfanyl, C1-C4 haloalkylsulfanyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C1-C4 alkylsulfonyl and C1-C4 haloalkylsulfonyl are each 1-3R 7Sa may be substituted by a substituent, C3-C6 cycloalkyl, phenyl, 5- or 6-membered heteroaryl and 3- to 7-membered heterocyclyl are 1-3R 7Sc may be substituted by a substituent, and R 20 are independently hydrogen, C1-C4 alkyl, C1-C4 haloalkyl, or C3-C6 cycloalkyl; C3-C6 cycloalkyl is optionally substituted by 1 or 2 substituents independently selected from the group consisting of halogen and C1-C4 alkyl; R 21 is hydroxyl, C1-C4 alkyl or C1-C4 alkoxy, R 22 is hydrogen, C1-C4 alkyl or C1-C4 haloalkyl, R 25 , and R 26 are independently hydrogen or C1-C4 alkyl, and R 7Sa are independently cyano, hydroxyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C3-C6 cycloalkyl, C1-C4 alkoxycarbonyl, —O—Si(C1-C4 alkyl)3, or phenyl; R 7Scare independently halogen, hydroxyl, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy or C1-C4 haloalkoxy; R 7M is hydrogen, halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C1-C4 alkylsulfanyl, C1-C4 haloalkylsulfanyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C3-C4 cycloalkyl, phenyl, 3- to 7-membered heterocyclyl, 5- or 6-membered heteroaryl, C3-C6 cycloalkoxy, phenoxy, 3- to 7-membered heterocyclyloxy, 5- or 6-membered heteroaryloxy or -N(R 30 )2, The C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C1-C4 alkylsulfanyl, C1-C4 haloalkylsulfanyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C1-C4 alkylsulfonyl and C1-C4 haloalkylsulfonyl are each independently selected from the group consisting of 1-3R 8Sa may be substituted by a substituent, The C3-C6 cycloalkyl, phenyl, 3- to 7-membered heterocyclyl, 5- or 6-membered heteroaryl, C3-C6 cycloalkoxy, phenoxy, 3- to 7-membered heterocyclyloxy, and 5- or 6-membered heteroaryloxy are each independently selected from the group consisting of 1 to 3R 8Sc may be substituted by a substituent, and R 30 are independently hydrogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, and C3-C6 cycloalkyl; The C1-C4 alkyl, C2-C4 alkenyl and C2-C4 haloalkenyl are then each selected from the group consisting of 1 or 2R8Sa may be substituted by a substituent, The C3-C6 cycloalkyl and phenyl are then 1 or 2R 8Sc may be substituted by a substituent, and R 8Sa is hydroxyl, carboxyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkoxy-C1-C4 alkoxy, C1-C4 alkoxycarbonyl, C3-C6 cycloalkyl, C1-C4 alkylsulfanyl, -O-Si(C1-C6 alkyl)3, -Si(C1-C6 alkyl)3, 3- to 7-membered heterocyclyl, and -N(R 32 )2 independently selected from the group consisting of: The 3- to 7-membered heterocyclyl may in turn be substituted by 1 or 2 substituents independently selected from the group C1-C6 alkyl, R 32 are independently hydrogen, formyl, C1-C4 alkyl, and C1-C4 alkylcarbonyl; R 8Sc is independently selected from the group consisting of halogen, cyano, hydroxyl, oxo, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 alkoxycarbonyl, C3-C6 cycloalkyl, and 3- to 7-membered heterocyclyl; The 3- to 7-membered heterocyclyl may in turn be substituted by 1 or 2 substituents independently selected from the group C1-C4 alkyl, or 2nd Round 8Sc The substituents, together with the carbon atoms to which they are attached, may form a 3- to 7-membered heterocyclyl ring; p is 0, 1 or 2; Q is preferably phenyl, naphthyl, bicyclo[4.2.0]octa-1(6)2,4-trienyl, indanyl, tetrahydronaphthalenyl, indenyl, dihydronaphthalenyl, dihydrobenzofuranyl, dihydroisobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, dihydro-1,4-benzodioxinyl, [1,3]dioxolo[4,5-b]pyridinyl, tetrahydroquinolinyl, dihydro-5H-cyclopenta[b]pyridinyl, pyrrolyl, furanyl, thienyl, imidazolyl, triazolyl, oxazolyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinolinyl, furopyridinyl, thienothiophenyl or thienothiazolyl, Phenyl, naphthyl, bicyclo[4.2.0]octa-1(6)2,4-trienyl, indanyl, tetrahydronaphthalenyl, indenyl, dihydronaphthalenyl, dihydrobenzofuranyl, dihydroisobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, dihydro-1,4-benzodioxinyl, [1,3]dioxolo[4,5-b]pyridinyl, tetrahydroquinolinyl, dihydro-5H-cyclopenta[b]pyridinyl, pyrrolyl, furanyl, thienyl, imidazolyl, triazolyl, oxazolyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinolinyl, furopyridinyl, thienothiophenyl and thienothiazolyl are substituted with 1 to 3 substituents Q S and optionally substituted by Q Sis selected from halogen, cyano, nitro, hydroxyl, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkylcarbonyl, C1-C4 haloalkylcarbonyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkoxy-C1-C4 alkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C1-C4 alkylsulfanyl, C1-C4 haloalkylsulfanyl, C3-C6 cycloalkyl, oxetanyl, and -N(R 43 )2 independently selected from the group consisting of: the C3-C6 cycloalkyl is optionally substituted by 1 or 2 substituents independently selected from the group consisting of halogen, C1-C4 alkyl, and C1-C4 haloalkyl; and R 43 are independently hydrogen or C1-C4 alkyl; The present invention relates to compounds, as well as N-oxides, salts, hydrates, and hydrates of the salts and N-oxides thereof.
[0081] More preferably, the present invention relates to a compound of formula (I), wherein: A 2 is O, m is 1, R 3 , and R 4 are independently hydrogen, fluoro or methyl; R 5 is hydrogen, T is hydrogen; L is a direct bond or methylene; R 6 is phenyl, Phenyl may contain 1 to 3 substituents R 6S and optionally substituted by R 6S are independently selected from the group consisting of halogen, C1-C4 alkyl, difluoromethyl, and trifluoromethyl; Ring Y is represented by formula (II-a), (II-ab) or (II-ac):
[0082] [ka]
[0083] is a group of the formula * is the group -S(O) p -Q is the connection point, # is the point of attachment to another heterocycle, A 1 is CR 8 Or N, R 8 is hydrogen or methyl, R 7A is hydrogen, R 7B is hydrogen, R 7C is hydrogen, R 7D is hydrogen, R 7L is hydrogen, chloro or methyl, R 7M is hydrogen, p is 0, 1 or 2; Q is phenyl; Phenyl may contain one or two substituents Q S and optionally substituted by Q S is independently selected from the group consisting of halogen, nitro, methyl, ethyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, difluoromethoxy, and trifluoromethoxy; The present invention relates to compounds, as well as salts, hydrates and hydrates of the salts thereof.
[0084] Equally more preferably, the present invention relates to compounds of formula (I), wherein A 2 is O, m is 1, R 3 , and R 4 are independently hydrogen, fluoro or methyl; R 5 is hydrogen, T is hydrogen; L is a direct bond or methylene; R 6 is phenyl or thienyl, Phenyl and thienyl may have 1 to 3 substituents R 6S and optionally substituted by R 6S are independently selected from the group consisting of halogen, C1-C4 alkyl, difluoromethyl, and trifluoromethyl; Ring Y is represented by formula (II-a), (II-ab) or (II-ac-1):
[0085] [ka]
[0086] is the basis of * is the group -S(O) p -Q is the connection point, # is the point of attachment to another heterocycle, A 1 is CR 8 Or N, R 8 is hydrogen or methyl, R 7A is hydrogen, R 7B is hydrogen, R 7C is hydrogen, R 7D is hydrogen, R 7L is hydrogen, chloro or methyl, R 7M is hydrogen or methyl, p is 0 or 2; Q is phenyl, naphthyl or pyridinyl; Phenyl, naphthyl and pyridinyl may be substituted with one or two substituents Q S and optionally substituted by Q S are independently selected from the group consisting of halogen, nitro, (C1-C4)-alkyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, difluoromethoxy and trifluoromethoxy; The present invention relates to compounds, as well as salts, hydrates and hydrates of the salts thereof.
[0087] A 2 is preferably O, S, C(=O), S(=O)2, NR 1 , or CR 2A R 2B and R 1 , R 2A , and R 2B are, independently of one another, hydrogen, methyl, ethyl, n-propyl, iso-propyl, cyclopropyl or cyclobutyl.
[0088] More preferably, A 2 , O, NR 1 or CR 2A R 2B and R 1 , R 2A , and R 2B are, independently of one another, hydrogen, methyl, ethyl, cyclopropyl or cyclobutyl.
[0089] Even more preferably, A 2 is O.
[0090] m is preferably 0 or 1, more preferably 1.
[0091] T is preferably hydrogen or C1-C4 alkyl, more preferably hydrogen, methyl, ethyl, n-propyl or iso-propyl, even more preferably hydrogen.
[0092] R 3 and R 4 are preferably independently selected from the group consisting of hydrogen, fluoro, chloro, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl and C3-C6 cycloalkyl; C1-C4 alkyl, C2-C4 alkenyl and C2-C4 alkynyl are optionally substituted by 1 to 3 substituents independently selected from the group consisting of fluoro, chloro, hydroxyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C3-C6 cycloalkyl and C3-C6 halocycloalkyl; and the C3-C6 cycloalkyl is optionally substituted by 1 to 3 substituents independently selected from the group consisting of fluoro, chloro, hydroxyl, oxo, methylidene, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C3-C6 cycloalkyl, and C3-C6 halocycloalkyl; or R 3 and R 4 together with the carbon atoms to which they are attached form a C3-C6 cycloalkyl ring.
[0093] More preferably, R 3 and R 4 are independently selected from the group consisting of hydrogen, fluoro, chloro, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl and C3-C6 cycloalkyl, even more preferably from the group consisting of hydrogen, fluoro and C1-C4 alkyl, even more preferably from the group consisting of hydrogen, fluoro, methyl, ethyl, n-propyl and iso-propyl.
[0094] Even more preferably, R 3 and R 4 Both are each hydrogen.
[0095] R 5 is preferably hydrogen, hydroxyl, C1-C4 alkyl, C1-C4 alkoxy or C1-C4 alkylsulfanyl, C1-C4 alkyl, C1-C4 alkoxy and C1-C6 alkylsulfanyl are optionally substituted by 1 to 3 substituents independently selected from the group consisting of fluoro, chloro, hydroxyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C3-C6 cycloalkyl and C3-C6 halocycloalkyl; and the C3-C6 cycloalkyl is optionally substituted by 1 to 3 substituents independently selected from the group consisting of fluoro, chloro, hydroxyl, oxo, methylidene, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C3-C6 cycloalkyl, and C3-C6 halocycloalkyl; or R 3 and R 5 Or R 4 and R 5 together with the carbon atoms to which they are attached form a C3-C6 cycloalkyl ring.
[0096] R 5 is more preferably hydrogen, hydroxyl, C1-C4 alkyl, C1-C4 alkoxy or C1-C4 alkylsulfanyl, even more preferably hydrogen, hydroxyl or C1-C4 alkyl, even more preferably hydrogen, methyl, ethyl, n-propyl or iso-propyl, even more preferably hydrogen.
[0097] More preferably, A 2 is O, NH, or CH, m is 0 or 1, T is hydrogen, and R 3 , R 4 and R 5 Each of is hydrogen.
[0098] Even more preferably, A 2 is O, m is 1, T is hydrogen, and R 3 , R 4 and R 5 is hydrogen.
[0099] L is preferably a direct bond, C1-C6 alkylene or a group of the formula:
[0100] [ka]
[0101] is a group of the formula The C1-C6 alkylene may be substituted with 1 to 3 substituents L SA and optionally substituted by # is the point of attachment to the heterocyclyl moiety; ## is R 6 It is the connection point with L 1 is a direct bond or C1-C6 alkylene, L 2 is a direct bond or C1-C6 alkylene, E is a C3-C6 cycloalkyl or a 3- to 7-membered heterocyclyl; The C3-C6 cycloalkyl and 3- to 7-membered heterocyclyl are then each selected from 1 to 3 substituents L SC and optionally substituted by L SA are independently fluoro, chloro, hydroxyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C3-C6 cycloalkyl or C3-C6 halocycloalkyl; or Two substituents L attached to the same carbon atom SA together with the carbon atoms to which they are attached form a C3-C6 cycloalkyl ring or a 3- to 7-membered heterocyclyl ring; L SC are independently fluoro, chloro, hydroxyl, oxo, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C3-C6 cycloalkyl and C3-C6 halocycloalkyl; It is the base.
[0102] L is more preferably a direct bond or a C1-C6 alkylene, and the C1-C6 alkylene is preferably a group having 1 to 3 substituents L SA and L SA are independently fluoro, chloro, hydroxyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C3-C6 cycloalkyl and C3-C6 halocycloalkyl.
[0103] L is even more preferably methylene, said methylene being optionally substituted by one or two fluoro substituents.
[0104] Likewise, L is even more preferably a direct bond or methylene, said methylene being optionally substituted by 1 or 2 substituents fluoro.
[0105] Preferably, R 6are indanyl, 1,2,3,4-tetrahydronaphthalenyl, bicyclo[4.2.0]octa-1,3,5-trienyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, indenyl, 1,2-dihydronaphthalenyl, spiro[cyclopropane-2,1'-indan]-1-yl, spiro[cyclopropane-2,1'-tetralin]-1-yl, phenyl, naphthyl, phenoxy, benzyloxy, OCF2-phenyl, phenylsulfanyl, 3-dihydrobenzofuranyl, 2,3-dihydrobenzothiophenyl, indolinyl, 1 ,3-benzodioxolyl, 1,2,3,4-tetrahydroquinolinyl, chromanyl, isochromanyl, thiochromanyl, 2,3-dihydro-1,4-benzodioxinyl, 6,7-dihydro-5H-cyclopenta[b]pyridinyl, 5,6,7,8-tetrahydroquinolinyl, 4,5,6,7-tetrahydrobenzothiophenyl, 4,5,6,7-tetrahydrobenzofuranyl, 4,5,6,7-tetrahydro-1,3-benzoxazolyl, 4,5,6,7-tetrahydro-1,3-benzothiazolyl, 4,5,6,7-tetrahydro-1H-benzoyl Midazolyl, 4,5,6,7-tetrahydro-1H-indazolyl, 4,5,6,7-tetrahydro-2H-isoindolyl, 4,5,6,7-tetrahydro-2-benzothiophenyl, 5,6-dihydro-4H-cyclopenta[b]thiophenyl, 5,6-dihydro-4H-cyclopenta[d]thiazolyl, 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydroimidazo[1,2-a]pyridinyl, 6,7-dihydro -5H-thieno[3,2-b]pyranyl, spiro[chroman-3,1'-cyclopropan]-yl, spiro[7,8-dihydro-5H-quinoline-6,1'-cyclopropan]-yl, furanyl, thienyl, pyrazolyl, imidazolyl, thiazolyl, oxazolyl, oxadiazolyl, thiazolyl, thiadiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, quinoxalinyl, pyrrolo[2,3-b]pyridin-3-yl, imidazo[1,2-a]pyridinyl, [1,2,4]triazolo[4,3-a]pyridinyl, thieno[3,2-b]pyrrol-6-yl, thieno[3,2-b]thiophenyl, imidazo[2,1-b]oxazolyl, furo[2,3-d]isoxazolyl or thieno[2,3-d]thiazolyl, and are not limited to indanyl, 1,2,3,4-tetrahydronaphthalenyl, bicyclo[4.2.0]octa-1,3,5-trienyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, indenyl, 1 ,2-Dihydronaphthalenyl, spiro[cyclopropane-2,1'-indan]-1-yl, spiro[cyclopropane-2,1'-tetralin]-1-yl, phenyl, naphthyl, phenoxy, benzyloxy, OCF2-phenyl, phenylsulfanyl, 3-dihydrobenzofuranyl, 2,3-dihydrobenzothiophenyl, indolinyl, 1,3-benzodioxolyl, 1,2,3,4-tetrahydroquinolinyl, chromanyl, isochromanyl, thiochromanyl, 2,3-dihydro-1,4-benzodioxinyl, 6,7-dihydro 4,5,6,7-tetrahydro-5H-cyclopenta[b]pyridinyl, 5,6,7,8-tetrahydroquinolinyl, 4,5,6,7-tetrahydrobenzothiophenyl, 4,5,6,7-tetrahydrobenzofuranyl, 4,5,6,7-tetrahydro-1,3-benzoxazolyl, 4,5,6,7-tetrahydro-1,3-benzothiazolyl, 4,5,6,7-tetrahydro-1H-benzimidazolyl, 4,5,6,7-tetrahydro-1H-indazolyl, 4,5,6,7-tetrahydro-2H-isoindolyl, 4,5,6,7-tetrahydro-2-benzophenone zothiophenyl, 5,6-dihydro-4H-cyclopenta[b]thiophenyl, 5,6-dihydro-4H-cyclopenta[d]thiazolyl, 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydroimidazo[1,2-a]pyridinyl, 6,7-dihydro-5H-thieno[3,2-b]pyranyl, spiro[chroman-3,1'-cyclopropan]-yl, spiro[7,8-dihydro-5H-quinoline-6,1'-cyclopropan]-yl, furanyl, thienyl, pyrazolyl, imidazolyl, thiazolyl, oxazolyl, oxadiazolyl, thiazolyl, thiadiazolyl, pyridinyl, pyridazinyl, and pyrimidinyl, indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl , quinoxalinyl, pyrrolo[2,3-b]pyridin-3-yl, imidazo[1,2-a]pyridinyl, [1,2,4]triazolo[4,3-a]pyridinyl, thieno[3,2-b]pyrrol-6-yl, thieno[3,2-b]thiophenyl, imidazo[2,1-b]oxazolyl, furo[2,3-d]isoxazolyl and thieno[2,3-d]thiazolyl are substituted with one to three substituents R, 6S and optionally substituted by R 6S is halogen, cyano, nitro, hydroxyl, mercapto, pentafluorosulfanyl, oxo, methylidene, halomethylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C6 alkylsulfanyl, C1-C6 haloalkylsulfanyl, C3-C6 cycloalkylsulfanyl, C3-C6 cycloalkyl, C3-C6 cycloalkyloxy, C6-C 14 Aryl, 5- or 6-membered heteroaryl, 3- to 7-membered heterocyclyl, -C(=O)(OR 17 ) and -C(=O)N(R 18)2, wherein C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C6 alkylsulfanyl and C1-C6 haloalkylsulfanyl are optionally further substituted by 1 to 3 substituents independently selected from the group consisting of fluoro, chloro, hydroxyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C3-C6 cycloalkyl and C3-C6 halocycloalkyl, and C3-C6 cycloalkylsulfanyl, C3-C6 cycloalkyl, C3-C6 cycloalkyloxy, C6-C 14 The aryl, 5- or 6-membered heteroaryl, and 3- to 7-membered heterocyclyl may be further substituted by 1 to 3 substituents independently selected from the group consisting of fluoro, chloro, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, and C1-C4 haloalkoxy; and R 17 , and R 18 are independently hydrogen or C1-C4 alkyl, The C1-C4 alkyl or C1-C4 haloalkyl may in turn be substituted with 1 to 3 substituents independently selected from the group consisting of fluoro, chloro, hydroxyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C3-C6 cycloalkyl, and C3-C6 halocycloalkyl.
[0106] More preferably, R 6 is indanyl, 1,2,3,4-tetrahydronaphthalenyl, phenyl, naphthyl, dihydrobenzofuranyl or dihydrobenzodioxinyl, and indanyl, 1,2,3,4-tetrahydronaphthalenyl, phenyl, naphthyl, dihydrobenzofuranyl and dihydrobenzodioxinyl are 1 or 2R 6S may be substituted by a substituent, R 6Sare independently selected from the group consisting of fluoro, chloro, bromo, C1-C4 alkyl, difluoromethyl, trifluoromethyl, C1-C4 alkoxy, difluoromethoxy, trifluoromethoxy, C2-C4 alkenyl, methylcarbonyl, ethylcarbonyl, C2-C4 alkynyl, cyclopropyl, cyclobutyl, ocetanyl, tetrahydrofuranyl, pyrazolyl, and pyridyl; Cyclopropyl, cyclobutyl, oxetanyl, tetrahydrofuranyl, pyrazolyl and pyridyl may in turn be substituted with 1 to 3 substituents independently selected from the group consisting of fluoro, chloro, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy and C1-C4 haloalkoxy.
[0107] Equally more preferably, R 6 is phenyl or thienyl, and phenyl and thienyl are 1 or 2R 6S is substituted by a substituent, and R 6S is independently selected from the group consisting of chloro, bromo and methyl.
[0108] Even more preferably, R 6 is 1 or 2R 6S is a phenyl substituted by a substituent, During the ceremony, R 6S is independently selected from the group consisting of chloro, bromo and methyl.
[0109] Even more preferably, R 6 teeth, [ka]
[0110] where: § 1 is the point of attachment to L, R 6S1 and R 6S2 are independently hydrogen or R 6S and R6S is halogen, C1-C4 alkyl, difluoromethyl, trifluoromethyl, C1-C4 alkoxy, difluoromethoxy or trifluoromethoxy, However, R 6S1 and R 6S2 At least one of is different from hydrogen.
[0111] Even more preferably, L is a direct bond or methylene and R 6 is phenyl, and the phenyl is 1 or 2R 6S may be substituted by a substituent, R 6S is independently selected from the group consisting of fluoro, chloro, C1-C4 alkyl, difluoromethyl, trifluoromethyl, C1-C4 alkoxy, difluoromethoxy, and trifluoromethoxy.
[0112] Likewise even more preferably, L is a direct bond or methylene and R 6 is phenyl or thienyl, and phenyl and thienyl are 1 or 2R 6S is substituted by a substituent, and R 6S is independently selected from the group consisting of fluoro, chloro, bromo and C1-C4 alkyl.
[0113] Even more preferably, A 2 is O, m is 1, T is hydrogen, and R 3 , R 4 and R 5 is hydrogen, L is methylene, and R 6 is 1 or 2R 6S phenyl substituted by a substituent, R 6S is independently selected from the group consisting of chloro, bromo and methyl.
[0114] Q is preferably phenyl, naphthyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, indanyl, tetrahydronaphthalenyl, indenyl, dihydronaphthalenyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, dihydrobenzofuranyl, 1,3-dihydroisobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, dihydro-1,4-benzodioxinyl, [1,3]dioxolo[4,5-b]pyridinyl, tetrahydrobenzofuran ... hydroquinolinyl, 6,7-dihydro-5H-cyclopenta[b]pyridinyl, pyrrolyl, furanyl, thienyl, imidazolyl, triazolyl, oxazolyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinolinyl, furo[3,2-b]pyridinyl, thieno[3,2-b]thiophenyl, or thieno[2,3-d]thiazolyl. , phenyl, naphthyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, indanyl, tetrahydronaphthalenyl, indenyl, dihydronaphthalenyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, dihydrobenzofuranyl, 1,3-dihydroisobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, dihydro-1,4-benzodioxinyl, [1,3]dioxolo[4,5-b]pyridinyl, tetrahydroquinolinyl , 6,7-dihydro-5H-cyclopenta[b]pyridinyl, pyrrolyl, furanyl, thienyl, imidazolyl, triazolyl, oxazolyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinolinyl, furo[3,2-b]pyridinyl, thieno[3,2-b]thiophenyl, and thieno[2,3-d]thiazolyl are substituted with one to three substituents Q S and optionally substituted by Q Sis halogen, cyano, nitro, hydroxyl, formyl, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkylcarbonyl, C1-C6 haloalkylcarbonyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxy-C1-C6 alkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C6 alkylsulfanyl, C1-C6 haloalkylsulfanyl, C3-C6 cycloalkyl, oxetanyl, and -N(R 43 ) 2, wherein the C3-C6 cycloalkyl and oxetanyl are in turn optionally substituted with 1 or 2 substituents independently selected from the group consisting of halogen, C1-C4 alkyl, and C1-C4 haloalkyl; R 43 is hydrogen and C1-C6 alkyl.
[0115] More preferably, Q is phenyl, naphthyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, benzodioxolyl, 2,3-dihydrobenzofuranyl, pyridinyl, thienyl, or indolyl, and phenyl, naphthyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, benzodioxolyl, 2,3-dihydrobenzofuranyl, pyridinyl, thienyl, and indolyl are substituted with 1 to 3 substituents Q S and optionally substituted by Q S are independently selected from the group consisting of halogen, cyano, nitro, formyl, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkylcarbonyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C2-C4 alkynyl, and C3-C6 cycloalkyl, wherein said C3-C6 cycloalkyl is in turn optionally substituted with 1 or 2 substituents independently selected from the group consisting of fluoro and methyl.
[0116] Even more preferably, Q is phenyl, wherein the phenyl has one or two substituents Q independently selected from the group consisting of halogen, cyano, nitro, formyl, C1-C4 alkyl, difluoromethyl, trifluoromethyl, C1-C4 alkoxy, difluoromethoxy and trifluoromethoxy. S is replaced by
[0117] Most preferably, Q is
[0118] [ka]
[0119] where: § 2 is the point of attachment to the oxygen atom, Q S1 is hydrogen or fluoro, Q S2 is hydrogen, chloro, bromo, methyl, trifluoromethyl, difluoromethyl, ethenyl, ethynyl or cyclopropyl, However, Q S1 and Q S2 At least one of is different from hydrogen. Preferably, ring Y is of formula (II-a), (II-b), (II-g), (II-h), (II-i), (II-r), (II-s), (II-u), (II-v), (II-ab) or (II-ac):
[0120] [ka]
[0121] is a group of the formula * is the group -S(O) p -Q is the connection point, # is the point of attachment to another heterocycle, A 1 is CR 8 or N, R 8is hydrogen or methyl, G is O, S or NR 7L and R 7L is hydrogen, q is 0, 1 or 2; x1 is 1 or 2, x2 is 0, 1, or 2; R 7A is hydrogen, R 7B is hydrogen, fluoro, methyl or methoxy, R 7C is hydrogen, fluoro, methyl or methoxy, R 7D is hydrogen, R 7E is hydrogen, R 7F is hydrogen, R 7K is hydroxyl or methyl, R 7L is hydrogen, halogen, cyano, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 hydroxyalkyl, C1-C4 alkylcarbonyl, C1-C4 haloalkylcarbonyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C1-C4 alkylsulfanyl, C1-C4 haloalkylsulfanyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C3-C6 cycloalkyl, phenyl, 5- or 6-membered heteroaryl, 3- to 7-membered heterocyclyl, -N(R 20 )2, -C(=NR 21 )R 22 , -C(=O)(OR 25 ) or -C(=O)N(R 26 )2, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 hydroxyalkyl, C1-C4 alkylcarbonyl, C1-C4 haloalkylcarbonyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C1-C4 alkylsulfanyl, C1-C4 haloalkylsulfanyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C1-C4 alkylsulfonyl and C1-C4 haloalkylsulfonyl are each 1-3R 7Sa may be substituted by a substituent, C3-C6 cycloalkyl, phenyl, 5- or 6-membered heteroaryl and 3- to 7-membered heterocyclyl are 1-3R 7Sc may be substituted by a substituent, and R 20 are independently hydrogen, C1-C4 alkyl, C1-C4 haloalkyl, or C3-C6 cycloalkyl; C3-C6 cycloalkyl is optionally substituted by 1 or 2 substituents independently selected from the group consisting of halogen and C1-C4 alkyl; R 21 is hydroxyl, C1-C4 alkyl or C1-C4 alkoxy, R 22 is hydrogen, C1-C4 alkyl or C1-C4 haloalkyl, R 25 , and R 26 are independently hydrogen or C1-C4 alkyl, and R 7Sa are independently cyano, hydroxyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C3-C6 cycloalkyl, C1-C4 alkoxycarbonyl, —O—Si(C1-C4 alkyl)3, or phenyl; R 7Sc are independently halogen, hydroxyl, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy or C1-C4 haloalkoxy; R 7M is hydrogen, halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C1-C4 alkylsulfanyl, C1-C4 haloalkylsulfanyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C3-C4 cycloalkyl, phenyl, 3- to 7-membered heterocyclyl, 5- or 6-membered heteroaryl, C3-C6 cycloalkoxy, phenoxy, 3- to 7-membered heterocyclyloxy, 5- or 6-membered heteroaryloxy or -N(R 30 )2, The C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C1-C4 alkylsulfanyl, C1-C4 haloalkylsulfanyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C1-C4 alkylsulfonyl and C1-C4 haloalkylsulfonyl are each independently selected from the group consisting of 1-3R 8Sa may be substituted by a substituent, The C3-C6 cycloalkyl, phenyl, 3- to 7-membered heterocyclyl, 5- or 6-membered heteroaryl, C3-C6 cycloalkoxy, phenoxy, 3- to 7-membered heterocyclyloxy, and 5- or 6-membered heteroaryloxy are each independently selected from the group consisting of 1 to 3R 8Sc may be substituted by a substituent, and R 30 are independently hydrogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, and C3-C6 cycloalkyl; The C1-C4 alkyl, C2-C4 alkenyl and C2-C4 haloalkenyl are then each selected from the group consisting of 1 or 2R 8Sa may be substituted by a substituent, The C3-C6 cycloalkyl and phenyl are then 1 or 2R 8Scmay be substituted by a substituent, and R 8Sa is hydroxyl, carboxyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkoxy-C1-C4 alkoxy, C1-C4 alkoxycarbonyl, C3-C6 cycloalkyl, C1-C4 alkylsulfanyl, -O-Si(C1-C6 alkyl)3, -Si(C1-C6 alkyl)3, 3- to 7-membered heterocyclyl, and -N(R 32 )2 independently selected from the group consisting of: The 3- to 7-membered heterocyclyl may in turn be substituted by 1 or 2 substituents independently selected from the group C1-C6 alkyl, R 32 are independently hydrogen, formyl, C1-C4 alkyl, and C1-C4 alkylcarbonyl; R 8Sc is independently selected from the group consisting of halogen, cyano, hydroxyl, oxo, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 alkoxycarbonyl, C3-C6 cycloalkyl, and 3- to 7-membered heterocyclyl; The 3- to 7-membered heterocyclyl may in turn be substituted by 1 or 2 substituents independently selected from the group C1-C4 alkyl, or 2nd Round 8Sc The substituents, together with the carbon atoms to which they are attached, may form a 3- to 7-membered heterocyclyl ring.
[0122] More preferably, ring Y is of formula (II-a), (II-ab) or (II-ac):
[0123] [ka]
[0124] is a group of the formula * is the group -S(O) p -Q is the connection point, # is the point of attachment to another heterocycle, A 1 is CR 8 or N, R 8 is hydrogen or methyl, R 7A is hydrogen, R 7B is hydrogen, R 7C is hydrogen, R 7D is hydrogen, R 7L is hydrogen, chloro or methyl, R 7M is hydrogen.
[0125] Even more preferably, ring Y is of formula (II-a), (II-ab-1) or (II-ac):
[0126] [ka]
[0127] is a group of the formula * is the group -S(O) p -Q is the connection point, # is the point of attachment to another heterocycle, A 1 is CR 8 or N, R 8 is hydrogen or methyl, R 7A is hydrogen, R 7B is hydrogen, R 7C is hydrogen, R 7D is hydrogen, R 7L is hydrogen, chloro or methyl, R 7M is hydrogen.
[0128] Likewise, even more preferably, ring Y is of formula (II-a), (II-ab-1) or (II-ac-1):
[0129] [ka]
[0130] is a group of the formula * is the group -S(O) p -Q is the connection point, # is the point of attachment to another heterocycle, A 1 is CR 8 or N, R 8 is hydrogen or methyl, R 7A is hydrogen, R 7B is hydrogen, R 7C is hydrogen, R 7D is hydrogen, R 7L is hydrogen, chloro or methyl, R 7M is hydrogen or methyl.
[0131] A 1 , A 2 , R 1 , R 2A , R 2B , R 3 , R 4 , R 5 , R 6 The above specific definitions of L, m, p, T, Q and Y (broad definitions as well as preferred, more preferred, even more preferred and most preferred definitions) can be combined in various ways. Thus, these combinations of definitions provide subclasses of compounds according to the invention, such as, for example, those disclosed below.
[0132] Preferred are compounds of formula (I) in which each of the definitions (substituents and variables) has the preferred meanings given above.
[0133] Particularly preferred are compounds of formula (I) in which each of the definitions (substituents and variables) has the more, more and / or most preferred meanings given above.
[0134] The present invention also relates to any of the compounds of formula (I) disclosed in Table 1.
[0135] The compounds of formula (I) may be used as antifungals (to control phytopathogenic fungi), in particular in a method for controlling phytopathogenic fungi which comprises the step of applying one or more compounds of formula (I) to plants, plant parts, seeds, fruit or the soil in which plants grow.
[0136] Processes for preparing compounds of formula (I) and intermediates The present invention also relates to processes for the preparation of compounds of formula (I) and intermediates thereof. Unless otherwise specified, the variables A used below 1 , A 2 , R 1 , R 2A , R 2B , R 3 , R 4 , R 5 , R 6 , L, m, p, T, Q and Y have the meanings given above for compounds of formula (I). These definitions apply not only to the final product of formula (I) but also to all intermediates comprising each variable.
[0137] The compounds of formula (Ia) are various subsets of formula (I). The compounds of formulas (Ia-1) to (Ia-3) are various subsets of formula (Ia). All variables in formula (Ia) and formulas (Ia-1) to (Ia-3) are as defined above for formula (I) unless otherwise specified.
[0138] Process for preparing compounds of formula (I) Method A Q, Y, A 1 , L, R 3 , R 4 , R 5and R 6 Compounds of formula (Ia-1), wherein A 2 is O, T is hydrogen; m is 1 or 2; p is 1 or 2; Prepare well By reacting a compound of formula (Ia-2) with an oxidizing agent as shown in Scheme 1
[0139] [ka]
[0140] Compounds of formula (Ia-1) may be obtained by treating compounds of formula (Ia-2) with a peracid, preferably m-chloroperbenzoic acid, in a halogenated solvent such as dichloromethane.
[0141] Such methods for producing sulfones or sulfoxides are known and described in the literature (Catalysis Communications (2018), 111, 52-58; CS Omega (2018), 3(5), 4860-4870).
[0142] Method B Q, Y, A 1 , L, R 3 , R 4 , R 5 and R 6 is as defined above, A 2 is O, T is hydrogen; m is 1 or 2; p is 0, The compound of formula (Ia-2) When W is hydrogen, the compound of formula (Ia-1) may be prepared directly by treating the compound of formula (4) with a dehydrating agent, optionally in the presence of a base; or When W is an amino-protecting group, preferably tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl, the compound of formula (4) may be treated with a dehydrating agent, optionally in the presence of a base, followed by a deprotection step, as shown in Scheme 2, to give the compound of formula (Ia-2).
[0143] [ka]
[0144] The compound of formula (Ia-2) can be obtained by treating the compound of formula (4) with a dehydrating agent such as POCl3, PO5 or triflic anhydride, optionally in the presence of a base. Such methods for producing an oxadiazine ring are known and are described in the literature (J. Med. Chem. 2017, 60, 2383-2400 or WO 2020 / 127780). The reaction can be carried out in any conventional inert organic solvent. If necessary, it is preferable to use petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene, or decalin; halogenated aliphatic, alicyclic, or aromatic hydrocarbons such as chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichloroethane, or trichloroethane; ethers such as diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane, or anisole; nitriles such as acetonitrile, propionitrile, n- or i-butyronitrile, or benzonitrile; or alcohols such as ethanol or isopropanol.
[0145] If T is an amino-protecting group, step 3 can be followed by an additional deprotection step using reaction conditions described in Greene's Protective Groups in Organic Synthesis; Peter GM Wuts; Wiley; Fifth Edition; 2014; 895-1194. For example, the tert-butoxycarbonyl group can be removed in an acidic medium such as hydrochloric acid or trifluoroacetic acid.
[0146] m, p, Q, Y, A 1 , A 2 , L, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 is as defined above, p, A 1 , Q and Y are as defined above; U 1 is hydroxyl, halogen or C1-C6 alkoxy m, A 2 , L, R 3 , R 4 , R 5 and R 6 is as defined above, by first reacting with an amine of formula (2) where W is hydrogen or an amino protecting group, preferably tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl, or a salt thereof; m, p, Q, Y, A 1 , A 2 , L, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 is as defined above, from which m, p, Q, Y, A 1 , A 2 , L, R 1 , R 2 , R3 , R 4 , R 5 and R 6 may be obtained by removing the phthalimido group of compound (3), wherein is as defined above, to obtain a compound of formula (4).
[0147] The reaction conditions for removing the phthalimide group are well known and reported in the literature (Greene's Protective Groups in organic Synthesis; Peter GM Wuts; Wiley; Fifth Edition; 2014; 1012-1014).
[0148] Compounds of formula (1) may be prepared by one or more of the methods described herein (see Methods H, I and J).
[0149] Amines of formula (2) may be prepared by the methods described in WO 2020 / 127780.
[0150] U 1Compounds of formula (1) in which is a hydroxyl group can be reacted with amines of formula (2) in the presence of a condensing reagent by methods described in the literature (e.g., Tetrahedron 2005, 61, 10827-10852). Examples of suitable condensing reagents include halogenating agents (e.g., phosgene, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus trichloride oxide, oxalyl chloride, or thionyl chloride), dehydrating agents (e.g., ethyl chloroformate, methyl chloroformate, isopropyl chloroformate, isobutyl chloroformate, or methanesulfonyl chloride), carbodiimides (e.g., N,N'-dicyclohexylcarbodiimide (DCC)), or other conventional condensing (or peptide bond) reagents (e.g., phosphorus pentoxide, polyphosphoric acid, bis(2-oxo-3-oxazolidinyl)phosphinic chloride, 1-[bis(dimethyl amino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU), N,N'-carbonyldiimidazole, 2-ethoxy-N-ethoxycarbonyl-1,2-dihydroquinoline (EEDQ), triphenylphosphine / tetrachloromethane, 4-(4,6-dimethoxy[1.3.5]-triazin-2-yl)-4-methylmorpholinium chloride hydrate, bromotripyrrolidinophosphonium hexafluorophosphate, or propanephosphonic anhydride (T3P).
[0151] U 1 A compound of formula (1) in which is a halogen atom can be reacted with an amine of formula (2) in the presence of an acid scavenger by well-known methods. Suitable acid scavengers include inorganic and organic bases commonly used for such reactions, such as those described herein. Alkali metal carbonates, alkaline earth metal acetates, tertiary amines, or aromatic bases are preferred.
[0152] U 1 A compound of formula (1) in which is a C1-C6 alkoxy group can be reacted with an excess of an amine of formula (2), optionally in the presence of a Lewis acid such as trimethylaluminum.
[0153] Method C Q, Y, A 1 , L, R 3 , R 4 , R 5 and R 6 is as defined above, A 2 is O, T is hydrogen; A compound of formula (Ia-2), wherein m is 1 or 2, m, Y, T, A 1 , L, R 3 , R 4 , R 5 and R 6 is as defined above, X 1 is a halogen, preferably bromo, trifluoromethylsulfonate or p-toluenesulfonate, a compound of formula (6) wherein Q is as defined above; As shown in Scheme 3, it may be prepared by reaction in the presence of a base (eg, an organic or inorganic base), optionally in the presence of a suitable copper salt or complex.
[0154] [ka]
[0155] m, Y, A 1 , A 2 , L, T, X 1 , R 3 , R 4 , R 5 and R 6 Compounds of formula (5), wherein is as defined above, may be prepared according to the procedures described in WO 2020 / 127780.
[0156] Compounds of formula (6) are commercially available or may be obtained by converting or derivatizing other compounds of formula (6) according to well-known methods.
[0157] Method D p, Q, Y, A 1 , L, R 3 , R 4 and R 6 is as defined above, m is 1 or 2; A 2 is O, T is hydrogen; R 5 is hydrogen or C1-C6 alkoxy, as shown in Scheme 4, m, p, Q, Y, A 1 , L, R 3 , R 4 , R 5 and R 6 It may be prepared by adding a reducing agent under acidic conditions to a compound of formula (10), wherein is as defined above.
[0158] [ka]
[0159] Compounds of formula (10) may be cyclized under acidic conditions in the presence of a reducing agent such as sodium cyanoborohydride to give compounds of formula (Ia-1). The reaction conditions for producing the oxadiazine ring using this method are known and are described in the literature (Heterocycles 2016, 92, 2166-2200).
[0160] m, p, Q, Y, A 1 , T, L, R 3 , R 4 , R 5 and R 6 A compound of formula (10) in which p, Q, Y, A are as defined above 1 and T are as defined above, 3 , R 4 and R 6as defined above with a compound of formula (9). Suitable bases are alkali metal hydrides such as sodium hydride, alkali metal carbonates such as potassium carbonate, alkali metal hydroxides such as potassium hydroxide, or phosphazene bases such as BEMP, as described in the literature (Heterocycles 2016, 92, 2166-2200).
[0161] p, Q, Y, A 1 and T are as defined above, 1 may be obtained by reacting a compound of formula (7), wherein is as defined above, with hydroxylamine or a salt thereof. The reaction conditions for carrying out such a transformation are known and reported in the literature (WO 2010 / 138600).
[0162] Compounds of formula (7) may be prepared by Method K described herein.
[0163] Compounds of formula (9) are commercially available or may be prepared by methods described in the literature (Eur. J. Med. Chem. 2014, 84, 302, Eur. J. Med. Chem. 2015, 100, 18-23, WO 2017 / 031325).
[0164] Method E p, Q, Y, A 1 , L, R 3 , R 4 , R 5 and R 6 is as defined above, m is 1 or 2; A 2 is O, Compounds of formula (Ia-1) in which T is hydrogen can be prepared by p, Q, Y and A 1 is as defined above, U 1is hydroxyl, halogen or C1-C6 alkoxy m, L, R 3 , R 4 , R 5 and R 6 is as defined above, E 1 is hydroxyl or halogen, by first reacting with an amine of formula (11), where W is hydrogen, tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl, under the conditions described in Method B, m, p, Q, Y, A 1 , E 1 , L, W, R 3 , R 4 , R 5 and R 6 is as defined above, which is then treated with a dehydrating agent and then with hydroxylamine (13) to give a compound of formula (12) in which m, p, Q, Y, A 1 , E 1 , L, W, R 3 , R 4 , R 5 and R 6 is as defined above, which is finally converted to a compound of formula (Ia-1) as shown in Scheme 5.
[0165] [ka]
[0166] E 1 When E is a hydroxyl, compounds of formula (14) are converted to compounds of formula (Ia-1) using Mitsunobu reaction conditions known to those skilled in the art (Strategic Applications of Named Reactions in Organic Synthesis; Laszlo Kurti, Barbara Czako; Elsevier; 2005; 294-295 and references therein). 1When is a halogen, the compound of formula (14) is converted to a compound of formula (Ia-1) in the presence of a base.
[0167] If W is an amino protecting group, step 3 may be followed by an additional deprotection step using reaction conditions described in the literature (Greene's Protective Groups in organic Synthesis; Peter GM Wuts; Wiley; Fifth Edition; 2014; 895-1194) to give compounds of formula (Ia-1).
[0168] Equation (11-a, E 1 = hydroxyl) may be commercially available or may be prepared by methods described in the literature (Molecules, 9 (6), 405-426; 2004, WO 2017 / 203474). 1 = halogen) can be obtained from the corresponding amino alcohols by well-known methods.
[0169] Method F p, Q, Y, A 1 , R 3 , R 4 and R 5 is as defined above, A 2 is O, L is a direct bond; T is hydrogen; m is 2, R 6 is C3~C 12 Carbocyclyl, C6-C 14 aryl, 3- to 14-membered heterocyclyl, or 5- or 6-membered heteroaryl; C3~C 12 Carbocyclyl, C6-C 14 Aryl, 3- to 14-membered heterocyclyl, and 5- to 14-membered heteroaryl are 1 to 4R 6S may be substituted by a substituent, R 6Sis as defined above, in the presence of a suitable base as described herein, a compound of formula (Ia-3) containing p, Q, Y and A 1 is as defined above, 3 , R 4 and R 5 is as defined above to form a hydroxylamine (15) 1 , R 3 , R 4 and R 5 is as defined above, which is then reacted with R 6 is as defined above, X 2 is reacted with a reagent of formula (17) which is a halogen to form p, Q, Y, A in the presence of a metal catalyst and a suitable ligand. 1 , R 3 , R 4 , R 5 and R 6 is as defined above, which is then treated with iodine and phenylsilane to produce a compound of formula (Ia-3), as shown in Scheme 6.
[0170] [ka]
[0171] Reagents of formula (15) are either commercially available or can be prepared by methods described in the literature (WO 2010 / 099279).
[0172] Reagents of formula (17) are commercially available or can be prepared by known methods. Compounds of formula (7) may be prepared by Method K described herein.
[0173] Method G In one or more steps as illustratively shown in Scheme 7: m, p, L, A 2 , Q, R 3 , R 4 , R 5 and R 6 is as defined above, T is hydrogen; Ring Y has the formula (II-a), (II-c), (II-d), (II-e), (II-g), (II-h), (II-i), (II-j), (II-k), (II-l), (II -m), (II-n), (II-o), (II-p), (II-q), (II-w), (II-y), (II-z), (II-aa), (II-ab) or (II-ac):
[0174] [ka]
[0175] is a group of the formula * , #, A 1 , R 7A , R 7C , R 7D , R 7E , R 7F , R 7H and R 7M is as defined above, R 7B1 , R 7F1 and R 7L1 are independently hydrogen or halogen, by methods described in the literature, m, p, L, A 1 , A 2 , Q, R 3 , R 4 , R 5 and R 6 is as defined above, R 7B2 and R 7F2 are independently hydroxyl, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy or C3-C8 cycloalkyl; R 7L2is cyano, amino, mercapto, hydroxyl, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C3-C6 cycloalkenyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C2-C6 alkynyloxy, C2-C6 haloalkynyloxy, C3-C8 cycloalkyloxy, C6-C 14 Aryloxy, 3- to 14-membered heterocyclyloxy, 5- to 14-membered heteroaryloxy, C6-C 14 Aryl, 5- to 14-membered heteroaryl, 3- to 14-membered heterocyclyl, -N(R 30 )2, -SR 31 , -S(=O)R 31 or -S(=O)2R 31 and C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C3-C6 cycloalkenyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C2-C6 alkynyloxy, C2-C6 haloalkynyloxy, C3-C8 cycloalkyloxy, C6-C 14 Aryloxy, 3- to 14-membered heterocyclyloxy, 5- to 14-membered heteroaryloxy, C6-C 14 Aryl, 5- to 14-membered heteroaryl and 3- to 14-membered heterocyclyl may be substituted as defined above. to the corresponding compound of formula (Ib), or m, n, p, A 1 , Q, T, Y, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 is as defined above, R7L3 is nitro, formyl, C1-C6 alkylcarbonyl, C1-C6 haloalkylcarbonyl, C1-C6 hydroxyalkyl, C1-C6 fluoroalkyl, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C3-C8 cycloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, C3-C8 cycloalkylsulfonyl, -C(=NR 21 )R 22 , -C(=O)N(R 26 )2, -S(=O)(=NR 28 )R 29 or -S(=O)2N(R 27 )2, C1-C6 alkylcarbonyl, C1-C6 haloalkylcarbonyl, C1-C6 hydroxyalkyl, C1-C6 fluoroalkyl, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C3-C8 cycloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl and C3-C8 cycloalkylsulfonyl may be substituted as defined above. may be converted to the corresponding compound of formula (Ic).
[0176] [ka]
[0177] Non-limiting examples of transformations that can be carried out according to Scheme 7 are shown below.
[0178] R 7L1 or R 7B1 or R 7F1 Compounds of formula (Ia), wherein R is a halogen, can be converted to R in the presence of a base as described herein and in the presence of a transition metal catalyst such as a metal salt or complex, and optionally in the presence of a ligand, or by metal photoredox catalysis methods similar to those described in the literature (WO 2008 / 151211; WO 2000 / 050401; J. Org. Chem. 2005, 70, 1432-1437). 7L2or R 7B2 or R 7F2 are cyano, amino, mercapto, hydroxyl, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C3-C6 cycloalkenyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C2-C6 alkynyloxy, C2-C6 haloalkynyloxy, C3-C8 cycloalkyloxy, C6-C 14 Aryloxy, 3- to 14-membered heterocyclyloxy, 5- to 14-membered heteroaryloxy, C6-C 14 Aryl, 5- to 14-membered heteroaryl, 3- to 14-membered heterocyclyl, -N(R 30 )2 or -SR 31 can be converted to a compound of formula (Ib)
[0179] R 7L2 Ga-SR 31 The compound of formula (Ib), wherein R 7L2 -S(=O)R 31 or -S(=O)2R 31 can be further converted to a compound of formula (Ia-4):
[0180] R 7L2 The compound of formula (Ib) where R is C2-C6 alkenyl substituted by C1-C3 alkoxy can be prepared by the method described in the literature (e.g., J. Org. Chem. 1993, 55, 3114). 7L3 can be converted to a compound of formula (Ic) wherein:
[0181] R 7L2aThe compound of formula (Ic) in which R is C1-C6 alkylcarbonyl can be prepared by the method described in the literature (e.g., Greene's Protective Groups in organic Synthesis; Peter GM Wuts; Wiley; Fifth Edition; 2014; 655, 661, 667). 7L3 -C(=NR 21 )R 22 and R 21 is as defined above, and R 22 can be further converted to a compound of formula (Ic) wherein is C1-C6 alkyl.
[0182] R 7L3 Compounds of formula (Ic) where R is a C1-C6 alkylcarbonyl can be converted to R by classical functional group interconversions such as reduction of the ketone to an alcohol in the presence of NaBH4 in methanol. 7L3 can be further converted to a compound of formula (Ic) wherein is C1-C6 hydroxyalkyl.
[0183] R 7L3 is C1-C6 hydroxyalkyl, in the presence of a fluorinating agent, 7L3 can be further converted to a compound of formula (Ic) wherein is C1-C6 fluoroalkyl. Non-limiting examples of fluorinating agents include sulfur fluorides such as sulfur tetrafluoride, diethylaminosulfur trifluoride, morpholinosulfur trifluoride, bis(2-methoxyethyl)aminosulfur trifluoride, 2,2-difluoro-1,3-dimethylimidazolidine, or 4-tert-butyl-2,6-dimethylphenylsulfur trifluoride.
[0184] Compounds of formula (Ia) may be prepared by one or more of the methods described herein.
[0185] Method for preparing compounds of formula (1) Compounds of formula (1) may be obtained directly by carrying out method H described below, or may be obtained by converting or derivatizing another compound of formula (1) prepared according to the methods described herein. Compounds of formulas (1-a) through (1-e) are various subsets of formula (1).
[0186] Method H p, Q and A 1 is as defined above, U 1 is hydroxyl or C1-C6 alkoxy, The compound of formula (1-a) in which p is 1 or 2 is 1 and U 1 may be prepared by oxidation of a compound of formula (1-b), wherein
[0187] The compound of formula (1-b) U 1 and A 1 is as defined above, X 1 may be prepared by reacting a compound of formula (20), where Q is a halogen, with a reagent of formula (6), where Q is as defined above, in the presence of a base and optionally in the presence of a suitable transition metal catalyst salt or complex and optionally in the presence of a ligand, as shown in Scheme 8.
[0188] [ka]
[0189] The compound of formula (20) is reacted with X 1 and A 1 is as defined above, by reacting a compound of formula (18) with a base (e.g., nBuLi or LDA) and carbon dioxide or E 3 is halogen, cyano, C1-C6 alkoxy or C1-C6 alkoxycarbonyloxy, U 2 is C1-C6 alkoxy It can be prepared by treatment with a reagent of formula (19).
[0190] U 1 The compound of formula (1-b) in which U is hydroxyl can be esterified by well-known esterification methods. 1 can be converted to a compound of formula (1-b) in which
[0191] U 1 Compounds of formula (1-b), where is C1-C6 alkoxy, can be converted to compounds of formula (1-a) by the well-known method of oxidizing thioethers in the presence of a peracid reagent such as m-chloroperbenzoic acid, as described in Catalysis Communications (2018), 111, 52-58.
[0192] U 1 Compounds of formula (1-a) where is C1-C6 alkoxy can be converted to U by well-known functional group interconversion methods, for example, hydrolysis of the ester group with LiOH in THF / water. 1 can be converted to a compound of formula (1-a) in which is hydroxyl.
[0193] U 1 is hydroxyl, in the presence of a halogenating agent, by a well-known method, 1 is a halogen. Suitable halogenating reagents include, but are not limited to, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus trichloride oxide, oxalyl chloride, or thionyl chloride.
[0194] Compounds of formula (6) and formula (19) are commercially available.
[0195] Compounds of formula (18) are commercially available or may be obtained by converting or derivatizing another compound of formula (18) according to well-known methods, for example, WO 2020 / 109391 or WO 2020 / 127780.
[0196] Method I In one or more steps as illustratively shown in Scheme 9: p, Q and A 1 is as defined above, U 1 is C1-C6 alkoxy, Ring Y has the formula (II-a), (II-c), (II-d), (II-e), (II-g), (II-h), (II-i), (II-j), (II-k), (II-l), (II -m), (II-n), (II-o), (II-p), (II-q), (II-w), (II-y), (II-z), (II-aa), (II-ab) or (II-ac):
[0197] [ka]
[0198] is a group of the formula * , #, A 1 , R 7A , R 7C , R 7D , R 7E , R 7F , R 7H and R 7M is as defined above, R 7B1 , R 7F1 and R 7L1 are independently hydrogen or halogen The compound of formula (1-c) is prepared by a known method. U 1 , Q and A 1 is as defined above, R 7B2 and R 7F2 are independently hydroxyl, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy or C3-C8 cycloalkyl; R 7L2is cyano, amino, mercapto, hydroxyl, C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C3-C6 cycloalkenyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C2-C6 alkynyloxy, C2-C6 haloalkynyloxy, C3-C8 cycloalkyloxy, C6-C 14 Aryloxy, 3- to 14-membered heterocyclyloxy, 5- to 14-membered heteroaryloxy, C6-C 14 Aryl, 5- to 14-membered heteroaryl, 3- to 14-membered heterocyclyl, -N(R 30 )2, -SR 31 , -S(=O)R 31 or -S(=O)2R 31 and C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, C3-C6 cycloalkenyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C2-C6 alkynyloxy, C2-C6 haloalkynyloxy, C3-C8 cycloalkyloxy, C6-C 14 Aryloxy, 3- to 14-membered heterocyclyloxy, 5- to 14-membered heteroaryloxy, C6-C 14 Aryl, 5- to 14-membered heteroaryl and 3- to 14-membered heterocyclyl may be substituted as defined above. The corresponding compound of formula (1-d) or p, U 1 , Q and A 1 is as defined above, R 7L3is nitro, formyl, C1-C6 alkylcarbonyl, C1-C6 haloalkylcarbonyl, C1-C6 hydroxyalkyl, C1-C6 fluoroalkyl, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C3-C8 cycloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, C3-C8 cycloalkylsulfonyl, -C(=NR 21 )R 22 , -C(=O)N(R 26 )2, -S(=O)(=NR 28 )R 29 or -S(=O)2N(R 27 )2, C1-C6 alkylcarbonyl, C1-C6 haloalkylcarbonyl, C1-C6 hydroxyalkyl, C1-C6 fluoroalkyl, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C3-C8 cycloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl and C3-C8 cycloalkylsulfonyl may be substituted as defined above. It can be converted into a compound of formula (1-e).
[0199] [ka]
[0200] A non-limiting example of the conversion may be carried out according to the description provided in Method G.
[0201] Next, U 1 The resulting compounds of formula (1-d) and (1-e), wherein is C1-C6 alkoxy, are treated with U 1 can be converted to compounds of formula (1-d) and (1-e) where is hydroxyl or halogen.
[0202] Examples of such transformations are given below.
[0203] U 1Compounds of formula (1-c), (1-d) and (1-e) where U is C1-C6 alkoxy can be converted to U by well-known functional group interconversion methods, for example, hydrolysis of the ester group with LiOH in THF / water. 1 can be converted to compounds of formula (1-c), (1-d) and (1-e) where is hydroxyl.
[0204] Next, U 1 Compounds of formula (1-c), (1-d) and (1-e) in which is hydroxyl can be reacted with U in the presence of a halogenating agent by well-known methods. 1 can be further converted to compounds of formula (1-c), (1-d), and (1-e) where is a halogen. Suitable halogenating reagents include, but are not limited to, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus trichloride oxide, oxalyl chloride, or thionyl chloride.
[0205] Compounds of formula (1-c) can be prepared by one or more of the methods described herein.
[0206] Method J As shown in Scheme 10, Y, Q and A 1 is as defined above, U 1 is hydroxy or C1-C6 alkoxy, 1 is as defined above, by reacting a compound of formula (23) with carbon dioxide or E 3 is halogen, cyano, C1-C6 alkoxy or C1-C6 alkoxycarbonyloxy, U 2 may be prepared by reacting with a reagent of formula (19) wherein is C1-C6 alkoxy.
[0207] [ka]
[0208] The compound of formula (23) Y and A 1 is as defined above, in the presence of a base and in the presence of a suitable transition metal catalyst salt or complex, and optionally in the presence of a ligand as described herein, similar to the method described in the literature (Chemistry - A European Journal (2020), 26(3), 620-624), E 4 is the expression # -B(OR 44 )2 group, # is the point of attachment to Q, R 44 is hydrogen or C1-C6 alkyl, or both R 44 together to form a -C(CH3)2-C(CH3)2- bridge It may be prepared by reaction with a reagent of formula (22).
[0209] U 1 is C1-C6 alkoxy, the compound of formula (1-b) is prepared by reacting U 1 may be converted to a compound of formula (1-b) wherein is hydroxyl or halogen.
[0210] The starting materials of formula (19), formula (21) and formula (22) are commercially available.
[0211] Method for preparing a compound of formula (7) Compounds of formula (7) may be obtained by carrying out Method N described below, or by converting or derivatizing another compound of formula (7) prepared according to the methods described herein. Compounds of formula (7-a) and formula (7-b) are various subsets of formula (7).
[0212] Method K In one or more steps as illustratively shown in Scheme 11: Y, Q and A 1is as defined above, by a method described in the literature, Y, Q and A 1 is as defined above, p is 1 or 2 It may be converted to the corresponding compound of formula (9-b).
[0213] [ka]
[0214] In Method K, R 20 is as defined above.
[0215] X 3 Compounds of formula (24) in which is halogen are commercially available or can be prepared by methods described in the literature (WO 2019 / 087129).
[0216] X 3 A compound of formula (24), wherein Q is a halogen, may be converted to a compound of formula (7-a) according to step 1 of method K in the presence of a reagent of formula (6), wherein Q is as defined above, and a base (e.g., an organic or inorganic base) as described herein.
[0217] Compounds of formula (7-a) can be further converted to compounds of formula (7-b) by oxidation of the sulfur atom as shown in Method H.
[0218] Compounds of formula (8) are commercially available or may be obtained by converting or derivatizing other compounds of formula (8) according to well-known methods.
[0219] Method for preparing compounds of formula (5) Amines of formula (5) may be prepared according to procedures described herein.
[0220] Method L Y.A. 1 , R3 , R 4 and R 5 is as defined above, X 1 is a halogen, m is 1, T is hydrogen; L is a direct bond; R 6 C6~C 14 Aryl, n-aromatic C7-C 14 carbocyclyl, 7- to 14-membered heterocyclyl, or 5- to 14-membered heteroaryl; C6~C 14 Aryl, n-aromatic C7-C 14 Carbocyclyl, 7- to 14-membered heterocyclyl and 5- to 14-membered heteroaryl may be optionally substituted as defined above. The compound of formula (5) m, T, Y, X 1 , A 1 , L, R 3 , R 4 and R 5 is as defined above, R 6 C6~C 14 Aryl, n-aromatic C7-C 14 carbocyclyl, 7- to 14-membered heterocyclyl, or 5- to 14-membered heteroaryl; C6~C 14 Aryl, n-aromatic C7-C 14 Carbocyclyl, 7- to 14-membered heterocyclyl and 5- to 14-membered heteroaryl may be optionally substituted as defined above. It may be prepared by reacting with a compound of formula (25).
[0221] Compounds of formula (26) can be reacted with Y, X under oxidative conditions as shown in Scheme 12. 1 , A 1 , R 3 , R 4 and R 5may be prepared by reacting a compound of formula (27), wherein
[0222] [ka]
[0223] The compound of formula (26) is reacted with R 6 C6~C 14 Aryl, C7-C 14 carbocyclyl, 7- to 14-membered heterocyclyl, or 5- to 14-membered heteroaryl; C6-C 14 Aryl, C7-C 14 Carbocyclyl, 7- to 14-membered heterocyclyl, and 5- to 14-membered heteroaryl can be reacted with a compound of formula (25), optionally substituted as defined above, to give a compound of formula (5). The reaction conditions for producing an oxadiazine ring using this method are known and are described in the literature (WO 2017 / 031325).
[0224] The compound of formula (25) is commercially available.
[0225] Compounds of formula (26) can be obtained from compounds of formula (27) under oxidative conditions, for example, in the presence of osmium tetroxide and sodium periodide.
[0226] Compounds of formula (27) may be prepared by Method M described herein.
[0227] Method M Y, X 1 , A 1 , R 3 , R 4 and R 5 is as defined above, m is 1 The compound of formula (27) m, Y, X 3 and A 1 is as defined above, and R 3 , R 4 and R 5 is as defined above, m is 1, X 4 is a halogen It may be prepared by reacting a compound of formula (28).
[0228] Compounds of formula (27) may be prepared by reacting compounds of formula (29) with hydroxylamine, as shown in Scheme 13.
[0229] [ka]
[0230] Compounds of formula (27) can be obtained by reacting compounds of formula (29) with compounds of formula (28) in the presence of a base. Suitable bases can be alkali metal hydrides such as sodium hydride, alkali metal carbonates such as potassium carbonate, alkali metal hydroxides such as potassium hydroxide, or phosphazene bases such as BEMP, as described in the literature (Heterocycles 2016, 92, 2166-2200).
[0231] Compounds of formula (29) can be obtained by reacting compounds of formula (24) with hydroxylamine or one of its salts. The reaction conditions for such a transformation are known and reported in the literature (WO 2010 / 138600).
[0232] Compounds of formula (24) are commercially available or can be prepared by methods described in the literature (WO 2019 / 087129).
[0233] Compounds of formula (28) are either commercially available or may be prepared by methods described in the literature (Eur. J. Med. Chem. 2014, 84, 302, Eur. J. Med. Chem. 2015, 100, 18-23; WO 2017 / 031325).
[0234] Intermediates The present invention also relates to intermediates for preparing compounds of formula (I).
[0235] Thus, the present invention provides a compound of formula (I): [ka]
[0236] The compound of formula (I) p, A 1 , Y, and Q are as defined in equation (1); U 1 is hydroxyl, halogen or C1-C6 alkoxy, However, the compound of formula (1) is 412339-07-2 3-Phenylsulfanylpyridine-4-carboxylic acid 1513480-16-4 3-Phenylsulfanylpyridazine-4-carboxylic acid 1872712-59-8 5-Phenylsulfanylpyridine-4-carboxylic acid 847143-61-7 3-Phenylsulfanylpyridine-4-carboxylic acid methyl ester 1161865-36-6 2-(methylsulfanyl)-5-(phenylsulfonyl)pyridine-4-carboxylate methyl ester 1161865-37-7 2-(Methylsulfanyl)-5-(phenylsulfonyl)pyridine-4-carboxylic acid 1284425-70-2 2-Isopropyl-5-(phenylsulfanyl)pyridine-4-carboxylic acid 1457455-96-7 2-Isopropyl-5-[(3-methoxyphenyl)sulfanyl]pyridine-4-carboxylic acid 1457634-69-3 2-Isopropyl-5-[(3-methylphenyl)sulfanyl]pyridine-4-carboxylic acid 1477890-40-6 5,6-dimethyl-3-(phenylsulfanyl)pyridazine-4-carboxylic acid 1481576-65-1 3-[(3-methoxyphenyl)sulfanyl]-5,6-dimethylpyridazine-4-carboxylic acid 1485756-76-0 3-[(3-chlorophenyl)sulfanyl]-5,6-dimethylpyridazine-4-carboxylic acid 1486392-94-2 5,6-dimethyl-3-[(3-methylphenyl)sulfanyl]pyridazine-4-carboxylic acid 1486802-49-6 3-[(3-bromophenyl)sulfanyl]-5,6-dimethylpyridazine-4-carboxylic acid 1492325-99-1 5-[(3-bromophenyl)sulfanyl]-2-isopropylpyridine-4-carboxylic acid 1497232-08-2 5-[(3-chlorophenyl)sulfanyl]-2-isopropylpyridine-4-carboxylic acid 1503006-13-0 5,6-diethyl-3-[(3-methylphenyl)sulfanyl]pyridazine-4-carboxylic acid 1503379-82-5 3-[(3-fluorophenyl)sulfanyl]-5,6-dimethylpyridazine-4-carboxylic acid 1506283-90-4 5-[(3-fluorophenyl)sulfanyl]-2-isopropylpyridine-4-carboxylic acid 1513271-93-6 3-[(3-methylphenyl)sulfanyl]isonicotinic acid 1514092-46-6 3-[(3-fluorophenyl)sulfanyl]isonicotinic acid 1523158-39-5 3-[(3-bromophenyl)sulfanyl]isonicotinic acid 1523548-82-4 3-[(3-methoxyphenyl)sulfanyl]pyridazine-4-carboxylic acid 1526683-76-0 3-[(3-methoxyphenyl)sulfanyl]isonicotinic acid 1534896-19-9 3-[(3-bromophenyl)sulfanyl]pyridazine-4-carboxylic acid 1534983-76-0 3-[(3-methylphenyl)sulfanyl]pyridazine-4-carboxylic acid 1535324-96-9 5,6-Diethyl-3-[(3-fluorophenyl)sulfanyl]pyridazine-4-carboxylic acid 1536015-59-4 3-[(3-chlorophenyl)sulfanyl]isonicotinic acid 1540166-88-8 3-[(3-bromophenyl)sulfanyl]-5,6-diethylpyridazine-4-carboxylic acid 1540302-71-3 3-[(3-chlorophenyl)sulfanyl]-5,6-diethylpyridazine-4-carboxylic acid 1540390-44-0 5,6-Diethyl-3-(phenylsulfanyl)pyridazine-4-carboxylic acid 1541162-68-8 3-[(3-fluorophenyl)sulfanyl]pyridazine-4-carboxylic acid 1983474-99-2 2-Amino-5-[(3-chlorophenyl)sulfanyl]isonicotinic acid 1987381-07-6 2-amino-5-[(3-bromophenyl)sulfanyl]isonicotinic acid methyl ester 1995464-60-2 5-[(3-fluorophenyl)sulfanyl]pyridine-4-carboxylic acid 2005209-39-0 5-[(3-bromophenyl)sulfanyl]pyridine-4-carboxylic acid 2023489-79-2 5-[(3-chlorophenyl)sulfanyl]pyridine-4-carboxylic acid 2153328-78-8 5-[(3-methylphenyl)sulfanyl]pyridine-4-carboxylic acid 25818-44-4 5-[(3-methylphenyl)sulfanyl]-2-(methylsulfanyl)pyridine-4-carboxylic acid 26032-75-7 5-[(3-chlorophenyl)sulfanyl]-2-(methylsulfanyl)pyridine-4-carboxylic acid 30314-53-5 5-[(3-methylphenyl)sulfonyl]-2-(methylsulfanyl)pyridine-4-carboxylic acid 30321-89-2 5-[(3-chlorophenyl)sulfonyl]-2-(methylsulfanyl)pyridine-4-carboxylic acid 392728-45-9 2-Methyl-3-(phenylsulfanyl)quinoline-4-carboxylic acid 412337-18-9 2,6-dimethyl-3-(phenylsulfanyl)quinoline-4-carboxylic acid 61727-07-9 2-(Methylsulfanyl)-5-(phenylsulfanyl)pyridine-4-carboxylic acid 61727-12-6 Ethyl 2-(methylsulfanyl)-5-(phenylsulfanyl)pyridine-4-carboxylate 854861-13-5 2-methyl-3-[(3-methylphenyl)sulfanyl]quinoline-4-carboxylic acid 872284-02-1 2,6-dimethyl-3-[(3-methylphenyl)sulfanyl]quinoline-4-carboxylic acid 2773371-42-7 Ethyl 3-(phenylsulfanyl)isonicotinate 2210255-71-1 Methyl 3-[(2-amino-4-bromo-3-methylphenyl)sulfonyl]isonicotinate 2210255-70-0 Methyl 3-[(4-bromo-3-methyl-2-nitrophenyl)sulfonyl]isonicotinate 2210255-69-7 Methyl 3-[(4-bromo-3-methyl-2-nitrophenyl)sulfanyl]isonicotinate 2210255-66-4 3-[(2-amino-4-carboxyphenyl)sulfanyl]isonicotinic acid 2210255-65-3 3-[(4-carboxy-2-nitrophenyl)sulfanyl]isonicotinic acid 2210255-64-2 3-{[4-(methoxycarbonyl)-2-nitrophenyl]sulfanyl}isonicotinic acid methyl ester 1984183-85-8 3-[(3,5-dichlorophenyl)sulfanyl]pyridazine-4-carboxylic acid 1973918-64-7 3-[(4-acetamidophenyl)sulfanyl]isonicotinic acid 1552208-23-7 3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylsulfanyl)pyridazine-4-carboxylic acid 1552187-93-5 3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylsulfanyl)isonicotinic acid 1549767-56-7 3-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)pyridazine-4-carboxylic acid 1546517-23-0 3-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)isonicotinic acid 1542446-95-6 5,6-diethyl-3-[(4-methylphenyl)sulfanyl]pyridazine-4-carboxylic acid 1541090-34-9 3-[(2,5-dichlorophenyl)sulfanyl]pyridazine-4-carboxylic acid and is a valuable intermediate for preparing compounds of formula (I).
[0237] A given for formula (I) 1 The preferred, more preferred, even more preferred and most preferred definitions of Y, p and Q apply mutatis mutandis.
[0238] The present invention relates to a compound of formula (3): [ka]
[0239] The compound of formula (3) p, L, Q, Y, R 3 , R 4 , R 5 and R 6 is as defined in formula (I), m is 1 or 2; A 1 is CH or N, A 2 is O, W is hydrogen or an amino protecting group, preferably tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl; Concerning compounds.
[0240] m, R as given for formula (I) 3 , R 4 , R 5 , L, R 6 The preferred, more preferred, even more preferred and most preferred definitions of Y, T, p and Q apply mutatis mutandis.
[0241] The present invention relates to a compound of formula (4): [ka]
[0242] The compound of formula (4) L, Q, Y, R 3 , R 4 , R 5 and R 6 is as defined in formula (I), m is 1 or 2; A 1 is CH or N, A 2 is O, p is 0, 1 or 2; W is hydrogen or an amino protecting group, preferably tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl; It also relates to compounds.
[0243] m, R as given for formula (I) 3 , R 4 , R 5 , R 6 The preferred, more preferred, even more preferred and most preferred definitions of L, Y, T and Q apply mutatis mutandis.
[0244] The present invention relates to a compound of formula (7): [ka]
[0245] The compound of formula (7) p, Q, and Y are as defined in formula (1), A 1 is CH or N, However, the compound of formula (7) is 112584-73-3 3-(Phenylsulfanyl)pyridazine-4-carbonitrile 1280685-02-0 3-[(3-bromophenyl)sulfanyl]-5,6-dimethylpyridazine-4-carbonitrile 1283253-31-5 3-[(3-chlorophenyl)sulfanyl]-5,6-dimethylpyridazine-4-carbonitrile 1291761-03-9 3-[(3-methoxyphenyl)sulfanyl]-5,6-dimethylpyridazine-4-carbonitrile 1306171-90-3 5,6-dimethyl-3-[(3-methylphenyl)sulfanyl]pyridazine-4-carbonitrile 1507083-32-0 3-[(4-cyanopyridazin-3-yl)sulfanyl]benzoic acid 1507307-30-3 3-[(3-fluorophenyl)sulfanyl]pyridazine-4-carbonitrile 1512302-01-0 5,6-diethyl-3-[(3-methylphenyl)sulfanyl]pyridazine-4-carbonitrile 1514666-14-8 3-[(3-bromophenyl)sulfanyl]isonicotinonitrile 1515821-24-5 3-[(3-bromophenyl)sulfanyl]pyridazine-4-carbonitrile 1515835-55-8 3-[(3-chlorophenyl)sulfanyl]-5,6-diethylpyridazine-4-carbonitrile 1515998-25-0 3-[(3-chlorophenyl)sulfanyl]pyridazine-4-carbonitrile 1516801-59-4 3-[(3-methoxyphenyl)sulfanyl]pyridazine-4-carbonitrile 1517334-07-4 3-[(4-cyano-5,6-dimethylpyridazin-3-yl)sulfanyl]benzoic acid 1517383-36-6 3-(Phenylsulfanyl)isonicotinonitrile 1519328-48-3 3-[(3-methylphenyl)sulfanyl]isonicotinonitrile 1519940-37-4 3-[(3-bromophenyl)sulfanyl]-5,6-diethylpyridazine-4-carbonitrile 1521967-73-6 3-[(3-fluorophenyl)sulfanyl]-5,6-dimethylpyridazine-4-carbonitrile 1522520-64-4 3-[(4-cyanopyridin-3-yl)sulfanyl]benzoic acid 1526273-67-5 5,6-Diethyl-3-(phenylsulfanyl)pyridazine-4-carbonitrile 1526758-12-2 3-[(3-fluorophenyl)sulfanyl]isonicotinonitrile 1531111-48-4 3-[(3-methylphenyl)sulfanyl]pyridazine-4-carbonitrile 1534450-43-5 2-[(4-cyanopyridin-3-yl)sulfanyl]benzoic acid 1541618-13-6 3-[(3-chlorophenyl)sulfanyl]isonicotinonitrile 1541734-24-0 5,6-Diethyl-3-[(3-fluorophenyl)sulfanyl]pyridazine-4-carbonitrile 1542445-40-8 3-[(3-methoxyphenyl)sulfanyl]isonicotinonitrile 1565018-08-7 3-[(3-hydroxyphenyl)sulfanyl]pyridazine-4-carbonitrile 1567057-60-6 3-[(3-hydroxyphenyl)sulfanyl]isonicotinonitrile 1918944-71-4 3-[(3-hydroxyphenyl)sulfanyl]-5,6-dimethylpyridazine-4-carbonitrile 1919937-05-5 5,6-Diethyl-3-[(3-hydroxyphenyl)sulfanyl]pyridazine-4-carbonitrile 1994713-26-6 3-[(3-aminophenyl)sulfanyl]pyridazine-4-carbonitrile 93824-73-8 5,6-dimethyl-3-(phenylsulfanyl)pyridazine-4-carbonitrile 1505746-83-7 3-(pyrimidin-2-ylsulfanyl)pyridazine-4-carbonitrile 1507060-26-5 3-(Pyridin-4-ylsulfanyl)pyridazine-4-carbonitrile 1513275-52-9 3-(pyridin-2-ylsulfanyl)pyridazine-4-carbonitrile 1513360-57-0 3-(Pyrimidin-4-ylsulfanyl)pyridazine-4-carbonitrile 1513971-13-5 3-(pyrazin-2-ylsulfanyl)pyridazine-4-carbonitrile 1516397-06-0 3-(Pyridin-4-ylsulfanyl)isonicotinonitrile 1521473-09-5 3-(pyrazin-2-ylsulfanyl)isonicotinonitrile 1523320-54-8 3-(Pyrimidin-4-ylsulfanyl)isonicotinonitrile 1529676-43-4 3-(Pyridin-2-ylsulfanyl)isonicotinonitrile 1539518-84-7 3-(pyrimidin-2-ylsulfanyl)isonicotinonitrile 1541770-98-2 3-[(2,4-difluorophenyl)sulfanyl]pyridazine-4-carbonitrile 1542028-33-0 2-[(4-cyanopyridin-3-yl)sulfanyl]isonicotinic acid 1542111-08-9 3-[(2-fluorophenyl)sulfanyl]pyridazine-4-carbonitrile 1542425-06-8 2-[(4-cyano-5,6-dimethylpyridazin-3-yl)sulfanyl]isonicotinic acid 1542445-40-8 3-[(3-methoxyphenyl)sulfanyl]isonicotinonitrile 1542950-37-7 5,6-Diethyl-3-[(4-fluorophenyl)sulfanyl]pyridazine-4-carbonitrile 1544796-59-9 5,6-Diethyl-3-(pyrimidin-2-ylsulfanyl)pyridazine-4-carbonitrile 1545492-03-2 4-Bromo-2-[(4-cyanopyridin-3-yl)sulfanyl]benzoic acid 1546061-32-8 4-Bromo-2-[(4-cyanopyridazin-3-yl)sulfanyl]benzoic acid 1546518-00-6 3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylsulfanyl)isonicotinonitrile 1550621-17-4 3-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)pyridazine-4-carbonitrile 1552178-28-5 3-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)isonicotinonitrile 1552178-81-0 3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylsulfanyl)pyridazine-4-carbonitrile 1558544-05-0 4-Bromo-2-[(4-cyano-5,6-dimethylpyridazin-3-yl)sulfanyl]benzoic acid 1785765-67-4 3-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-5,6-dimethylpyridazine-4-carbonitrile 1912799-77-9 2-Bromo-5-[(4-cyanopyridazin-3-yl)sulfanyl]benzoic acid 1912836-17-9 2-chloro-5-[(4-cyano-5,6-dimethylpyridazin-3-yl)sulfanyl]benzoic acid 1912836-85-1 5-[(4-cyanopyridin-3-yl)sulfanyl]-2-methylbenzoic acid 1912875-58-1 3-{[4-(hydroxymethyl)phenyl]sulfanyl}-5,6-dimethylpyridazine-4-carbonitrile 1914411-96-3 5-[(4-cyano-5,6-dimethylpyridazin-3-yl)sulfanyl]-2-fluorobenzoic acid 1914413-02-7 5-[(4-cyano-5,6-dimethylpyridazin-3-yl)sulfanyl]-2-methylbenzoic acid 1915444-00-6 5-[(4-cyanopyridazin-3-yl)sulfanyl]-2-fluorobenzoic acid 1915444-57-3 5,6-Diethyl-3-{[4-(hydroxymethyl)phenyl]sulfanyl}pyridazine-4-carbonitrile 1918944-71-4 3-[(3-hydroxyphenyl)sulfanyl]-5,6-dimethylpyridazine-4-carbonitrile 1919937-05-5 5,6-Diethyl-3-[(3-hydroxyphenyl)sulfanyl]pyridazine-4-carbonitrile 1920157-21-6 2-Bromo-5-[(4-cyano-5,6-dimethylpyridazin-3-yl)sulfanyl]benzoic acid 1923641-72-8 3-{[4-(hydroxymethyl)phenyl]sulfanyl}isonicotinonitrile 1924412-51-0 2-Bromo-5-[(4-cyanopyridin-3-yl)sulfanyl]benzoic acid 1949164-34-4 3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylsulfanyl)-5,6-dimethylpyridazine-4-carbonitrile 1973661-63-0 3-[(4,6-dimethylpyridin-2-yl)sulfanyl]-5,6-dimethylpyridazine-4-carbonitrile 1973661-82-3 3-[(4,6-dimethylpyridin-2-yl)sulfanyl]-5,6-diethylpyridazine-4-carbonitrile 1973828-14-6 3-[(4,6-dimethylpyridin-2-yl)sulfanyl]isonicotinonitrile 1983026-97-6 3-[(4,6-dimethylpyridin-2-yl)sulfanyl]pyridazine-4-carbonitrile 1985156-20-4 2-chloro-5-[(4-cyanopyridin-3-yl)sulfanyl]benzoic acid 1985156-33-9 2-chloro-5-[(4-cyanopyridazin-3-yl)sulfanyl]benzoic acid 1985156-42-0 5-[(4-cyanopyridin-3-yl)sulfanyl]-2-fluorobenzoic acid 1989307-73-4 5-[(4-cyanopyridazin-3-yl)sulfanyl]-2-methylbenzoic acid 2025176-86-5 3-[(3-aminophenyl)sulfanyl]isonicotinonitrile 2156558-81-3 3-[(6-methylpyridazin-3-yl)sulfanyl]pyridazine-4-carbonitrile 2162100-69-6 3-[(3-methylpyridin-2-yl)sulfanyl]isonicotinonitrile 2162831-11-8 3-(pyridazin-3-ylsulfanyl)pyridazine-4-carbonitrile 2273509-45-6 3-[(3-methylpyridin-2-yl)sulfanyl]pyridazine-4-carbonitrile 2285249-30-9 3-[(6-methylpyridazin-3-yl)sulfanyl]isonicotinonitrile 2285251-65-0 3-(pyridazin-3-ylsulfanyl)isonicotinonitrile 2296602-18-9 3-[(2-methylpyridin-4-yl)sulfanyl]pyridazine-4-carbonitrile 2300504-07-6 3-[(2-methylpyridin-4-yl)sulfanyl]isonicotinonitrile 2818388-52-0 N-{4-[(4-cyano-6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)sulfanyl]phenyl}acetamide 2815167-63-4 N-{3-[(4-cyano-6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)sulfanyl]phenyl}acetamide 2804863-26-9 3-Bromo-5-{[4-(hydroxymethyl)phenyl]sulfanyl}isonicotinonitrile 2802854-42-6 3-{[4-(hydroxymethyl)phenyl]sulfanyl}-5,6,7,8-tetrahydrocinnoline-4-carbonitrile No, It also relates to compounds.
[0246] The preferred, more preferred, even more preferred and most preferred definitions of p, Y and Q given for formula (I) apply mutatis mutandis.
[0247] The present invention relates to a compound of formula (7): [ka]
[0248] The compound of formula (7) p, Q, and Y are as defined in formula (1), A 1 is CH or N, provided that Y is not pyridazinyl or pyridinyl and the compound of formula (7) is: 2818388-52-0 N-{4-[(4-cyano-6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)sulfanyl]phenyl}acetamide 2815167-63-4 N-{3-[(4-cyano-6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)sulfanyl]phenyl}acetamide 2802854-42-6 3-{[4-(hydroxymethyl)phenyl]sulfanyl}-5,6,7,8-tetrahydrocinnoline-4-carbonitrile But not, It also relates to compounds.
[0249] The preferred, more preferred, even more preferred and most preferred definitions of p, Y and Q given for formula (I) apply mutatis mutandis.
[0250] The present invention relates to a compound of formula (8):
[0251] [ka]
[0252] In the formula (8), p, Y, and Q are as defined in equation (1), A 1 is CH or N, However, R 7 and R 8 At least one of these is different from hydrogen: However, the compound of formula (8) is 1286350-52-4 N-Hydroxy-5,6-dimethyl-3-(phenylsulfanyl)pyridazine-4-carboximidamide 1308753-11-8 N-Hydroxy-3-[(3-methoxyphenyl)sulfanyl]-5,6-dimethylpyridazine-4-carboximidamide 1308757-67-6 N-Hydroxy-5,6-dimethyl-3-[(3-methylphenyl)sulfanyl]pyridazine-4-carboximidamide 1562116-93-1 3-[(3-chlorophenyl)sulfanyl]-N-hydroxypyridazine-4-carboximidamide 1562117-91-2 3-[(3-bromophenyl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1562164-34-4 N-Hydroxy-3-[(3-methoxyphenyl)sulfanyl]pyridazine-4-carboximidamide 1562337-74-9 N-Hydroxy-3-[(3-methylphenyl)sulfanyl]pyridine-4-carboximidamide 1562998-25-7 3-[(3-chlorophenyl)sulfanyl]-N-hydroxy-5,6-dimethylpyridazine-4-carboximidamide 1563049-05-7 3-[(3-bromophenyl)sulfanyl]-N-hydroxy-5,6-dimethylpyridazine-4-carboximidamide 1563249-55-7 3-[(3-fluorophenyl)sulfanyl]-N-hydroxypyridazine-4-carboximidamide 1563329-43-0 N-Hydroxy-3-[(3-methylphenyl)sulfanyl]pyridazine-4-carboximidamide 1563336-23-1 N-Hydroxy-3-[(3-methoxyphenyl)sulfanyl]pyridine-4-carboximidamide 1563674-18-9 3-[(3-chlorophenyl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1563728-63-1 3-[(3-fluorophenyl)sulfanyl]-N-hydroxy-5,6-dimethylpyridazine-4-carboximidamide 1563783-01-6 N-Hydroxy-3-(phenylsulfanyl)pyridazine-4-carboximidamide 1563798-42-4 3-[(3-bromophenyl)sulfanyl]-N-hydroxypyridazine-4-carboximidamide 1563907-88-9 5,6-Diethyl-N-hydroxy-3-(phenylsulfanyl)pyridazine-4-carboximidamide 1563972-91-7 N-Hydroxy-3-(phenylsulfanyl)pyridine-4-carboximidamide 1564075-67-7 3-[(3-fluorophenyl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1562159-07-2 N-Hydroxy-3-(pyrimidin-4-ylsulfanyl)pyridazine-4-carboximidamide 1562313-29-4 N-Hydroxy-3-(pyrimidin-2-ylsulfanyl)pyridine-4-carboximidamide 1562313-71-6 N-Hydroxy-3-(pyrimidin-2-ylsulfanyl)pyridazine-4-carboximidamide 1562360-06-8 N-Hydroxy-3-(pyrazin-2-ylsulfanyl)pyridazine-4-carboximidamide 1563324-93-5 N-Hydroxy-3-(pyridin-2-ylsulfanyl)pyridazine-4-carboximidamide 1563334-78-0 N-Hydroxy-3-(pyrimidin-4-ylsulfanyl)pyridine-4-carboximidamide 1563522-28-0 N-Hydroxy-3-(pyrazin-2-ylsulfanyl)pyridine-4-carboximidamide 1563662-99-6 N-Hydroxy-3-[(4-methylphenyl)sulfanyl]pyridazine-4-carboximidamide 1563683-50-0 3-[(2,5-dichlorophenyl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1563704-19-7 3-[(2,4-dimethylphenyl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1563724-99-1 N-Hydroxy-3-[(4-methoxyphenyl)sulfanyl]pyridazine-4-carboximidamide 1563730-63-1 3-[(2-bromophenyl)sulfanyl]-N-hydroxypyridazine-4-carboximidamide 1563751-68-7 3-[(5-chloropyridin-2-yl)sulfanyl]-N-hydroxypyridazine-4-carboximidamide 1563753-97-8 5,6-Diethyl-N-hydroxy-3-(pyrimidin-4-ylsulfanyl)pyridazine-4-carboximidamide 1563756-57-9 3-[(4-tert-butylphenyl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1563758-96-2 5,6-Diethyl-N-hydroxy-3-(pyridin-2-ylsulfanyl)pyridazine-4-carboximidamide 1563762-09-3 N-Hydroxy-3-[(6-oxo-1,6-dihydropyrimidin-2-yl)sulfanyl]pyridine-4-carboximidamide 1563779-73-6 3-[(2-bromophenyl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1563810-30-9 N-Hydroxy-3-[(5-methylpyrimidin-2-yl)sulfanyl]pyridazine-4-carboximidamide 1563811-27-7 3-[(2,5-dimethylphenyl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1563822-98-9 3-[(4-bromophenyl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1563828-54-5 3-[(3,4-dichlorophenyl)sulfanyl]-N-hydroxypyridazine-4-carboximidamide 1563840-16-3 3-[(3-bromopyridin-2-yl)sulfanyl]-N-hydroxypyridazine-4-carboximidamide 1563844-09-6 N-Hydroxy-3-(pyridin-2-ylsulfanyl)pyridine-4-carboximidamide 1563851-79-5 3-[(3,4-dichlorophenyl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1563867-64-0 N-Hydroxy-3-{[5-(trifluoromethyl)pyridin-2-yl]sulfanyl}pyridazine-4-carboximidamide 1563872-32-1 3-[(2,4-difluorophenyl)sulfanyl]-N-hydroxypyridazine-4-carboximidamide 1563885-17-5 3-[(5-chloropyridin-2-yl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1563943-06-5 3-[(4-bromophenyl)sulfanyl]-N-hydroxypyridazine-4-carboximidamide 1563943-97-4 3-[(3,4-dimethylphenyl)sulfanyl]-N-hydroxypyridazine-4-carboximidamide 1563946-14-4 3-[(3,4-difluorophenyl)sulfanyl]-N-hydroxypyridazine-4-carboximidamide 1563947-34-1 N-Hydroxy-3-[(4-isopropylphenyl)sulfanyl]pyridine-4-carboximidamide 1563949-29-0 N-Hydroxy-3-[(4,5,6-trimethylpyrimidin-2-yl)sulfanyl]pyridine-4-carboximidamide 1563960-00-8 3-[(4-tert-butylphenyl)sulfanyl]-N-hydroxypyridazine-4-carboximidamide 1563962-97-9 N-Hydroxy-3-[(2-methylphenyl)sulfanyl]pyridine-4-carboximidamide 1563986-18-4 5,6-Diethyl-N-hydroxy-3-(pyrazin-2-ylsulfanyl)pyridazine-4-carboximidamide 1563991-72-9 3-(2,3-dihydro-1H-inden-5-ylsulfanyl)-N-hydroxypyridazine-4-carboximidamide 1563995-18-5 N-Hydroxy-3-(pyridin-4-ylsulfanyl)pyridazine-4-carboximidamide 1563997-68-1 3-[(4-chlorophenyl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1564010-87-2 N-Hydroxy-3-(pyridin-4-ylsulfanyl)pyridine-4-carboximidamide 1564038-19-2 N-Hydroxy-3-[(2-methoxyphenyl)sulfanyl]pyridazine-4-carboximidamide 1564051-09-7 N-Hydroxy-3-[(4-methylpyrimidin-2-yl)sulfanyl]pyridazine-4-carboximidamide 1564051-95-1 3-[(3-bromopyridin-2-yl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1564055-75-9 3-[(5-bromopyridin-2-yl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1564057-14-2 N-Hydroxy-3-[(2-nitrophenyl)sulfanyl]pyridazine-4-carboximidamide 1564066-99-4 N-Hydroxy-3-[(4-nitrophenyl)sulfanyl]pyridazine-4-carboximidamide 1564069-64-2 3-[(3,4-difluorophenyl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1564071-00-6 3-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]-N-hydroxypyridazine-4-carboximidamide 1564431-48-6 3-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-N-hydroxypyridazine-4-carboximidamide 1564431-54-4 3-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-N-hydroxypyridine-4-carboximidamide 1982471-58-8 3-[(4,6-dimethylpyridin-2-yl)sulfanyl]-N-hydroxypyridine-4-carboximidamide 1982477-46-2 3-[(4,6-dimethylpyridin-2-yl)sulfanyl]-N-hydroxy-5,6-dimethylpyridazine-4-carboximidamide 1982481-66-2 3-[(4,6-dimethylpyridin-2-yl)sulfanyl]-N-hydroxypyridazine-4-carboximidamide No, It also relates to compounds.
[0253] The preferred, more preferred, even more preferred and most preferred definitions of p, Y and Q given for formula (I) apply mutatis mutandis.
[0254] The present invention relates to a compound of formula (8):
[0255] [ka]
[0256] In the formula (8), p, Y, and Q are as defined in equation (1), A 1 is CH or N, However, R 7 and R 8 at least one of is different from hydrogen and Y is not pyridazinyl or pyridinyl; It also relates to compounds.
[0257] The preferred, more preferred, even more preferred and most preferred definitions of p, Y and Q given for formula (I) apply mutatis mutandis.
[0258] The present invention relates to a compound of formula (10):
[0259] [ka]
[0260] The compound of formula (10) p, L, Q, T, Y, R 3 , R 4 and R 6 is as defined in formula (I), A 1 is CH or N, m is 1 or 2; It also relates to compounds.
[0261] p, L, Q, T, Y, R as given for formula (I) 3 , R 4 and R 6 The definitions of preferred, more preferred, even more preferred and most preferred in the above paragraphs apply mutatis mutandis.
[0262] The present invention relates to a compound of formula (12):
[0263] [ka]
[0264] The compound represented by the formula (12): p, L, Q, T, Y, R 3 , R 4 , R 5 and R 6 is as defined in formula (I), m is 1 or 2; A 1 is CH or N, E 1 is hydroxyl or halogen, W is hydrogen or an amino protecting group, preferably tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl; It also relates to compounds.
[0265] p, L, Q, T, Y, R as given for formula (I) 3 , R 4 , R 5 and R 6 The definitions of preferred, more preferred, even more preferred and most preferred in the above paragraphs apply mutatis mutandis.
[0266] The present invention relates to a compound of formula (14):
[0267] [ka]
[0268] The compound represented by the formula (14): p, L, Q, T, Y, R 3 , R 4 , R 5 and R 6 is as defined in formula (I), m is 1 or 2; A 1 is CH or N, E 1 is hydroxyl or halogen, E 2 is hydroxyl, W is hydrogen or an amino protecting group, preferably tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl; It also relates to compounds.
[0269] m, p, L, Q, T, Y, R as given for formula (I) 3 , R 4 , R 5 and R 6 The definitions of preferred, more preferred, even more preferred and most preferred in the above paragraphs apply mutatis mutandis.
[0270] The present invention relates to a compound of formula (16):
[0271] [ka]
[0272] The compound represented by formula (16) is p, Q, T, Y, R 3 , R 4 and R 5 is as defined in formula (I), A 1 is CH or N, It also relates to compounds.
[0273] p, Q, Y, R as given for formula (I) 3 , R 4 and R 5 The definitions of preferred, more preferred, even more preferred and most preferred in the above paragraphs apply mutatis mutandis.
[0274] The present invention relates to a compound of formula (18): [ka]
[0275] The compound represented by the formula (18): p, Q, T, Y, R 3 , R 4 , R 5 and R 6 is as defined in formula (I), A 1 is CH or N, It also relates to compounds.
[0276] p, Q, T, Y, R as given for formula (I) 3 , R 4 , R 5 and R 6 The definitions of preferred, more preferred, even more preferred and most preferred in the above paragraphs apply mutatis mutandis.
[0277] The present invention relates to a compound of formula (6): Q-SH(6), During the ceremony, Q is a group having the formula:
[0278] [ka]
[0279] is a group of the formula § 1 is the point of attachment to sulfur, A 3 is CH or N, Q S is C3-C4 cycloalkyl, C3-C8 halocycloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, or C2-C6 alkynyl The basis is It also relates to intermediates.
[0280] Therefore, the present invention provides a compound of formula (26):
[0281] [ka]
[0282] The compound represented by formula (26) Y is as defined in equation (1), m is 1, A 1 is CH or N, X 1 is a halogen, R 3 and R 4 are independently hydrogen, halogen, cyano, hydroxyl, formyl, carboxyl, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C8 cycloalkyl, C6-C 14 aryl, 5- to 14-membered heteroaryl, 3- to 14-membered heterocyclyl, or —O—Si(C1-C6 alkyl)3; C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, C2-C6 alkenyl, C2-C6 alkynyl and -O-Si(C1-C6 alkyl)3 are optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; and C3-C8 cycloalkyl, C6-C 14 The aryl, 5- to 14-membered heteroaryl, and 3- to 14-membered heterocyclyl are optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3, and 3- to 7-membered heterocyclyl; or R 3 and R 4 together with the carbon atoms to which they are attached form a carbonyl, methylidene, C3-C8 cycloalkyl ring, or 3- to 7-membered heterocyclyl ring; The C3-C8 cycloalkyl and the 3- to 7-membered heterocyclyl are optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; R 5is hydrogen, hydroxyl, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylcarbonyloxy, C1-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C3-C8 cycloalkyl or -O-Si(C1-C6 alkyl)3; C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylcarbonyloxy, C1-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl and -O-Si(C1-C6 alkyl)3 are optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; and the C3-C8 cycloalkyl is optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; T is hydrogen; Concerning compounds.
[0283] Y, R as given for formula (I) 3 , R 4 and R 5 The definitions of preferred, more preferred, even more preferred and most preferred in the above paragraphs apply mutatis mutandis.
[0284] The present invention relates to a compound of formula (27): [ka]
[0285] The compound represented by formula (27) Y is as defined in formula (1), m is 1, A 1 is CH or N, X 1 is a halogen, R 3 and R 4 are independently hydrogen, halogen, cyano, hydroxyl, formyl, carboxyl, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C8 cycloalkyl, C6-C 14 aryl, 5- to 14-membered heteroaryl, 3- to 14-membered heterocyclyl, or —O—Si(C1-C6 alkyl)3; C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, C2-C6 alkenyl, C2-C6 alkynyl and -O-Si(C1-C6 alkyl)3 are optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; and C3-C8 cycloalkyl, C6-C 14 The aryl, 5- to 14-membered heteroaryl, and 3- to 14-membered heterocyclyl are optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3, and 3- to 7-membered heterocyclyl; or R 3and R 4 together with the carbon atoms to which they are attached form a carbonyl, methylidene, C3-C8 cycloalkyl ring, or 3- to 7-membered heterocyclyl ring; The C3-C8 cycloalkyl and the 3- to 7-membered heterocyclyl are optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; R 5 is hydrogen, hydroxyl, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylcarbonyloxy, C1-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C3-C8 cycloalkyl or -O-Si(C1-C6 alkyl)3; C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylcarbonyloxy, C1-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl and -O-Si(C1-C6 alkyl)3 are optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkoxycarbonyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; and C3-C8 cycloalkyl is optionally substituted by 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C2-C6 alkenyl, C3-C8 cycloalkyl, C3-C8 halocycloalkyl, -O-Si(C1-C6 alkyl)3 and 3- to 7-membered heterocyclyl; It also relates to compounds.
[0286] Y, R as given for formula (I) 3 , R 4 and R 5 The definitions of preferred, more preferred, even more preferred and most preferred in the above paragraphs apply mutatis mutandis.
[0287] The present invention relates to a compound of formula (29):
[0288] [ka]
[0289] The compound represented by the formula (29): Y is as defined in formula (1), A 1 is CH or N, X 1 is a halogen, However, the compound of formula (29) is 1937347-23-3 3-Fluoro-N'-hydroxypyridine-4-carboximidamide 1824883-82-0 3-Bromo-N'-hydroxypyridine-4-carboximidamide 411222-41-8 3-chloro-N'-hydroxypyridine-4-carboximidamide 2387453-83-8 5-Bromo-2-chloro-N'-hydroxypyridine-4-carboximidamide 2387409-08-5 2-Bromo-5-fluoro-N'-hydroxypyridine-4-carboximidamide It also relates to compounds that are not
[0290] Compositions and Formulations The present invention further relates to compositions, especially compositions for controlling unwanted microorganisms, which can be applied to the microorganisms and / or their habitat.
[0291] The compositions comprise at least one compound of formula (I) and at least one agriculturally suitable adjuvant, such as a carrier and / or surfactant.
[0292] Carriers are generally inert, solid or liquid, natural or synthetic, organic or inorganic materials. Carriers generally improve the application of compounds to, for example, plants, plant parts, or seeds. Examples of suitable solid carriers include, but are not limited to, ammonium salts, especially ammonium sulfate, ammonium phosphate, and ammonium nitrate; natural rock powders such as kaolin, clay, talc, chalk, quartz, attapulgite, montmorillonite, and diatomaceous earth; silica gels and synthetic rock powders such as finely divided silica, alumina, and silicates. Examples of typically useful solid carriers for preparing granules include, but are not limited to, crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite, and dolomite; synthetic granules of inorganic and organic flours; and granules of organic materials such as paper, sawdust, coconut shells, corn cobs, and tobacco stalks. Examples of suitable liquid carriers include, but are not limited to, water, organic solvents, and combinations thereof. Examples of suitable solvents include, for example, polar and non-polar organic chemical liquids from the classes of aromatic and non-aromatic hydrocarbons (such as cyclohexane, paraffins, alkylbenzenes, xylenes, toluene, tetrahydronaphthalene, alkylnaphthalenes, chlorinated aromatic or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylene, or methylene chloride), alcohols and polyols (which may be substituted, etherified, and / or esterified, such as ethanol, propanol, butanol, benzyl alcohol, cyclohexanol, or glycols), ketones (such as acetone, methyl ethyl ketone, methyl isobutyl ketone, or cyclohexanone), esters (including fats and oils) and (poly)ethers, unsubstituted and substituted amines, amides (such as dimethylformamide or fatty acid amides) and esters thereof, lactams (such as N-alkylpyrrolidones, in particular N-methylpyrrolidone) and lactones, sulfones and sulfoxides (such as dimethyl sulfoxide), oils of vegetable or animal origin. The carrier may also be a liquefied gas extender, ie, a liquid that is a gaseous liquid at standard temperature and pressure, such as an aerosol propellant, for example, halohydrocarbon, butane, propane, nitrogen, carbon dioxide, and the like.
[0293] Preferred solid carriers are selected from clay, talc and silica.
[0294] Preferred liquid carriers are selected from water, fatty acid amides and esters thereof, aromatic and non-aromatic hydrocarbons, lactams, and carbonate esters.
[0295] The amount of carrier will typically range from 1 to 99.99%, preferably from 5 to 99.9%, more preferably from 10 to 99.5%, and most preferably from 20 to 99% by weight of the composition.
[0296] The liquid carrier will typically be present in the range 20 to 90% by weight of the composition, for example 30 to 80% by weight.
[0297] The solid carrier will typically be present in the range 0 to 50% by weight of the composition, preferably 5 to 45% by weight, for example 10 to 30% by weight.
[0298] If the composition comprises two or more carriers, the ranges outlined refer to the total amount of carriers.
[0299] The surfactant may be an ionic (cationic or anionic), amphoteric or nonionic surfactant such as an ionic or nonionic emulsifier, a foaming agent, a dispersing agent, a wetting agent, a penetration enhancer, or a mixture of any of these. Examples of suitable surfactants include salts of polyacrylic acid, salts of lignosulfonic acid (such as sodium lignosulfonate), salts of phenolsulfonic acid or naphthalenesulfonic acid, polycondensates of ethylene oxide and / or propylene oxide with fatty alcohols, fatty acids or fatty amines (e.g., polyoxyethylene fatty acid esters such as castor oil ethoxylate, polyoxyethylene fatty alcohol ethers, e.g., alkylaryl polyglycol ethers), substituted phenols (preferably alkylphenols or arylphenols) and their ethoxylates (e.g., tristyrylphenols), Examples of suitable salts include, but are not limited to, ethoxylates, salts of sulfosuccinates, taurine derivatives (preferably alkyl taurates), phosphate esters of polyethoxylated alcohols or phenols, fatty esters of polyols (such as fatty acid esters of glycerol, sorbitol, or sucrose), sulfates (such as alkyl sulfates and alkyl ether sulfates), sulfonates (e.g., alkyl sulfonates, aryl sulfonates, and alkyl benzene sulfonates), phosphate esters, protein hydrolysates, lignosulfite waste liquor, and methylcellulose. Any reference to salts in this paragraph preferably refers to the respective alkali, alkaline earth, and ammonium salts.
[0300] Preferred surfactants are selected from polyoxyethylene fatty alcohol ethers, polyoxyethylene fatty acid esters, alkylbenzene sulfonates such as calcium dodecylbenzene sulfonate, castor oil ethoxylates, sodium lignosulfonates, and arylphenol ethoxylates such as tristyrylphenol ethoxylate.
[0301] The amount of surfactant will typically be in the range 5 to 40%, for example 10 to 20% by weight of the composition.
[0302] Further examples of suitable auxiliaries include water repellents, desiccants, binders (adhesives, tackifiers, fixatives such as carboxymethylcellulose, natural and synthetic polymers in powder, granule or latex form such as gum arabic, polyvinyl alcohol and polyvinyl acetate, natural and synthetic phospholipids such as cephalin and lecithin, polyvinylpyrrolidone, and tylose), thickeners and secondary thickeners (cellulose ethers, acrylic acid derivatives, xanthan gum, modified clays, such as products available under the name BENTONE®, and finely divided silica), stabilizers (such as low-temperature stabilizers, preservatives such as dichlorophene and benzyl alcohol), and the like. and hydroxybenzoates, ...
[0303] The choice of adjuvant depends on the intended method of application of the compound of formula (I) and / or the physical properties of the compound. Furthermore, the adjuvant may be selected to impart specific properties (technical, physical, and / or biological properties) to the composition or the use form prepared therefrom. The choice of adjuvant may allow the composition to be customized to specific needs.
[0304] The compositions of the present invention may be provided to the end user as ready-to-use formulations, i.e., the compositions may be applied directly to the plants or seeds by suitable equipment, such as spray or dusting equipment, or alternatively, the compositions may be provided to the end user in the form of a concentrate that must be diluted, preferably with water, before use.
[0305] The compositions of the present invention may be prepared in a conventional manner, for example by mixing a compound of formula (I) with one or more suitable auxiliaries such as those disclosed hereinabove.
[0306] The composition comprises a fungicidally effective amount of a compound of formula (I). The term "effective amount" refers to an amount sufficient to control harmful fungi on cultivated plants or to protect materials without causing substantial damage to the treated plants. Such amounts can vary widely and depend on various factors, such as the fungal species to be controlled, the cultivated plants or materials to be treated, climatic conditions, and the particular compound of formula (I) used. Typically, compositions according to the present invention contain 0.01 to 99% by weight, preferably 0.05 to 98% by weight, more preferably 0.1 to 95% by weight, even more preferably 0.5 to 90% by weight, and most preferably 1 to 80% by weight of a compound of formula (I). It is possible for a composition to comprise two or more compounds of the present invention. In such cases, the recited ranges represent the total amount of compounds of the present invention.
[0307] The compositions of the present invention may be in any of the customary composition types, such as solutions (e.g., aqueous solutions), emulsions, aqueous and oily suspensions, dusts (e.g., wettable powders, water-soluble powders), dusts, pastes, granules (e.g., water-soluble granules, granules for broadcast), suspoemulsion concentrates, natural or synthetic products impregnated with a compound of formula (I), fertilizers, and microencapsulated polymeric materials. The compound of formula (I) may be present in suspended, emulsified, or dissolved form. Examples of specific suitable composition types include solutions, water-soluble concentrates (e.g., SL, LS), dispersible concentrates (DC), suspensions and suspension concentrates (e.g., SC, OD, OF, FS), emulsifiable concentrates (e.g., EC), emulsions (e.g., EW, EO, ES, ME, SE), capsules (e.g., CS, ZC), pastes, lozenges, wettable powders or dusts (e.g., WP, SP, WS, DP, DS), compacted powders (e.g., BR, TB, DT), granules (e.g., WG, SG, GR, FG, GG, MG), insecticides (e.g., LN), and gel formulations for treating plant propagation materials such as seeds (e.g., GW, GF). These and other composition types are defined by the Food and Agriculture Organization of the United Nations (FAO). A review is provided in "Catalogue of Pesticide Formulation Types and International Coding System," Technical Monograph No. 2, 6th Ed. May 2008, Croplife International.
[0308] Preferably, the composition of the present invention is in the form of one of the following types: EC, SC, FS, SE, OD, and WG, more preferably EC, SC, OD, and WG.
[0309] Examples of composition types and further details about their preparation are provided below. When more than one compound of the invention is present, the approximate amount of compound of the invention refers to the total amount of compounds of the invention. This applies mutatis mutandis to any further components of the composition, for example, wetting agents or binders, when there is more than one representative of such component.
[0310] i) Water-soluble concentrates (SL, LS) 10-60% by weight of at least one compound of formula (I) and 5-15% by weight of a surfactant (e.g., a polyoxyethylene fatty alcohol ether) are added to such an amount of water and / or a water-soluble solvent (e.g., a carbonate such as propylene glycol or propylene carbonate) that the total amount becomes 100% by weight. Before application, the concentrate is diluted with water.
[0311] ii) Dispersible Concentrate (DC) 5 to 25% by weight of at least one compound of formula (I) and 1 to 10% by weight of a surfactant and / or binder (e.g., polyvinylpyrrolidone) are dissolved in an amount of organic solvent (e.g., cyclohexanone) to make the total amount 100% by weight, and then diluted with water to obtain a dispersant.
[0312] iii) Emulsifiable concentrate (EC) 15-70% by weight of at least one compound of formula (I) and 5-10% by weight of a surfactant (e.g., a mixture of calcium dodecylbenzenesulfonate and castor oil ethoxylate) are mixed with a water-insoluble organic solvent (e.g., an aromatic hydrocarbon or a fatty acid amide), and, if necessary, an additional water-soluble solvent, to give a total of 100% by weight. Upon dilution with water, an emulsion is obtained.
[0313] iv) Emulsion formulations (EW, EO, ES) 5-40% by weight of at least one compound of formula (I) and 1-10% by weight of a surfactant (e.g., a mixture of calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in 20-40% by weight of a water-insoluble organic solvent (e.g., an aromatic hydrocarbon). This mixture is added to the same amount of water using an emulsifier to make the total amount 100% by weight. The resulting composition is a homogeneous emulsion formulation. The emulsion formulation may be further diluted with water before application.
[0314] v) Suspension Agents and Suspension Concentrates v-1) Aqueous (SC, FS) For example, in a suitable grinding device, such as an agitator ball mill, 20-60% by weight of at least one compound of formula (I) is ground with 2-10% by weight of a surfactant (e.g., sodium lignosulfonate and polyoxyethylene fatty alcohol ether), 0.1-2% by weight of a thickener (e.g., xanthan gum), and water to obtain a fine suspension of the active substance. Water is added in an amount such that the total amount is 100% by weight. Dilution with water to obtain a stable suspension of the active substance is performed. For FS-type compositions, up to 40% by weight of a binder (e.g., polyvinyl alcohol) is added.
[0315] v-2) Oil-based (OD, OF) For example, 20-60% by weight of at least one compound of formula (I) is ground in a suitable grinding device, such as an agitator ball mill, with 2-10% by weight of a surfactant (e.g., sodium lignosulfonate and polyoxyethylene fatty alcohol ether), 0.1-2% by weight of a thickener (e.g., modified clay, especially BENTONE® or silica), and an organic carrier to obtain a fine oily suspension of the active substance. The organic carrier is added in an amount such that the total amount is 100% by weight. Dilution with water results in a stable dispersion of the active substance.
[0316] vi) Water-dispersible granules and water-soluble granules (WG, SG) 50-80% by weight of at least one compound of formula (I) is pulverized with the addition of surfactants (e.g., sodium lignosulfonate and polyoxyethylene fatty alcohol ether) and converted into water-dispersible or water-soluble granules in technical equipment (e.g., extruders, spray towers, fluidized beds). The surfactants are used in an amount such that the total amount is 100% by weight. Dilution with water results in a stable dispersion or solution of the active substance.
[0317] vii) Water-dispersible and water-soluble powders (WP, SP, WS) 50-80% by weight of at least one compound of formula (I) is mixed with 1-8% by weight of a surfactant (e.g., sodium lignosulfonate, polyoxyethylene fatty alcohol ether) and a solid carrier such as silica gel, and the resulting mixture is ground in a rotor-stator mill to a total of 100% by weight. The mixture is then diluted with water to obtain a stable dispersion or liquid of the active substance.
[0318] viii) Gel preparations (GW, GF) In a stirred ball mill, 5-25% by weight of at least one compound of formula (I) is ground with 3-10% by weight of a surfactant (e.g., sodium lignosulfonate), and 1-5% by weight of a binder (e.g., carboxymethylcellulose) and an amount of water such that the total amount reaches 100% by weight. This results in a fine suspension of the active substance. Dilution with water results in a stable suspension of the active substance.
[0319] ix) Microemulsifiers (ME) 5-20% by weight of at least one compound of formula (I) is added to 5-30% by weight of an organic solvent blend (e.g., fatty acid dimethylamide and cyclohexanone), 10-25% by weight of a surfactant blend (e.g., polyoxyethylene fatty alcohol ether and arylphenol ethoxylate), and an amount of water such that the total amount is 100% by weight. The mixture is stirred for 1 hour to spontaneously form a thermodynamically stable microemulsion agent.
[0320] x) Microcapsules (CS) An oil phase containing 5 to 50% by weight of at least one compound of formula (I), 0 to 40% by weight of a water-insoluble organic solvent (e.g., aromatic hydrocarbon), and 2 to 15% by weight of an acrylic monomer (e.g., methyl methacrylate, methacrylic acid, di- or tri-acrylate) are dispersed in an aqueous solution of a protective colloid (e.g., polyvinyl alcohol). Poly(meth)acrylate microcapsules are formed by radical polymerization initiated by a radical initiator. Alternatively, an oil phase containing 5 to 50% by weight of at least one compound of formula (I), 0 to 40% by weight of a water-insoluble organic solvent (e.g., aromatic hydrocarbon), and an isocyanate monomer (e.g., diphenylmethene-4,4'-diisocyanate) are dispersed in an aqueous solution of a protective colloid (e.g., polyvinyl alcohol). Addition of a polyamine (e.g., hexamethylenediamine) results in the formation of polyurea microcapsules. This monomer accounts for 1 to 10% by weight of the total CS composition.
[0321] xi) Dust powder (DP, DS) 1 to 10% by weight of at least one compound of formula (I) is finely ground and intimately mixed with such an amount of solid carrier, for example finely divided kaolin, that the total amount is 100% by weight.
[0322] xii) Granules (GR, FG) 0.5 to 30% by weight of at least one compound of formula (I) is finely ground and combined with an amount of a solid carrier (e.g., a silicate) to make up 100% by weight of the total. Granulation is accomplished by extrusion, spray drying, or fluidized bed.
[0323] xiii) Ultra-low volume liquid (UL) 1-50% by weight of at least one compound of formula (I) is dissolved in such an amount of organic solvent, such as an aromatic hydrocarbon, that the total amount is 100% by weight.
[0324] The compositions of types i) to xiii) may optionally contain 0.1 to 1% by weight of an adjuvant such as a preservative, 0.1 to 1% by weight of an antifoaming agent, 0.1 to 1% by weight of a dye and / or pigment, and 5 to 10% by weight of an antifreeze.
[0325] Mixtures / Combinations The compounds of formula (I) and compositions of the present invention can be mixed with other active ingredients, such as fungicides, fungicides, acaricides, nematicides, insecticides, biological control agents, or herbicides. Mixtures with fertilizers, growth regulators, safeners, nitrification inhibitors, semiochemicals, and / or other agriculturally beneficial agents are also possible. This can broaden the spectrum of activity and prevent the development of resistance. Examples of known fungicides, insecticides, acaricides, nematicides, and fungicides are disclosed in the "Pesticide Manual" (17th Edition).
[0326] Examples of antifungal agents that can be mixed with the compounds of formula (I) and compositions of the present invention are: 1) Inhibitors of ergosterol synthesis, for example: (1.001) cyproconazole, (1.002) difenoconazole, (1.003) epoxiconazole, (1.004) fenbuconazole, (1.005) fenhexamid, (1.006) fenpropidin, (1.007) fenpropimorph, (1.008) fenpyrazamine, (1.009) fluoxythioconazole, (1.010) fluquinconazole, (1.011) flutriafol, (1.012) hexaconazole, (1.013) imazalil, (1.01 4) Imazalil sulfate, (1.015) Ipconazole, (1.016) Ipfentrifluconazole, (1.017) Mefentrifluconazole, (1.018) Metconazole, (1.019) Myclobutanil, (1.020) Paclobutrazol, (1.021) Penconazole, (1.022) Prochloraz, (1.023) Propiconazole, (1.024) Prothioconazole, (1.025) Pyrizoxazole, (1.026) Spiroxamine, (1.027) Tebuconazole, (1.028) Tetraconazole, ( 1.029) Triadimenol, (1.030) Tridemorph, (1.031) Triticonazole, (1.032) (1R,2S,5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.033) (1S,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.034) (2R)-2-(1-chlorocyclo (1.035)(2R)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.036)(2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.037)(2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.038)(2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.039)(2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.040)(2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.041)(2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.042)(2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.043)(2R037) (2S)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.038) (2S)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.039) (2S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl )phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.040) (R)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (1.041) (S)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (1.042 ) [3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (1.043) 1-({(2R,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.044) 1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4- Methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.045) 1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate, (1.046) 1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate, (1.047) 1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate, (1.048) 2-[(2R,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.049) 2-[(2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.050) 2-[(2R,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione 2-[(2R,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.051) 2-[(2R,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.052) 2-[(2S,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4- Triazole-3-thione, (1.053) 2-[(2S,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.054) 2-[(2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.055) 2-[(2S,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione chlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.056) 2-[1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.057) 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, (1.058) 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, (1.059) 2-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.060) 2-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2 ,4-Dihydro-3H-1,2,4-triazole-3-thione, (1.061) 2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.062) 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, (1.063) 5-(4-chlorobenzyl)-2-(chloro (1.064) 5-(allylsulfanyl)-1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole, (1.065) 5-(allylsulfanyl)-1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole, (1.066) 5-(allylsulfanyl)-1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole, (1.067) 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoic acid methyl ester, (1.068) N'-(2-chloro-5-methyl-4-phenoxyphenyl)-N-ethyl-N-methylimidoformamide, (1.069) N'-[2-chloro-4-(2-fluorophenoxy)-5-methylphenyl]-N-ethyl-N-methylimidoformamide, (1.070) N'-[5-bromo-6-(2,3-dihydro-1H-inden-2-yloxy)-2-methylpyridin-3-yl]-N-ethyl-N-methylimidoformamide, (1.071) N'-{4-[(4,5-dichloro-1,3-thiazol-2-yl)oxy]-2,5-dimethylphenyl} -N-ethyl-N-methylimidoformamide, (1.072) N'-{5-bromo-2-methyl-6-[(1-propoxypropan-2-yl)oxy]pyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.073) N'-{5-bromo-6-[(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.074) N'-{5-bromo -6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.075)N'-{5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.076)N'-{5-bromo-6-[(trans-4-isopropylcyclohexyl)oxy]-2- Methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.077) N'-{5-bromo-6-[1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.078) N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenylethyl)phenyl]-N-methylimidoformamide. 2) Inhibitors of the respiratory chain in complex I or II, such as (2.001) benzovindiflupyr, (2.002) bixafen, (2.003) boscalid, (2.004) carboxin, (2.005) cyclobutrifluram, (2.006) fluveneteram, (2.007) fluindapyr, (2.008) fluopyram, (2.009) flutolanil, (2.010) fluxapyroxad, (2.011) furametpyr, (2.012) inpirfluxam, (2.013) isofetamide, (2 014) Isoflucipram, (2.015) Isopyrazam, (2.016) Penflufen, (2.017) Penthiopyrad, (2.018) Pydiflumetofen, (2.019) Pyrapropoin, (2.020) Pyraziflumide, (2.021) Sedaxane, (2.022) Thifluzamide, (2.023) 1,3-dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.024) 1,3-dimethyl-N-[(3R )-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.025) 1,3-dimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.026) 1-methyl-3-(trifluoromethyl)-N-[2'-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (2.027) 2-fluoro-6-(trifluoromethyl)biphenyl-2-yl (3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)benzamide, (2.028) 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.029) 3-(difluoromethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.030) 3-(Difluoromethyl)-N-[(3R)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.031) 3-(Difluoromethyl)-N-[(3S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.032) 5,8-Difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazolin-4-amine, (2.033) N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro- [Dr-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.034) N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.035) N-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.036) N-[rac-(1S,2S)-2-(2,4-dichlorophenyl)cyclobutyl]-2-(trifluoromethyl)nicotinamide. 3) Inhibitors of the respiratory chain in complex III, such as (3.001) ametoctrazine, (3.002) amisulbrom, (3.003) azoxystrobin, (3.004) methoxystrobin, (3.005) cumoxystrobin, (3.006) cyazofamid, (3.007) cimoxystrobin, (3.008) enoxastrobin, (3.009) famoxadone, (3.010) fenamidone, (3.011) fenpicoxamide, (3.012) flurylpicoxamide, (3.013) flufen. Noxystrobin, (3.014) Fluoxastrobin, (3.015) Kresoxim-methyl, (3.016) Mandestrobin, (3.017) Methallylpicoxamide, (3.018) Metominostrobin, (3.019) Methyltetraprole, (3.020) Orysastrobin, (3.021) Picoxystrobin, (3.022) Pyraclostrobin, (3.023) Pyrametstrobin, (3.024) Pyraoxystrobin, (3.025) Trifloxystrobin, (3.026) (2E)-2- {2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide, (3.027) (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.028) (2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N -methylacetamide, (3.029) (2S)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.030) N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-formamido-2-hydroxybenzamide, (3.031) (2E,3Z)-5-{[1-(4-chloro-2-fluorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.032) methyl {5-[3-(2,4-dimethylphenyl)-1H-pyrazol-1-yl]-2-methylbenzyl}carbamate. 4) Inhibitors of mitosis and cell division, for example (4.001) carbendazim, (4.002) diethofencarb, (4.003) ethaboxam, (4.004) fluopicolide, (4.005) fluopimomide, (4.006) metrafenone, (4.007) pencycuron, (4.008) pyridaclomethyl, (4.009) pyriophenone (clazafenone), (4.010) thiabendazole, (4.011) thiophanate-methyl, (4.012) zoxamide, (4.013) 3-chloro-5-(4-chlorophenyl)-2-methyl-2-propanol, )-4-(2,6-difluorophenyl)-6-methylpyridazine, (4.014) 3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine, (4.015) 4-(2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.016) 4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4. 017) 4-(2-bromo-4-fluorophenyl)-N-(2-bromophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.018) 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.019) 4-(2-bromo-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.020) 4-(2-bromo-4-fluorophenyl)-N-(2-fluorophenyl)- (4.021) 4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.022) 4-(2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.023) 4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.024) 4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.025) 4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.026) 4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.027) 4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.028) 4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.029) 4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.030) 4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.031) 4-(2-chloro-4-fluorophenyl)-N-(024) 4-(2-chloro-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.025) 4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine, (4.026) N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.027) N-(2-bromophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.028) N-(4-chloro-2,6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine. 5) Compounds capable of multisite action, for example: (5.001) Bordeaux mixture, (5.002) captafol, (5.003) captan, (5.004) chlorothalonil, (5.005) copper hydroxide, (5.006) copper naphthenate, (5.007) copper oxide, (5.008) copper oxychloride, (5.009) copper(II) sulfate, (5.010) dithianon, (5.011) dodine, (5.012) folpet, (5.013) mancozeb, (5.01 4) Maneb, (5.015) Metiram, (5.016) Metiram zinc, (5.017) Oxine copper, (5.018) Propineb, (5.019) Sulfur preparations containing sulfur and calcium polysulfide, (5.020) Thiram, (5.021) Zineb, (5.022) Ziram, (5.023) 6-Ethyl-5,7-dioxo-6,7-dihydro-5H-pyrrolo[3',4':5,6][1,4]dithiino[2,3-c][1,2]thiazole-3-carbonitrile. 6) Compounds that can involve host defense, for example (6.001) acibenzolar-S-methyl, (6.002) fosetyl aluminum, (6.003) fosetyl calcium, (6.004) fosetyl sodium, (6.005) isotianil, (6.006) phosphorous acid and its salts, (6.007) probenazole, (6.008) tiadinil. 7) Inhibitors of amino acid and / or protein biosynthesis, such as (7.001) cyprodinil, (7.002) kasugamycin, (7.003) kasugamycin hydrochloride hydrate, (7.004) oxytetracycline, (7.005) pyrimethanil. 8) Inhibitors of ATP production, for example (8.001) silthiofam. 9) Inhibitors of cell wall synthesis, for example (9.001) benthiavalicarb, (9.002) dimethomorph, (9.003) flumorph, (9.004) iprovalicarb, (9.005) mandipropamide, (9.006) pyrimorph, (9.007) valifenalate, (9.008) (2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one, (9.009) (2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one. 10) Inhibitors of lipid synthesis or transport, or membrane synthesis, for example (10.001) fluoxapiproline, (10.002) natamycin, (10.003) oxathiapiproline, (10.004) propamocarb, (10.005) propamocarb hydrochloride, (10.006) propamocarb fosetylate, (10.007) tolclofos-methyl, (10.008) 1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl )-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, (10.009) 1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, (10.010) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yne-1- (10.011) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (10.012) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, 1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (10.013) 2-{(5R)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate, (10.014) 2-{(5S)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate, (10.015) 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl methanesulfonate, (10.016) 3-[2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-1,5-dihydro-2,4-benzodioxepin-6-yl methanesulfonate (10.017) 9-fluoro-3-[2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-1,5-dihydro-2,4-benzodioxepin-6-yl methanesulfonate, (10.018) 3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl] [2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-9-fluoro-1,5-dihydro-2,4-benzodioxepin-6-yl methanesulfonate, (10.019) 3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-9-fluoro-1,5-dihydro-2,4-benzodioxepin-6-yl methanesulfonate. 11) Inhibitors of melanin biosynthesis, for example, (11.001) tolprocarb, (11.002) tricyclazole. 12) Inhibitors of nucleic acid synthesis, for example (12.001) benalaxyl, (12.002) benalaxyl-M (chiralaxyl), (12.003) metalaxyl, (12.004) metalaxyl-M (mefenoxam). 13) Inhibitors of signal transduction, for example (13.001) fludioxonil, (13.002) iprodione, (13.003) procymidone, (13.004) proquinazide, (13.005) quinoxyfen, (13.006) vinclozolin. 14) Compounds capable of acting as uncouplers, for example (14.001) fluazinam, (14.002) meptyldinocap. 15) Further compounds, for example: (15.001) abscisic acid, (15.002) aminopyrifen, (15.003) benthazole, (15.004) bethoxadin, (15.005) capsimycin, (15.006) carvone, (15.007) quinomethionate, (15.008) chlorinconazide, (15.009) kufuraneb, (15.010) cyflufenamid, (15.011) cymoxanil, (15.012) cyprosulfamide, (15.013) dipimethitrone, (15.014 ) Flutianil, (15.015) Flufenoxadiazam, (15.016) Flumethylsulfolim, (15.017) Ipflufenoquine, (15.018) Methyl isothiocyanate, (15.019) Mildiomycin, (15.020) Nickel dimethyldithiocarbamate, (15.021) Nitrothalisopropyl, (15.022) Oxyfenthiin, (15.023) Pentachlorophenol and salts, (15.024) Picarburazox, (15.025) Quinofumelin, (15.0 26) D-tagatose, (15.027) tebufloquine, (15.028) tecloftalam, (15.029) tolnifanide, (15.030) 2-(6-benzylpyridin-2-yl)quinazoline, (15.031) 2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline, (15.032) 2-phenylphenol and salts, (15.033) 4-amino-5-fluoropyrimidin-2-ol (tautomer: 4-amino-5-fluoropyrimidin-2(1H)- on), (15.034) 4-oxo-4-[(2-phenylethyl)amino]butanoic acid, (15.035) 5-amino-1,3,4-thiadiazole-2-thiol, (15.036) 5-chloro-N'-phenyl-N'-(prop-2-yn-1-yl)thiophene-2-sulfonohydrazide, (15.037) 5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidin-4-amine, (15.038) 5-fluoro-2-[(4-methylbenzyl)oxy]pyrimidin-4-amine, (15.039) But-3-yn-1-yl{6-[({[(Z)-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate, (15.040) Ethyl (2Z)-3-amino-2-cyano-3-phenylacrylate, (15.041) Phenazine-1-carboxylic acid, (15.042) Propyl 3,4,5-trihydroxybenzoate, (15.043) Quinolin-8-ol, (15.044) Quinolin-8-ol sulfate (2:1), (15.045) 1-(4,5-dimethylbenzoyl)- (15.046) 1-(5-(fluoromethyl)-6-methyl-pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.047) 1-(5,6-dimethylpyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.048) 1-(6-(difluoromethyl)-5-methoxy-pyridin-3-yl)-4,4-difluoro 1-(6-(difluoromethyl)-5-methyl-pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.049) 1-(6-(difluoromethyl)-5-methyl-pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.050) 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.051) 2-{2-fluoro-6-[(8-fluoro-2-methylquinolin-3-yl)oxy]phenyl}propan-2-ol, (1 5.052) 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, (15.053) 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)-8-fluoroquinoline, (15.054) 3-(4,4-difluoro-5,5-dimethyl-4,5-dihydrothieno[2,3-c]pyridin-7-yl)quinoline, (15.055) 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline, (15.056) 5-Bromo-1-(5,6-dimethylpyridin-3-yl)-3,3-dimethyl-3,4-dihydroisoquinoline, (15.057) 8-Fluoro-3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)-quinoline, (15.058) 8-Fluoro-3-(5-fluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)-quinoline, (15.059) 8-Fluoro-N-(4,4,4-trifluoro-2-methyl-1-phenylbutan-2-yl)quinoline Phosphorus-3-carboxamide, (15.060) 8-Fluoro-N-[(2S)-4,4,4-trifluoro-2-methyl-1-phenylbutan-2-yl]quinoline-3-carboxamide, (15.061) 9-Fluoro-2,2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro-1,4-benzoxazepine, (15.062) N-(2,4-dimethyl-1-phenylpentan-2-yl)-8-fluoroquinoline-3-carboxamide, (15.063) N-[(2S)-2,4-dimethyl-1-phenylpentan-2-yl]quinoline 1,1-Diethyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.065) 1,3-Dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.066) 1-[[3-Fluoro-4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl]methyl thyl]azepan-2-one, (15.067) 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one, (15.068) 1-methoxy-1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.069) 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.070) 1-Methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.071) 2,2-Difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide, (15.072) 3,3-Dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one, (15.073) 3-Ethyl-1-methoxy-1-[[4-[5 -(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.074) 4,4-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one, (15.075) 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, (15.076) 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl Dimethyl carbamate, (15.077) 5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, (15.078) 5-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one, (15.079) ethyl 1-{4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzyl}-1H-pyrazole-4-carboxylate, (15.080) methyl {4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}carbamate, (15.081) N-(1-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.082) N-(2,4-difluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.083) N,2-Dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, (15.084) N,N-Dimethyl-1-{4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzyl}-1H-1,2,4-triazol-3-amine, (15.085) N-[(E)-Methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.086) N-[( E)-N-Methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.087) N-[(Z)-Methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.088) N-[(Z)-N-Methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.089) N-[[2,3- Difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3,3-trifluoro-propanamide, (15.090) N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, (15.091) N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]cyclopropanecarboxamide, (15.092) N-{2,3-difluoro-4-[5-(trifluoro (15.093) N-{4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzyl}butanamide, (15.094) N-{4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}propanamide, (15.095) N-allyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide, (15.096) N-Allyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, (15.097) N-Ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, (15.098) N-Methoxy-N-[[4-[5-(trifluoromethyl)-1,2 ,4-Oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, (15.099) N-Methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.100) N-Methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarbothioamide, (15.101) N-Methyl-N-phenyl-. 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide.
[0327] All named mixing partners of the above classes (1) to (15) can be present in the form of free compounds or, if their functional groups allow this, in the form of their pesticidal active salts.
[0328] The compounds of formula (I) and compositions of the present invention may also be combined with one or more biological control agents.
[0329] As used herein, the term "biological control" is defined as the control of pests such as plant pathogenic fungi and / or insects and / or mites and / or nematodes through the use or employment of biological control agents.
[0330] As used herein, the term "biological control agent" is defined as an organism other than a harmful organism and / or a protein or secondary metabolite produced by such an organism for biological control. Mutants of a second organism are included in the definition of a biological control agent. The term "mutant" refers to a variant of a parent strain, as well as methods for obtaining mutants or variants with greater insecticidal activity than that expressed by the parent strain. "Parent strain" is defined herein as the original strain prior to mutagenesis. To obtain such mutants, the parent strain can be thoroughly treated with chemicals such as N-methyl-N'-nitro-N-nitrosoguanidine, ethyl methanesulfone, or by irradiation using gamma, X-ray, or UV radiation, or by other means known to those skilled in the art. A known mechanism of biological control agents involves enterobacteria that control root rot by outcompeting fungi for space on the root surface. Bacterial toxins, such as antibiotics, have been used to control pathogens. Toxins can be isolated and applied directly to plants, or bacterial species can be administered to produce the toxin in situ.
[0331] A "variant" is a strain that has all the identifying characteristics of the NRRL or ATCC accession number set forth in the specification and can be identified as having a genome that hybridizes under high stringency conditions to the genome of the NRRL or ATCC accession number.
[0332] "Hybridization" refers to a reaction in which one or more polynucleotides react to form a complex stabilized through hydrogen bonding between the bases of nucleotide residues. Hydrogen bonding can occur through Watson-Crick base pairing, Hoogstein binding, or other sequence-specific methods. The complex can comprise two strands forming a duplex structure, three or more strands forming a multi-stranded complex, a single self-hybridizing strand, or any combination thereof. Hybridization reactions can be performed under conditions of varying "stringency." Generally, low stringency hybridization reactions are performed at about 40°C in 10x SSC or a solution of equivalent ionic strength / temperature. Moderate stringency hybridization reactions are typically performed at about 50°C in 6x SSC, and high stringency hybridization reactions are generally performed at about 60°C in 1x SSC.
[0333] A variant of a designated NRRL or ATCC accession number may also be defined as a strain having a genome sequence that has greater than 85%, more preferably greater than 90%, or more preferably greater than 95% sequence identity to the genome of the designated NRRL or ATCC accession number. A polynucleotide or polynucleotide region (or polypeptide or polypeptide region) having a certain percentage (e.g., 80%, 85%, 90%, or 95%) of "sequence identity" to another sequence means that, when aligned, a percentage of the bases (or amino acids) are identical when the two sequences are compared. This alignment and percent homology or sequence identity can be determined using software programs known in the art, such as those described in "Current Protocols in Molecular Biology" (F.M. Ausubel et al., eds., 1987).
[0334] "NRRL" is an abbreviation for "Agricultural Research Service Culture Collection," an international depository for the purpose of depositing microbial strains under the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure, and is located at the Agricultural Research Service, National Center for Agricultural Utilization Research, 1815 North University Street, Pereira, Illinois, USA (Zip Code 61604).
[0335] "ATCC" is an abbreviation for "American Type Culture Collection," an international depository for the purpose of depositing microbial strains under the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure, and is located at 10801 University Boulevard, Manassas, Virginia, USA (Zip Code 10110).
[0336] Examples of biological control agents that can be combined with the compounds of formula (I) and compositions of the present invention are: (A) an antibacterial agent selected from the group consisting of: (A1) (A1.1) Bacillus subtilis, in particular strain QST713 / AQ713 (available from Bayer CropScience LP, USA as SERENADE OPTI or SERENADE ASO, NRRL Accession No. B21661, U.S. Patent No. 6,060,051); (A1.2) Bacillus sp., in particular strain D747 (available from Kumiai Chemical Industry Co., Ltd. as DOUBLE NICKEL®), Accession No. FERM BP-8234, U.S. Patent No. 7,094,592; (A1.3) Bacillus pumilus, in particular strain BU F-33, NRRL Accession No. 50185 (CARTISSA®) (A1.4) Bacillus subtilis var. amyloliquefaciens strain FZB24 accession number DSM 10271 (available from Novozymes as TAEGRO® or TAEGRO®, ECO (EPA registration number 70127-5)); (A1.5) Paenibacillus sp. strain accession number NRRL B-50972 or accession number NRRL B-67129, WO 2016 / 154297; (A1.6) Bacillus subtilis (A1.7) Bacillus mojavensis strain R3B (Accession No. NCAIM(P)B001389) (WO 2013 / 034938), from Certis USA LLC, a Mitsui & Co. subsidiary; (A1.8) Bacillus subtilis CX-9060, from Certis USA LLC, a Mitsui & Co. subsidiary; (A1.9) Bacteria such as Paenibacillus polymyxa, in particular strain AC-1 (e.g., TOPSEED®, from Green Biotech Company Ltd.); (A1.10) Pseudomonas proradix (e.g., PRORADIX®, from Sourcon Padena); (A1.11) Pantoea agglomerans, in particular strain E325 (Accession No. NRRL B-21856) (available from Northwest Agri Products as BLOOMTIME BIOLOGICAL™ FD BIOPESTICIDE); and (A2) (A2.1) Aureobasidium pullulans, in particular blastospores of the strain DSM 14940, blastospores of the strain DSM 14941 or a mixture of blastospores of the strains DSM 14940 and DSM 14941 (e.g. BOTECTOR® and BLOSSOM PROTECT® from bio-ferm, Switzerland); (A2.2) Pseudozyma aphidis (disclosed in WO 2011 / 151819 (Yissum Research Development Company, The Hebrew University)); (A2.3) Saccharomyces cerevisiae, in particular the strains CNCM No. I-3936, CNCM No. I-3937, CNCM No. I-3938 or CNCM No. I-3939. (WO 2010 / 086790), Lesaffre et Compagnie, France and other fungi; (B) a biological antifungal agent selected from the group consisting of: (B1) Bacteria, such as: (B1.1) Bacillus subtilis, in particular the strain QST713 / AQ713 (available from Bayer CropScience LP, USA as SERENADE OPTI or SERENADE ASO, described in NRRL Accession No. B21661 and U.S. Patent No. 6,060,051); (B1.2) Bacillus pumilus, in particular the strain QST2808 (available from Bayer CropScience LP, USA as SONATA®, described in NRRL Accession No. B-30087 and U.S. Patent No. 6,245,551); (B1.3) Bacillus pumilus, in particular the strain GB34 (available from Bayer CropScience LP, USA as Yield Shield®, described in NRRL Accession No. B-30087 and U.S. Patent No. 6,245,551); AG, Germany); (B1.4) Bacillus pumilus, in particular the strain BU F-33, NRRL accession no. 50185 (available from BASF as part of the CARTISSA range, European registration no. 71840-19); (B1.5) Bacillus amyloliquefaciens, in particular the strain D747 (available from Kumiai Chemical Industry Co., Ltd. as Double Nickel™, accession no. FERM BP-8234, U.S. Patent No. 7,094,592); (B1.6) Bacillus subtilis Y1336 (available from Bion-Tech, Taiwan as BIOBAC® WP, registered in Taiwan as a biological antifungal agent under registration numbers 4764, 5454, 5096, and 5277); (B1.7) Bacillus subtilis strain MBI 600 (available from BASF SE as SUBTILEX), accession number NRRL B-50595, U.S. Patent No. 5,061,495; (B1.8) Bacillus subtilis strain GB03 (available from Bayer AG, Germany as Kodiak®); (B1.9) Bacillus subtilis var. amyloliquefaciens strain FZB24, accession number DSM 10271 (available from Novozymes as TAEGRO® or TAEGRO® ECO (EPA registration number 70127-5)); (B1.10) Bacillus mycoides, isolate J, accession number B-30890 (available from Certis USA LLC, a Mitsui & Co. subsidiary as BMJ TGAI® or WG and LifeGard®); (B1.11) Bacillus licheniformis, specifically strain SB3086, accession number ATCC 55406, WO 2003 / 000051 (available from Novozymes as ECOGUARD® Biological Antifungal and GREEN RELEAF™); (B1.12) Paenibacillus sp. strain Accession No. NRRL B-50972 or Accession No. NRRL B-67129, WO 2016 / 154297; (B1.13) Bacillus subtilis strain BU1814 (available from BASF SE as VELONDIS® PLUS, VELONDIS® FLEX and VELONDIS® EXTRA); (B1.14) Bacillus subtilis CX-9060 from Certis USA LLC, Mitsui & Co. Co. subsidiaries; (B1.15) Bacillus amyloliquefaciens strain F727 (also known as strain MBI110) (NRRL Accession No. B-50768; WO 2014 / 028521) (available from Marrone Bio Innovations as STARGUS®); (B1.16) Bacillus amyloliquefaciens strain FZB42, Accession No. DSM 23117 (available from ABiTEP, Germany as RHIZOVITAL®); (B1.17) Bacillus licheniformis FMCH001 and Bacillus subtilis FMCH002 (QUARTZO® (WG) and PRESENCE® (WP) from FMC Corporation); (B1.18) Bacillus mojavensis strain R3B (Accession No. NCAIM(P)B001389) (WO 2013 / 034938) from Certis USA LLC, a subsidiary of Mitsui & Co.; (B1.19) Paenibacillus polymyxa ssp. Plantarum (WO 2016 / 020371), from BASF (B1.20) Paenibacillus epiphyticus (WO 2016 / 020371) from BASF SE; (B1.21) Pseudomonas chlororaphis strain AFS009, Accession No. NRRL B-50897, WO 2017 / 019448 (e.g., from AgBiome Innovations, USA, as HOWLER™ and ZIO™); (B1.22) Pseudomonas chlororaphis, in particular strain MA342 (e.g., from Bioagri and Koppert, as CEDOMON™, CERALL™, and CEDRESS™); (B1.23) Streptomyces lidicus lydicus strain WYEC108 (also known as Streptomyces lydicus strain WYCD108US) (from Novozymes as ACTINO-IRON® and ACTINOVATE®); (B1.24) Agrobacterium radiobacter strain K84 (from AgBioChem, Canada as GALLTROL-A®); (B1.25) Agrobacterium radiobacter strain K1026 (e.g., from BASF SE as NOGALL™); (B1.26) Bacillus subtilis strain KTSB (from Donaghys as FOLIACTIVE™); (B1.27) Bacillus subtilis IAB / BS03 (from STK Bio-Ag Technologies as AVIV™); (B1.28) Bacillus subtilis strain Y1336 (available from BioNTech, Taiwan as BIOBAC™ WP, registered as a biological antifungal agent under Taiwan registration numbers 4764, 5454, 5096, and 5277); (B1.29) Bacillus amyloliquefaciens isolate B246 (Bacillus amyloliquefaciens isolate B246) (e.g., from the University of Pretoria as AVOGREENTM); (B1.30) Bacillus methylotrophicus strain BAC-9912 (from Shenyang Institute of Applied Ecology); (B1.31) Pseudomonas proradix (e.g., from Sourcon Padena as PRORADIX®); (B1.32) Streptomyces griseoviridis strain K61 (also known as Streptomyces galbus strain K61) (Accession No. DSM 7206) (from Verdera as MYCOSTOP®; from BioWorks as PREFENCE®; Crop Protection 2006, 25, 468-475); (B1.33) Pseudomonas fluorescens strain A506 (e.g., from NuFarm as BLIGHTBAN® A506); and (B2) Fungi, for example: (B2.1) Coniothyrium minitans, in particular the strain CON / M / 91-8 (Accession No. DSM-9660; e.g., from Bayer CropScience Biologics GmbH under the trademark Contans®); (B2.2) Metschnikowia fructicola, in particular the strain NRRL Y-30752; (B2.3) Microsphaeropsis ochracea; (B2.5) Trichoderma atroviride, in particular the strain SC1 (Accession No. CBS 122089, WO 2009 / 116106 and U.S. Pat. No. 8,431,120 (from Bi-PA)), strain 77B (from Andermatt Biocontrol as T77) or strain LU132 (e.g., from Agrimm Technologies Limited as Sentinel); (B2.6) Trichoderma harzianum (Trichoderma harzianum) strain T-22 (e.g., from Andermatt Biocontrol or Koppert as Trianum-P) or strain Cepa Simb-T5 (from Simbiose Agro); (B2.14) Gliocladium roseum (also known as Clonostachys rosea f. rosea), in particular Adjuvants as strain 321U From Plus, strain ACM941 disclosed by Xue (Efficacy of Clonostachys rosea strain ACM941 and fungicide seed treatments for controlling the root tot complex of field pea, Can Jour Plant Sci 83(3): 519-524), or strain IK726 (Jensen DF, et al.Development of a biocontrol agent for plant disease control with special emphasis on the near-commercial fungal antagonist Clonostachys rosea strain 'IK726'; Australas Plant Pathol. 2007;36:95-101; (B2.35) Talaromyces flavus, strain V117b; (B2.36) Trichoderma viride, in particular strain B35 (Pietr et al., 1993, Zesz. Nauk. AR w Szczecinie 161: 125-137); (B2.37) Trichoderma asperellum, in particular strain SKT-1, Accession No. FERM P-16510 (e.g., from Kumiai Chemical Industry as ECO-HOPE®), strain T34. (e.g., from Biocontrol Technologies SL, Spain as T34 Biocontrol) or from Isagro as strain ICC 012; (B2.38) Trichoderma atroviride, strain CNCM I-1237 (e.g., from Agrauxine, France as Esquive® WP); (B2.39) Trichoderma atroviride, strain No. V08 / 002387; (B2.40) Trichoderma atroviride, strain NMI No. V08 / 002388; (B2.41) Trichoderma atroviride, strain NMI No. V08 / 002389; (B2.42) Trichoderma atroviride atroviride), strain NMI No. V08 / 002390; (B2.43) Trichoderma atroviride, strain LC52 (e.g., Tenet from Agrimm Technologies Limited); (B2.44) Trichoderma atroviride, strain ATCC 20476 (IMI 206040); (B2.45) Trichoderma atroviride, strain T11 (IMI352941 / CECT20498); (B2.46) Trichoderma harmatum; (B2.47) Trichoderma harzianum; (B2.48) Trichoderma harzianum rifai T39 (e.g., from Makhteshim, USA as Trichodex®); (B2.49) Trichoderma asperellum, in particular the strain kd (e.g., from Andermatt Biocontrol as T-Gro); (B2.50) Trichoderma harzianum (Trichoderma harzianum), strain ITEM 908 (e.g., from Koppert as Trianum-P); (B2.51) Trichoderma harzianum (Trichoderma harzianum), strain TH35 (e.g., from Mycontrol as Root-Pro); (B2.52) Trichoderma virens (also known as Gliocladium virens), in particular the strain GL-21 (e.g., SoilGard from Certis, USA); (B2.53) Trichoderma viride, strain TV1 (e.g., Trianum-P from Koppert); (B2.54) Ampelomyces quisqualis, in particular the strain AQ 10 (e.g., AQ 10® from IntrachemBio Italia); (B2.56) Aureobasidium pullulans, in particular blastospores of the strain DSM 14940; (B2.57) Aureobasidium pullulans, in particular blastospores of the strain DSM 14941; (B2.58) Aureobasidium pullulans, in particular a blastospore mixture of the strains DSM 14940 and DSM 14941 (e.g., Botector® from bio-ferm, Switzerland); (B2.64) Cladosporium cladosporioides cladosporioides, strain H39, Accession No. CBS122244, U.S. Patent Application Publication No. 2010 / 0291039 (Stichting Dienst Landbouwkundig Onderzoek); (B2.69) Gliocladium catenulatum (syn. Clonostachys rosea f. catenulate) strain J1446 (e.g., from Lallemand as Prestop®); (B2.70) conidia of Lecanicillium lecanii (formerly known as Verticillium lecanii) strain KV01 (e.g., from Vertalec®). from Koppert / Arysta; (B2.71) Penicillium vermiculatum; (B2.72) Pichia anomala, strain WRL-076 (NRRL Y-30842), U.S. Patent No. 7,579,183; (B2.75) Trichoderma atroviride, strain SKT-1 (FERM P-16510), JP 11-253151; (B2.76) Trichoderma atroviride, strain SKT-2 (FERM P-16511), JP 1999-253151; (B2.77) Trichoderma atroviride, strain SKT-3 (FERM P-17021), JP 1999-253151; (B2.78) Trichoderma gamsii (formerly T. viride), strain ICC080 (IMI CC 392151 CABI, e.g., from AGROBIOSOL DE MEXICO, SA DE CV as BioDerma); (B2.79) Trichoderma harzianum, strain DB 103 (B2.80) Trichoderma polysporum, strain IMI 206039 (e.g., from BINAB Bio-Innovation AB, Sweden as Binab TF WP); (B2.81) Trichoderma stromaticum, accession no. Ts3550 (e.g., from CEPLAC, Brazil as Tricovab); (B2.83) Ulocladium oudemansii, strain U3, accession no. NM99 / 06216 (e.g., from Botry-Zen as BOTRY-ZEN®). Ltd, New Zealand and from BioWorks, Inc. as BOTRYSTOP®; (B2.84) Verticillium albo-atrum (formerly V. dahliae), strain WCS850, accession number WCS850, deposited with the Central Bureau for Fungi Cultures (e.g., from Tree Care Innovations as DUTCH TRIG®); (B2.86) Verticillium chlamydosporium; (B2.87) a mixture of Trichoderma asperellum strain ICC 012 (also known as Trichoderma harzianum ICC012), accession number CABI CC IMI 392716, and Trichoderma gamsii (formerly T. viride) strain ICC 080, accession number IMI 392151 (e.g., from Isagro USA, Inc. as BIO-TAM™ and from Agrobiosol de Mexico, SA de CV as BIODERMA®); (B2.88) Trichoderma asperelloides JM41R (accession number NRRL B-50759) (BASF as TRICHO PLUS®) (B2.89) Aspergillus flavus strain NRRL 21882 (a product known as AFLA-GUARD® from Syngenta / ChemChina); (B2.90) Chaetomium cupreum (Accession No. CABI 353812) (e.g., from AgriLife as BIOKUPRUM™); (B2. 91) Saccharomyces cerevisiae, in particular the strain LASO2 (from Agro-Levures et Derives), the strain LAS117 cell wall (from Lesaffre as CEREVISANE®; from BASF SE as ROMEO®), the strains CNCM No. I-3936, CNCM No. I-3937, CNCM No. I-3938, CNCM No. I-3939 (WO 2010 / 086790) from Lesaffre et Compagnie, France; (B2.92) Trichoderma virens strain G-41, formerly known as Gliocladium virens (Accession No. ATCC 20906) (e.g., ROOTSHIELD® PLUS WP and TURFSHIELD® PLUS WP from BioWorks, USA; (B2.93) Trichoderma hamatum, accession number ATCC 28012; (B2.94) Ampelomyces quisqualis strain AQ10, accession number CNCM I-807 (e.g., from IntrachemBio Italia as AQ 10®); (B2.95) Phlebiopsis gigantea strain VRA 1992 (from Danstar Ferment as ROTSTOP® C); (B2.96) Penicillium steckii (DSM 27859; WO 2015 / 067800) from BASF from SE; (B2.97) Chaetomium globosum (available from Rivale as RIVADIOM®); (B2.98) Cryptococcus flavescens, strain 3C (NRRL Y-50378); (B2.99) Dactylaria candida; (B2.100) Dilophosphora alopecuri (available as TWIST FUNGUS®); (B2.101) Fusarium oxysporum, strain Fo47 (available as FUSACLEAN® from Natural Plant Protection); (B2.102) Pseudozyma flocculosa, strain PF-A22 UL (available as SPORODEX® L from Plant Products Co., Canada); (B2.103) Trichoderma gamsii (formerly T. viride), strain ICC 080 (IMI CC 392151 CABI) (available as BIODERMA® from AGROBIOSOL DE MEXICO, SA DE (B2.104) Trichoderma fertile (e.g., from BASF as the product TrichoPlus); (B2.105) Muscodor roseus, in particular, strain A3-5 (Accession No. NRRL 30548); (B2.106) Simplicillium lanosoniveum; Biological control agents with plant growth and / or plant health improving effects that can be combined in combinations of compounds according to the invention, including: (C1) Bacillus pumilus, in particular strain QST2808 (Accession No. NRRL No. B-30087); Bacillus subtilis, in particular strain QST713 / AQ713 (described in NRRL Accession No. B-21661 and U.S. Patent No. 6,060,051; available from Bayer CropScience LP, USA as SERENADE® OPTI or SERENADE® ASO); Bacillus subtilis, in particular strain AQ30002 (described in Accession No. NRRL B-50421 and U.S. Patent Application Publication No. 13 / 330,576); Bacillus subtilis, in particular strain AQ30004 (and NRRL B-50455 and described in U.S. Patent Application Publication No. 13 / 330,576; Sinorhizobium meliloti strain NRG-185-1 (available from Bayer CropScience as NITRAGIN® GOLD); Bacillus subtilis strain BU1814, (available from BASF SE as TEQUALIS®); Bacillus subtilis rm303 (available from Biofilm Crop Protection as RHIZOMAX®); Bacillus amyloliquefaciens pm414 (available from Biofilm Crop Protection as LOLI-PEPTA®); Bacillus mycoides BT155 (NRRL No. B-50921), Bacillus mycoides EE118 (NRRL No. B-50918), Bacillus mycoides EE141 (NRRL No. B-50916), Bacillus mycoides BT46-3 (NRRL No.B-50922), Bacillus cereus family member EE128 (NRRL No. B-50917), Bacillus thuringiensis BT013A (NRRL No. B-50924), also known as Bacillus thuringiensis 4Q7, Bacillus cereus family member EE349 (NRRL No. B-50928), Bacillus amyloliquefaciens SB3281 (ATCC#PTA-7542; WO 2017 / 205258), Bacillus amyloliquefaciens TJ1000 (available from Novozymes as QUIKROOTS®); Bacillus firmus, in particular the strain CNMC I-1582 (e.g., from BASF SE as VOTIVO®); Bacillus pumilus, in particular the strain GB34 (e.g., from Bayer Crop Science, Germany as YIELD SHIELD®); Bacillus amyloliquefaciens, in particular the strain IN937a; Bacillus amyloliquefaciens, in particular the strain FZB42 (e.g., from ABiTEP, Germany as RHIZOVITAL®); Bacillus amyloliquefaciens BS27 (Accession No.NRRL B-5015; a mixture of Bacillus licheniformis FMCH001 and Bacillus subtilis FMCH002 (available from FMC Corporation as QUARTZO® (WG), PRESENCE® (WP)); Bacillus cereus, in particular strain BP01 (ATCC 55675; e.g., from Arysta Lifescience, USA, as MEPICHLOR®); Bacillus subtilis, in particular strain MBI 600 (e.g., from BASF SE as SUBTILEX®); Bradyrhizobium japonicum (e.g., from Novozymes as OPTIMIZE®); Mesorhizobium cicer (e.g., from BASF SE as NODULATOR); Rhizobium leguminosarium biovar viciae (e.g., from BASF SE as NODULATOR); Delftia acidovorans, particularly the strain RAY209 (e.g., from Brett Young Seeds as BIOBOOST®); Lactobacillus sp. (e.g., from LactoPAFI as LACTOPLANT®); Paenibacillus polymyxa, particularly the strain AC-1 (e.g., from Green Biotech Company Ltd. as TOPSEED®); Pseudomonas proradix (e.g., from Sourcon Padena as PRORADIX®); Azospirillum brassirense brasilense) (e.g., available from KALO, Inc. as VIGOR®)Azospirillum lipoferum (e.g., from TerraMax, Inc. as VERTEX-IF™); a mixture of Azotobacter vinelandii and Clostridium pasteurianum (available from Agrinos as INVIGORATE®); Pseudomonas aeruginosa, particularly strain PN1; Rhizobium leguminosarum, particularly physiological type viceae strain Z25 (Accession No. CECT 4585); Azorhizobium caulinodans, particularly strain ZB-SK-5; Azotobacter Bacteria selected from the group consisting of: Bacillus chroococcum, in particular strain H23; Azotobacter vinelandii, in particular strain ATCC 12837; Bacillus siamensis, in particular strain KCTC 13613T; Bacillus tequilensis, in particular strain NII-0943; Serratia marcescens, in particular strain SRM (Accession No. MTCC 8708); Thiobacillus sp. (e.g., from Cropaid Ltd UK under the trademark CROPAID®); and (C2) Purpureocillium lilacinum (formerly known as Paecilomyces lilacinus) strain 251 (AGAL 89 / 030550; e.g., from Bayer CropScience Biologics GmbH as BioAct); Penicillium bilaii, strain ATCC 22348 (e.g., from Acceleron BioAg as JumpStart®), Talaromyces flavus strain V117b; Trichoderma atroviride strain CNCM I-1237 (e.g., from Agrauxine, France as Esquive® WP), Trichoderma viride, e.g., strain B35 (Pietr et al. al., 1993, Zesz. Nauk.AR w Szczecinie 161: 125-137; Trichoderma atroviride strain LC52 (also known as Trichoderma atroviride strain LU132; e.g., from Agrimm Technologies Limited as Sentinel); Trichoderma atroviride strain SC1, described in International Application No. PCT / IT2008 / 000196; Trichoderma asperellum strain kd (e.g., from Andermatt Biocontrol as T-Gro); Trichoderma asperellum strain Eco-T (Plant Health Products, South Africa); Trichoderma harzianum (Trichoderma harzianum) strain T-22 (e.g., from Andermatt Biocontrol or Koppert as Trianum-P); Myrothecium verrucaria strain AARC-0255 (e.g., from Valent Biosciences as DiTera®); Penicillium bilaii strain ATCC ATCC20851; Pythium oligandrum strain M1 (ATCC 38472; e.g., from Bioprepraty, Czech Republic as Polyversum); Trichoderma virens strain GL-21 (e.g., from Certis, USA as SoilGard®); Verticillium albo-atrum (formerly V. dahliae) strain WCS850 (CBS 276.92; e.g., from Tree Care Innovations as Dutch Trig); Trichoderma atroviride, in particular strain No. V08 / 002387, strain No. NMI No.V08 / 002388, strain NMI No. V08 / 002389, strain NMI No. V08 / 002390; Trichoderma harzianum strain ITEM 908; Trichoderma harzianum, strain TSTh20; Trichoderma harzianum strain 1295-22; Pythium oligandrum strain DV74; Rhizopogon amylopogon (e.g., contained in Myco-Sol from Helena Chemical Company); Rhizopogon fulvigleba (e.g., contained in Myco-Sol from Helena Chemical Company); and Trichoderma virens (Trichoderma virens) strain GI-3; an insecticidally active biological control agent selected from: (D1) Bacillus thuringiensis subsp. aizawai, in particular strain ABTS-1857 (SD-1372; e.g., from Valent BioSciences as XENTARI®); Bacillus mycoides isolate J. (e.g., from Certis USA LLC, a Mitsui & Co. subsidiary as BmJ); Bacillus sphaericus, in particular serotype H5a5b strain 2362 (strain ABTS-1743) (e.g., from Valent BioSciences, USA as VECTOLEX®); Bacillus thuringiensis subsp. kurstaki, in particular strain BMP 123 from Becker Microbial Bacillus thuringiensis subsp. aizawai, in particular serotype H-7 (e.g., as FLORBAC® WG from Valent BioSciences, USA); Bacillus thuringiensis subsp. kurstaki strain HD-1 (e.g., as DIPEL® ES from Valent BioSciences, USA); Bacillus thuringiensis subsp. kurstaki strain BMP 123 from Becker Microbial Products, Israel; Bacillus thuringiensis israelensis strain BMP 144 (e.g., as AQUABAC® from Becker Microbial Products, Israel); Burkholderia spp. spp.), in particular Burkholderia rinojensis strain A396 (also known as Burkholderia rinojensis strain MBI 305) (Accession No. NRRL B-50319; WO 2011 / 106491 and WO 2013 / 032693; e.g., from Marrone Bio Innovations as MBI-206 TGAI and ZELTO®); Chromobacterium subtsugae, in particular strain PRAA4-1T (MBI-203; e.g., from Marrone Bio Innovations as GRANDEVO®); Paenibacillus popilliae) (formerly Bacillus popilliae); e.g., MILKY SPORE POWDER™ and MILKY SPORE GRANULAR™ from St. Gabriel Laboratories; Bacillus thuringiensis subsp. israelensis (serotype H-14) strain AM65-52 (Accession No. ATCC 1276) (e.g., from Valent BioSciences, USA, as VECTOBAC®); Bacillus thuringiensis var. kurstaki strain EVB-113-19 (e.g., from AEF Global, as BIOPROTEC®); Bacillus thuringiensis subsp. tenebrionis strain NB 176 (SD-5428; e.g., from BioFa, Inc., as NOVODOR® FC). from Germany); Bacillus thuringiensis var. japonensis strain Buibui; Bacillus thuringiensis subsp.kurstaki strain ABTS 351; Bacillus thuringiensis subsp. kurstaki strain PB 54; Bacillus thuringiensis subsp. kurstaki strain SA 11; Bacillus thuringiensis subsp. kurstaki strain SA 12; Bacillus thuringiensis subsp. kurstaki strain EG 2348; Bacillus thuringiensis var. Colmeri (e.g., from Changzhou Jianghai Chemical Factory as TIANBAOBTC); Bacillus thuringiensis subsp. aizawai (Bacillus thuringiensis subsp. aizawai strain GC-91; Serratia entomophila (e.g., from Wrightson Seeds as INVADE®); Serratia marcescens, particularly strain SRM (Accession No. MTCC 8708); and Wolbachia pipientis strain ZAP (e.g., from MosquitoMate as ZAP MALES®); and (D2) Isaria fumosorosea (formerly known as Paecilomyces fumosoroseus) strain apopka 97; Beauveria bassiana strain ATCC 74040 (e.g., from Intrachem Bio Italia as NATURALIS®); Beauveria bassiana strain GHA (Accession No. ATCC 74250; e.g., from Laverlam International Corporation as BOTANIGUARD® ES and MYCONTROL-O®); Zoophtora radicans; Metarhizium robertsii 15013-1 (deposited under NRRL Accession No. 67073), Metarhizium robertsii and Metarhizium anisopliae 3213-1 (deposited under NRRL Accession No. 67074) (WO 2017 / 066094; Pioneer Hi-Bred International); Beauveria bassiana strain ATP02 (Accession No. DSM 24665). Among these, Isaria fumosorosea (formerly known as Paecilomyces fumosoroseus) strain apopka 97 is particularly preferred. (E) a virus selected from the group consisting of Adoxophyes orana (smaller apple tortrix moth) granulosis virus (GV), Cydia pomonella (codling moth) granulosis virus (GV), Helicoverpa armigera (cotton budworm larvae) nuclear polyhedrosis virus (NPV), Spodoptera exigua (beet armyworm larvae) mNPV, Spodoptera frugiperda (stalk fall armyworm) mNPV, and Spodoptera littoralis (African cotton leafworm) NPV; (F) Bacteria and fungi that can be added as "inoculants" to plants or plant parts or plant organs and that, by their specific properties, promote plant growth and plant health. For example: Agrobacterium spp., Azorhizobium caulinodans, Azospirillum spp., Azotobacter spp., Bradyrhizobium spp., Burkholderia spp., in particular Burkholderia cepacia (formerly known as Pseudomonas cepacia), Gigaspora spp. or Gigaspora monosporum, Glomus spp., Laccaria spp. spp., Lactobacillus buchneri, Paraglomus spp., Pisolithus tinctorus, Pseudomonas spp., Rhizobium spp., in particular Rhizobium trifolii, Rhizopogon spp., Scleroderma spp., Suillus spp., and Streptomyces spp.; and (G) Allium sativum, Artemisia absinthium, Azadirachtin, Biokeeper WP, Cassia nigricans, Celastrus angulatus, Chenopodium anthelminticum, Chitin, Armour-Zen, Dryopteris filix-mas, Equisetum arvense, Fortune Aza, Fungastop, Heads Up (Chenopodium quinoa saponin extract), Pyrethrum / Pyrethrins, Cassia amara amara, Quercus, Quillaja, Regalia, "Requiem™ Insecticide", rotenone, ryania / ryanodine, Symphytum officinale, Tanacetum vulgare, thymol, Triact 70, TriCon, Tropaeulum majus, Urtica dioica, veratrine, Viscum album, Brassicaceae extracts, in particular rapeseed flour or mustard flour, as well as olive oil, in particular those with carbon chain length C, as an active ingredient, for example as contained in products under the trade name FLiPPER®. 16 ~C 20 Plant extracts and products produced by microorganisms containing proteins and secondary metabolites that can be used as biological control agents such as bio-insecticide / acaricide active substances obtained from unsaturated fatty acids / carboxylic acids having the formula:
[0337] The compounds of formula (I) and compositions of the present invention may be combined with one or more active ingredients selected from insecticides, acaricides and nematicides.
[0338] The terms "insecticide" and "insecticidal" refer to the ability of a substance to increase mortality or inhibit growth rate of insects. As used herein, the term "insects" comprises all organisms of the class "Insecta."
[0339] "Nematicide" and "nematicidal" refer to the ability of a substance to increase mortality or inhibit the growth rate of nematodes. Generally, "nematodes" comprise eggs, larvae, juveniles, and adult forms of the organisms.
[0340] "Acaricide" and "acaricidal" refer to the ability of a substance to increase mortality or inhibit the growth rate of ectoparasites belonging to the class Arachnida, subclass Acari.
[0341] Examples of insecticides, acaricides and nematicides that can be mixed with the compounds of formula (I) and compositions of the present invention are respectively: (1) Acetylcholinesterase (AChE) inhibitors, such as carbamates, e.g., alanycarb, aldicarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC, and xylylcarb, or organic phosphates, e.g., acephate, azamethiphos, azinphos-ethyl, azinphos-methyl, cadusafos, chlorethoxyphos, chlorfenvinphos, chlormephos, chlorpyrifos-methyl, coumaphos, cyanophosphos, demeton-S-methyl, diazinon, dichlorvos / DDVP , dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famfur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, imicyaphos, isofenphos, isopropyl O-(methoxyaminothiophosphoryl)salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton methyl, parathion methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorfon and vamidothion.
[0342] (2) GABA-gated chloride channel blockers, such as cyclodiene-organochlorines, such as chlordane and endosulfan, or phenylpyrazoles (fiproles), such as ethiprole and fipronil.
[0343] (3) Sodium channel modulators / voltage-dependent sodium channel blockers, for example, pyrethroids, for example, acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin s-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, β-cyhalothrin, cyhalothrin, λ-cyhalothrin, γ-cyhalothrin, cypermethrin, α-cypermethrin, β-cypermethrin, θ-cypermethrin, zeta-cypermethrin, cyphenothrin [(1R)-trans isomer], del Tametrin, Empenthrin [(EZ)-(1R) isomer], Esfenvalerate, Etofenprox, Fenpropathrin, Fenvalerate, Flucythrinate, Flumethrin, Taufluvalinate, Halfenprox, Imiprothrin, Kadesrin, Momfluorotrin, Permethrin, Fenothrin [(1R)-trans isomer], Prallethrin, Pyrethrins (Pyrethrum), Resmethrin, Silafluofen, Tefluthrin, Tetramethrin, Tetramethrin [(1R)-isomer)], Tralomethrin and Transfluthrin or DDT or Methoxychlor.
[0344] (4) Nicotinic acetylcholine receptor (nAChR) agonists, such as neonicotinoids, such as acetamiprid, clothianidin, dinotefuran, imidacloprid, nithembiram, thiacloprid and thiamethoxam, or nicotine, or sulfoxaflor or flupyradifurone.
[0345] (5) Nicotinic acetylcholine receptor (nAChR) allosteric activators, such as spinetoram and spinosad.
[0346] (6) Chloride channel activators, such as avermectins / mibemycins, e.g., abamectin, emamectin benzoate, lepimectin, and milbemectin.
[0347] (7) Juvenile hormone mimetics, such as juvenile hormone analogs, such as hydroprene, kinoprene and methoprene or fenoxycarb or pyriproxyfen.
[0348] (8) Various nonspecific (multipoint) inhibitors, such as alkyl halides, e.g., methyl bromide and other alkyl halides; or chloropicrin or sulfuryl fluoride or borax or tartar emetic.
[0349] (9) Selective homopteran antifeedants, such as pymetrozine or flonicamide.
[0350] (10) Acarid growth inhibitors, such as clofentezine, hexythiazox and diflobidazine or etoxazole.
[0351] (11) Microbial disruptors of insect gut membranes, such as Bacillus thuringiensis subsp. israelensis, Bacillus sphaericus, Bacillus thuringiensis subsp. aizawai, Bacillus thuringiensis subsp. kurstaki, Bacillus thuringiensis subsp. tenebrionis, and B.T. crop proteins: Cry1Ab, Cry1Ac, Cry1Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, and Cry34 / 35Ab1.
[0352] (12) Inhibitors of mitochondrial ATP synthase, such as diafenthiuron or organotin acaricides, such as azocyclotin, cyhexatin and fenbutatin oxide, or propargite or tetradifon.
[0353] (13) Uncouplers of oxidative phosphorylation by perturbing the proton gradient, such as chlorfenapyr, DNOC, and sulfluramide.
[0354] (14) Nicotinic acetylcholine receptor (nAChR) channel blockers, such as bensultap, cartap hydrochloride, thiosultap, and thiosultap sodium salt.
[0355] (15) Inhibitors of chitin biosynthesis, type 0, such as bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, and triflumuron.
[0356] (16) Inhibitors of chitin biosynthesis, type 1, such as buprofezin.
[0357] (17) Molting disruptors, such as cyromazine.
[0358] (18) Ecdysone receptor agonists, such as chromafenozide, halofenozide, methoxyfenozide, and tebufenozide.
[0359] (19) Octopamine receptor agonists, such as amitraz.
[0360] (20) Mitochondrial electron transport chain complex III inhibitors, such as hydramethylnon or acequinocyl or fluacrypyrim.
[0361] (21) Mitochondrial electron transport chain complex I inhibitors, such as METI acaricides, such as fenazaquin, fenpyroximate, pyrimidifen, pirdaben, tebufenpyrad and tolfenpyrad or rotenone (Derris).
[0362] (22) Voltage-gated sodium channel inhibitors, such as indoxacarb or metaflumizone.
[0363] (23) Inhibitors of acetyl-CoA carboxylase, such as tetronic acid and tetramic acid derivatives, e.g., spirodiclofen, spiromesifen, spiropydione, and spirotetramat.
[0364] (24) Mitochondrial electron transport chain complex IV inhibitors, for example, phosphines, such as aluminum phosphide, calcium phosphide, phosphorus hydride and zinc phosphide or cyanide.
[0365] (25) Mitochondrial electron transport chain complex II inhibitors, such as cyenopyrafen and cyflumetofen.
[0366] (28) Ryanodine receptor modulators, for example, diamides, such as chlorantraniliprole, cyantraniliprole, flubendiamide, and tetraniliprole.
[0367] Further active ingredients with unknown or uncertain mode of action, such as afidopiropene, afoxolaner, azadirachtin, benclothiaz, benzoximate, bifenazate, brofuranilide, bromopropylate, chinomethionate, chlorprallethrin, cryolite, cyclaniliprole, cycloxapride, cyhalodiamide, dichloromezothiaz, dicofol, epsilon-metofluthrin, epsilon-momfluthrin, flometoquin, fluazaindolizine, fluensulfone, flufenerim, flufenol noxystrobin, flufiprole, fluhexafon, fluopyram, fluralaner, fluxamethamide, fufenozide, guadipyr, heptafluthrin, imidaclothiz, iprodione, lotilaner, mepafluthrin, paichondine, pyridalyl, pyrifluquinazone, pyriminostrobin, sarolaner, tetramethylfluthrin, tetraniliprole, tetrachlorantraniliprole, thioxazaphen, thiofluoximate, triflumezopyrim, and iodomethane; further Bacillus firmus-based preparations (e.g., strain CNCM, such as VOTiVO® BioNeem); I-1582) or one of the following known active compounds: 1-{2-fluoro-4-methyl-5-[(2,2,2-trifluoromethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine (known from WO 2006 / 043635), {1'-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indole-3,4'-piperidine]-1(2H)-yl}(2-chloropyrifos-1,4'-pyridin-1-yl)- N-(2-chloro-N-[2-{1-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]piperidin-4-yl}-4-(trifluoromethyl)phenyl]isonicotinamide (known from WO 2006 / 003494), 3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]dec-3-en-2-one (known from WO 2009 / 049851), 3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-yl (known from WO 2009 / 049851), 4-(but-2-yn-1-yloxy)-6-(3,5-dimethylpiperidin-1-yl)-5-fluoropyrimidine (known from WO 2004 / 099160), 4-(but-2-yn-1-yloxy)-6-(3-chlorophenyl)pyrimidine (known from WO 2003 / 076415), PF1364 (CAS 1204776-60-2), methyl 2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-chloro-3-methylbenzoyl]-2-methylhydrazinecarboxylate (known from WO 2005 / 085216), methyl 2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino]-5-chloro-3-methylbenzoyl]-2-methylhydrazinecarboxylate 2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-methylhydrazinecarboxylate (known from WO 2005 / 085216), 2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-methylhydrazinecarboxylate (known from WO 2005 / 085216), 2-[3 , 5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-2-ethylhydrazine methyl carboxylate (known from WO 2005 / 085216), N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloropyridin-2-yl)-1 H-pyrazole-5-carboxamide (known from Chinese Patent No. 102057925), 8-chloro-N-[(2-chloro-5-methoxyphenyl)sulfonyl]-6-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxamide (known from WO 2009 / 080250), N-[(2E)-1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-ylidene]-2,2,2-Trifluoroacetamide (known from WO 2012 / 029672), 1-[(2-chloro-1,3-thiazol-5-ylyl)methyl]-4-oxo-3-phenyl-4H-pyrido[1,2-a]pyrimidin-1-ium-2-olate (known from WO 2009 / 099929), 1-[(6-chloropyridin-3-yl)methyl]-4-oxo-3-phenyl-4H-pyrido[1,2-a]pyrimidin-1-ium-2-olate (known from WO 2009 / 099929), 4 -(3-{2,6-dichloro-4-[(3,3-dichloroprop-2-en-1-yl)oxy]phenoxy}propoxy)-2-methoxy-6-(trifluoromethyl)pyrimidine (known from Chinese Patent No. 101337940), N-[2-(tert-butylcarbamoyl)-4-chloro-6-methylphenyl]-1-(3-chloropyridin-2-yl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide (known from WO 2008 / 134969), carbonic acid [2-(2,4-dichlorofluorophenyl)-2-methyl-4-(trifluoromethyl)-2-propanol]-1H-pyrazole-5-carboxamide] (known from WO 2008 / 134969), (3E)-3-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-1,1,1-trifluoro-propan-2-one (known from WO 2013 / 144213), N-[methylsulfonyl)-6-[2-(pyridin-3-yl)-1,3-thiazol-5-yl]pyridine-2-carboxamide (known from WO 2012 / 000896), N-[3 -(benzylcarbamoyl)-4-chlorophenyl]-1-methyl-3-(pentafluoroethyl)-4-(trifluoromethyl)-1H-pyrazole-5-carboxamide (known from WO 2010 / 051926), 5-bromo-4-chloro-N-[4-chloro-2-methyl-6-(methylcarbamoyl)phenyl]-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide (known from Chinese Patent No. 103232431), thioxazaphene, 4-[5-(3,5-dichlorophenyl)-4,5-Dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(cis-1-oxido-3-thietanyl)-benzamide, 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(trans-1-oxido-3-thietanyl)-benzamide and 4-[(5S)-5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl] N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]-propanamide, (+)-N ... propanamide and (-)-N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]-propanamide (known from WO 2013 / 162715(A2), WO 2013 / 162716(A2), U.S. Patent Application Publication No. 2014 / 0213448(A1)), 5-[[(2E)-3-chloro-2-propen-1-yl]amino]-1-[2,6-dichloro-4-(trifluoropropyl) N-[4-chloro-2-methyl-6-[(methylamino)thioxomethyl]phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile (known from Chinese Patent Application Publication No. 101337937), 3-bromo-N-[4-chloro-2-methyl-6-[(methylamino)thioxomethyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide (Liudaibenjiaxuanan, known from Chinese Patent Application Publication No. 103109816); N-[4-chloro-2-[[(1,1-dimethylethylamino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridinyl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide (International Publication No. 2012 / 034403(A1)), N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide (known from WO 2011 / 085575(A1)), 4-[3-[2,6-dichloro-4-[(3,3-dichloro-2-propen-1-yl)oxy]phenoxy]propoxy]-2-methoxy-6-(trifluoromethyl)-pyrimidine (known from Chinese Patent Application Publication No. 101337940); (2E)- and 2(Z)-2-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl] Ethylidene]-N-[4-(difluoromethoxy)phenyl]-hydrazinecarboxamide (known from Chinese Patent Application Publication No. 101715774); 3-(2,2-dichloroethenyl)-2,2-dimethyl-4-(1H-benzimidazol-2-yl)phenyl-cyclopropanecarboxylic acid ester (known from Chinese Patent Application Publication No. 103524422); (4aS)-7-chloro-2,5-dihydro-2-[[(methoxycarbonyl)[4-[(trifluoromethyl)thio]phenyl]amino]carbonyl]-indeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylic acid methyl ester (known from Chinese Patent Application Publication No. 102391261).
[0368] Examples of herbicides that can be mixed with the compounds of formula (I) and compositions of the present invention are: Acetochlor, acifluorfen, acifluorfen sodium salt, aclonifen, alachlor, allidochlor, alloxydim, alloxydim sodium, ametryn, amicarbazone, amidochlor, amidosulfuron, 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-carboxylic acid, aminocyclopyrachlor, aminocyclopyrachlor potassium, aminocyclopyrachlor-methyl, aminopyralid, amitrole, ammonium sulfamate, anilofos, asulam , atrazine, azafenidine, azimsulfuron, beflubutamid, benazolin, benazolin ethyl, benfluralin, benfuresate, bensulfuron, bensulfuron methyl, bensulide, bentazon, benzobicyclon, benzofenap, bicyclopyrone, bifenox, viranaphos, viranaphos sodium, bispyribac, bispyribac sodium, bixlozone, bromacil, bromobutide, bromofenoxime, bromoxynil, bromoxynil butyrate, potassium heptanoate and potassium octanoate, butoxynil Non, butachlor, butafenacil, butamifos, butenachlor, butralin, butroxydim, butyrate, cafenstrole, carbetamide, carfentrazone, carfentrazone-ethyl, chloramben, chlorbromuron, 1-{2-chloro-3-[(3-cyclopropyl-5-hydroxy-1-methyl-1H-pyrazol-4-yl)carbonyl]-6-(trifluoromethyl)phenyl}piperidin-2-one, 4-{2-chloro-3-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]-4-(methylsulfonyl) sulfonyl)benzoyl}-1,3-dimethyl-1H-pyrazol-5-yl-1,3-dimethyl-1H-pyrazole-4-carboxylate, chlorfenac, chlorfenac sodium, chlorfenapyr, chlorflurenol, chlorflurenol methyl, chloridazon, chlorimuron, chlorimuron ethyl, 2-[2-chloro-4-(methylsulfonyl)-3-(morpholin-4-ylmethyl)benzoyl]-3-hydroxycyclohex-2-en-1-one, 4-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}-1-ethyl-1H-pyrazol-5-yl-1,3-dimethyl-1H-pyrazole-4-carboxylate, chlorphthalim, chlorotoluron, chlorthal dimethyl, 3-[5-chloro-4-(trifluoromethyl)pyridin-2-yl]-4-hydroxy-1-methylimidazolidin-2-one, chlorsulfuron, cinidon, cinidon ethyl, cinmethylin, cinosulfuron, clasifos, clethodim, clodinafop, clodinafop propargyl, clomazone, clomeprop, clodinafop Lopyralid, cloransulam, cloransulam-methyl, cumyluron, cyanamide, cyanazine, cycloate, cyclopyranyl, cycloprimolate, cyclosulfamuron, cycloxydim, cyhalofop, cyhalofop-butyl, cyprazine, 2,4-D, 2,4-D-butotyl, 2,4-D-butyl, 2,4-D-dimethylammonium, 2,4-D-diolamine, 2,4-D-ethyl, 2,4-D-2-ethylhexyl, 2,4-D-isobutyl, 2,4-D-isooctyl, 2,4-D-isopropylammonium, 2,4-D-potassium 2,4-DB, 2,4-DB-butyl, 2,4-DB-dimethylammonium, 2,4-DB-isooctyl, 2,4-DB-potassium, and 2,4-DB-sodium, daimuron (dymron), dalapon, dazomet, n-decanol, desmedipham, detosylpyrazolate (DTP), dicamba, dichlobenil, dichlorprop, dichlorprop-P, diclofop, diclofop-methyl, and diclofop-P -methyl, diclosulam, difenzoquat, diflufenican, diflufenzopyr, diflufenzopyr sodium salt, dimefron, dimepiperate, dimethachlor, dimethametrine, dimethenamid, dimethenamid-P, 3-(2,6-dimethylphenyl)-6-[(2-hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-1-methylquinazoline-2,4(1H,3H)-dione, 1,3-dimethyl-4-[2-(methylsulfonyl)-4-(trifluoromethyl)benzoyl]-1H-pyrazol-5-yl-1,3-Dimethyl-1H-pyrazole-4-carboxylate, dimetrasulfuron, dinitramine, dinoterb, diphenamide, diquat, diquat dibromide, dithiopyr, diuron, DMPA, DNOC, endothall, EPTC, esprocarb, ethalfluralin, ethametsurfuron, ethametsurfuron methyl, etiodin, ethofumesate, ethoxyfen, ethoxyfen ethyl, ethoxysulfuron, etobenzanide, ethyl-[(3-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)amino]phenyl]propanol] methyl)-3,6-dihydropyrimidin-1(2H)-yl]phenoxy}pyridin-2-yl)oxy]acetate, F-9960, F-5231, i.e., N-{2-chloro-4-fluoro-5-[4-(3-fluoropropyl)-5-oxo-4,5-dihydro-1H-tetrazol-1-yl]phenyl}ethanesulfonamide, F-7967, i.e., 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione, fenoxaprop, fenoxaprop-P, fenoxaprop-ethyl, fenoxaprop-P-ethyl, fenoxasulfone, fenquinotrione, fentrazamide, flamprop, flamprop-M-isopropyl, flamprop-M-methyl, flazasulfuron, florasulam, fluazifop, fluazifop-P, fluazifop-butyl, fluazifop-P-butyl, flucarbazone, flucarbazone sodium, flucetosulfuron, fluchloralin, flufenacet, flufenpyr, flufenpyr ethyl, flumetsulam, flumiclorac, flumiclorac pentyl, flumioxazin, fluometuron, flurenol, flurenol butyl, flurenol dimethylammonium and flurenol methyl, fluoroglycofen, Fluroglycofen ethyl, flupropanate, flupyrsulfuron, flupyrsulfuron methyl sodium, fluridone, flurochloridone, fluroxypyr, fluroxypyr meptyl, flurtamone, fluthiacet, fluthiacet methyl, fomesafen, fomesafen sodium, foramsulfuron, fosamine, glufosinate, glufosinate ammonium, glufosinate-P-sodium, glufosinate-P-ammonium, glufosinate-P-sodium, glyphosate, glyphosate ammonium, glyphosate isopropylammonium, glyphosate diammonium, glyphosate dimethylammonium, glyphosate potassium, glyphosate sodium, and glyphosate trimesium, H-9201, i.e., O-(2,4-dimethyl-6-nitrophenyl) O-Ethyl isopropyl phosphoramidothioate, haloxifene, haloxifene methyl, halosafen, halosulfuron, halosulfuron methyl, haloxyfop, haloxyfop-P, haloxyfop-ethoxyethyl, haloxyfop-P-ethoxyethyl, haloxyfop methyl, haloxyfop-P-methyl, hexazinone, HW-02, i.e., 1-(dimethoxyphosphoryl)ethyl (2,4-Dichlorophenoxy)acetate, 4-hydroxy-1-methoxy-5-methyl-3-[4-(trifluoromethyl)pyridin-2-yl]imidazolidin-2-one, 4-hydroxy-1-methyl-3-[4-(trifluoromethyl)pyridin-2-yl]imidazolidin-2-one, (5-hydroxy-1-methyl-1H-pyrazol-4-yl)(3,3,4-trimethyl-1,1-dioxide-2,3-dihydro-1-benzothiophen-5-yl)methanone, 6-[(2-hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-1,5-dimethyl-3-(2-methylphenyl) Quinazoline-2,4(1H,3H)-dione, imazamethabenz, imazamethabenz methyl, imazamox, imazamox ammonium, imazapic, imazapic ammonium, imazapyr, imazapyr isopropylammonium, imazaquin, imazaquin ammonium, imazethapyr, imazethapyr immonium, imazosulfuron, indanofan, indaziflam, iodosulfuron, iodosulfuron methyl sodium, Ioxynil, Ioxynil octanoate, Ioxynil potassium and Ioxynil sodium, Ipfencarbazone, Isoproturon, Isouron, Isoxaben, Isoxaflutole, Carbutilate, KUH-043, i.e., 3-({[5-(difluoromethyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-4,5-dihydro-1,2-oxazole, ketospiradox, lactofen, lenacil, linuron, MCPA, MCPA-butotyl, MCPA-dimethylammonium, MCPA-2-ethylhexyl, MCPA-isopropylammonium, MCPA-potassium, and MCPA-sodium, MCPB, MCPB-methyl, MCPB-ethyl, and MCPB-sodium, mecoprop, mecoprop sodium, and mecoprop-butotyl, mecoprop-P, mecoprop-P-butotyl, mecoprop-dimethylammonium, mecoprop-2-ethylhexyl, and mecoprop potassium, mefenacet, mefluidide, mesosulfuron, mesosulfuron methyl, mesotrione, metabenzthiazuron, metam, metamifop, metamitron, metazachlor, metazosulfuron, metabenzthiazuron, methiopyrsulfuron, methiozoline, 2-({2-[(2-methoxyethoxy)methyl]-6-(trifluoromethyl)pyridin-3-yl}carbonyl)cyclohexane-1,3-dione, methyl isothiocyanate, 1-methyl-4-[(3,3,4-trimethyl-1,1-dioxide-2,3-dihydro-1-benzothiophen-5-yl)carbonyl]-1H-pyrazol-5-ylpropane-1-sulfonate, metobromuron, metolachlor, S-methyl Trachlor, metosulam, metoxuron, metribuzin, metsulfuron, metsulfuron methyl, molinate, monolinuron, monosulfuron, monosulfuron ester, MT-5950, i.e., N-(3-chloro-4-isopropylphenyl)-2-methylpentanamide, NGGC-011, napropamide, NC-310, i.e., [5-(benzyloxy)-1-methyl-1H-pyrazol-4-yl](2,4-Dichlorophenyl)methanone, nebron, nicosulfuron, nonanoic acid (pelargonic acid), norflurazon, oleic acid (fatty acid), orbencarb, orthosulfamuron, oryzalin, oxadiargyl, oxadiazon, oxasulfuron, oxaziclomefone, oxyfluorfen, paraquat, paraquat dichloride, pebulate, pendimethalin, penoxsulam, pentachlorophenol, pentoxazone, petoxamid, petroleum, phenmedipham, picloram, pyrocolinafen, pinoxaden, piperophos, pretilachlor, primisulfuron, primisulfuron methyl, prodiamine, propoxydim, prometon, prometryn, propachlor, propanil, propaquizafop, propazine, propham, propham, propam Lopisochlor, propoxycarbazone, propoxycarbazone sodium, propyrisulfuron, propyzamide, prosulcarb, prosulfuron, pyraclonil, pyraflufen, pyraflufen-ethyl, pyrasulfotole, pyrazolinate (pyrazolate), pyrazosulfuron, pyrazosulfuron-ethyl, pyrazoxifen, pyribambenz, pyribambenzisopropyl, pyribambenzpropyl, pyribenzoxim, pyributicarb, pyridafol, pyridate, pyriftalid, pyriminobac, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyrithiobac-sodium, pyroxasulfone, pyroxsulam, quinclorac, quinmerac, quinoclamine, quizalofop, quizalofop-ethyl, quizalofop-P, quizalofop-P Quizalofop-P-ethyl, Quizalofop-P-tefuryl, QYM-201, QYR-301, Rimsulfuron, Saflufenacil, Sethoxydim, Siduron, Simazine, Simetryn, SL-261, Sulcotrione, Sulfentrazone, Sulfometuron, Sulfometuron methyl, Sulfosulfuron, SYN-523, SYP-249, i.e., 1-ethoxy-3-methyl -1-oxobut-3-en-2-yl 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoate, SYP-300, i.e., 1-[7-fluoro-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-3-propyl-2-thioxoimidazolidine-4,5-dione, 2,3,6-TBA, TCA (trichloroacetic acid), TCA-sodium, tebuthiuron, tefuryltrione, tembotrione, tepraloxydim, terbacil, terbucarb, terbumeton, terbuthylazine, terbutryn, tetfluprolimet, thenylchlor, thiazopyr, thiencarbazone, thiencarbazone methyl, thifensulfuron, thifensulfuron methyl, thiobencarb, thiafenacil, tolpyralate, topramezone, tralkoxydim, triafamone , triallate, triasulfuron, triaziflam, tribenuron, tribenuron methyl, triclopyr, trietazine, trifloxysulfuron, trifloxysulfuron sodium, trifludimoxazine, trifluralin, triflusulfuron, triflusulfuron methyl, tritosulfuron, urea sulfate, vernalate, ZJ-0862, i.e., 3,4-dichloro-N-{2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzyl}aniline.
[0369] Examples of plant growth regulators are: Acibenzolar, acibenzolar-S-methyl, 5-aminolevulinic acid, ancymidol, 6-benzylaminopurine, brassinolide, catechin, chlormequat chloride, cloprop, cyclanilide, 3-(cycloprop-1-enyl)propionic acid, daminozide, dazomet, n-decanol, dikegulac, dikegulac sodium, endothal, endothal dipotassium, disodium, and mono(N,N-dimethylalkylammonium), ethephon, flumetralin, flurenol, flurenol butyl, flurprimidol, forchlorfenuron, gibberellic acid, inabenfide, indole-3-acetic acid (IAA), 4-indole 3-ylbutyric acid, isoprothiolane, probenazole, jasmonic acid, maleic hydrazide, mepiquat chloride, 1-methylcyclopropene, methyl jasmonate, 2-(1-naphthyl)acetamide, 1-naphthylacetic acid, 2-naphthyloxyacetic acid, nitrophenolate mixture, paclobutrazol, N-(2-phenylethyl)-β-alanine, N-phenylphthalamic acid, prohexadione, prohexadione-calcium, prohydrojasmone, salicylic acid, strigolactone, tecnazene, thidiazuron, triacontanol, trinexapac, trinexapac-ethyl, tsitodef, uniconazole, uniconazole-P.
[0370] Examples of safeners that may be mixed with the compounds of formula (I) and compositions of the present invention include benoxacor, cloquintocet(-methyl), cyometrinil, cyprosulfamide, dichlormid, fenchlorazole(-ethyl), fenclorim, flurazole, fluxofenim, furilazole, isoxadifen(-ethyl), mefenpyr(-diethyl), naphthalic anhydride, oxabetrinil, 2-methoxy-N-({4-[(methylcarbamoyl)amino]phenyl}sulfonyl)benzamide (CAS No. 129531-12-0), 4-(dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane (CAS No. 71526-07-3), 2,2,5-trimethyl-3-(dichloroacetyl)-1,3-oxazolidine (CAS No. 52836-31-4).
[0371] Examples of nitrification inhibitors that can be mixed with the compounds of formula (I) and compositions of the present invention are selected from the group consisting of: 2-(3,4-dimethyl-1H-pyrazol-1-yl)succinic acid, 2-(4,5-dimethyl-1H-pyrazol-1-yl)succinic acid, 3,4-dimethylpyrazolium glycolate, 3,4-dimethylpyrazolium citrate, 3,4-dimethylpyrazolium lactate, 3,4-dimethylpyrazolium mandelate, 1,2,4-triazole, 4-chloro-3-methylpyrazole, N-((3(5)-methyl-1H-pyrazol-1-yl)methyl)acetamide, N-((3(5)-methyl-1H-pyrazol-1-yl)methyl)formamide, N-((3(5),4-dimethylpyrazol-1-yl)methyl)formamide, N-((4-chloro-3(5)-methyl-pyrazol-1-yl)methyl)formamide;Reactive adduct of dicyandiamide, urea and formaldehyde, triazonyl-formaldehyde-dicyandiamide adduct, 2-cyano-1-((4-oxo-1,3,5-triazinan-1-yl)methyl)guanidine, 1-((2-cyanoguanidino)methyl)urea, 2-cyano-1-((2-cyanoguanidino)methyl)guanidine, 2-chloro-6-(trichloromethyl)-pyridine (nitrapyrin or N-serve), dicyandiamide, 3,4-dimethylpyrazole phosphate, 4,5-dimethylpyrazole phosphate, 3,4-dimethylpyrazole, 4,5-dimethylpyrazole, ammonium thiosulfate, neem, neem-based products, linoleic acid, α-linoleic acid Ingredients: benzoic acid, methyl p-coumarate, methyl ferulate, methyl 3-(4-hydroxyphenyl)propionate, karanjin, brachialactone, p-benzoquinone sorgoleone, 4-amino-1,2,4-triazole hydrochloride, 1-amido-2-thiourea, 2-amino-4-chloro-6-methylpyrimidine, 2-mercapto-benzothiazole, 5-ethoxy-3-trichloromethyl-1,2,4-thiodiazole (telazol, etridiazole), 2-sulfanilamidothiazole, 3-methylpyrazole, 1,2,4-triazolethiourea, cyanamide, melamine, zeolite powder, catechol, benzoquinone, sodium tetraborate, allylthiourea, chlorate, and zinc sulfate;
[0372] The compounds of formula (I) and compositions of the present invention may be combined with one or more agriculturally beneficial agents.
[0373] Examples of agents with pesticidal activity include biostimulants, plant growth regulators, plant signaling molecules, growth promoters, microbial stimulating molecules, biomolecules, soil conditioners, nutrients, plant nutrition promoters, and others, such as lipochitooligosaccharides (LCO), chitooligosaccharides (CO), chitinous compounds, flavonoids, jasmonic acid or its derivatives (e.g., jasmonates), cytokinins, auxins, gibberellins, abscisic acid, ethylene, brassinosteroids, salicylates, macronutrients and micronutrients, linoleic acid or its derivatives, linolenic acid or its derivatives, karrikins, and effective microorganisms (e.g., Rhizobium spp., Bradyrhizobium spp., Sinorhizobium spp., Azorhizobium spp., Glomus spp., etc.). spp.), Gigaspora spp., Hymenoscyphous spp., Oidiodendron spp., Laccaria spp., Pisolithus spp., Rhizopogon spp., Scleroderma spp., Rhizoctonia spp., Acinetobacter spp., Arthrobacter spp., Arthrobotrys spp., Aspergillus spp., Azospirillum spp.), Bacillus spp., Burkholderia spp., Candida spp., Chryseomonas spp., Enterobacter spp., Eupenicillium spp., Exiguobacterium spp., Klebsiella spp., Kluyvera spp.), Microbacterium spp., Mucor spp., Paecilomyces spp., Paenibacillus spp., Penicillium spp., Pseudomonas spp., Serratia spp., Stenotrophomonas spp., Streptomyces spp., Streptosporangium spp., Swaminathania spp., Thiobacillus spp., Torulospora spp., Vibrio spp., Xanthobacter spp., Xanthomonas spp., and others), as well as combinations thereof.
[0374] Methods and Uses The compound of formula (I) and the composition of the present invention have strong fungicidal activity and / or plant defense regulation ability.They can be used to control unwanted microorganisms such as unwanted fungi and bacteria in plants.As will be described in more detail below, they can be particularly useful for crop protection (controlling microorganisms that cause plant diseases) or protecting materials (such as industrial materials, timber, and stored goods).More specifically, the compound of formula (I) and the composition of the present invention can be used to protect seeds, germinated seeds, sprouted seedlings, plants, plant parts, fruits, harvested products, and / or the soil in which plants grow from unwanted microorganisms.
[0375] As used herein, controlling or controlling includes the protection, treatment, and eradication of undesirable microorganisms. Undesirable microorganisms may be pathogenic bacteria, pathogenic viruses, pathogenic oomycetes, or pathogenic fungi, more specifically, plant pathogenic bacteria, plant pathogenic viruses, plant pathogenic oomycetes, or plant pathogenic fungi. As described in more detail below, these plant pathogenic microorganisms are the causative agents of a wide range of plant diseases.
[0376] More specifically, the compounds of formula (I) and compositions of the present invention can be used as antifungal agents. For the purposes of this specification, "antifungal agent" refers to a compound or composition that can be used in crop protection to control undesirable fungi such as Plasmodiophoromycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes, and Deuteromycetes, and / or to protect against oomycetes.
[0377] The compounds of formula (I) and compositions of the present invention can also be used as antibacterial agents.In particular, they can be used in crop protection, such as controlling unwanted bacteria, for example, Pseudomonadaceae, Rhizobiaceae, Xanthomonadaceae, Enterobacteriaceae, Corynebacteriaceae, and Streptomycetaceae.
[0378] The compounds of formula (I) and the compositions of the present invention can also be used as antiviral agents in crop protection. For example, the compounds of formula (I) and the compositions of the present invention can be used to combat Tobacco Mosaic Virus (TMV), Tobacco Rattle Virus, Tobacco Dwarf Virus (TStuV), Tobacco Leaf Curl Virus (VLCV), Tobacco Nervilia Mosaic Virus (TVBMV), Tobacco Necrotic Dwarf Virus (TNDV), Tobacco Streak Virus (TSV), Potato Virus X (PVX), Potato Virus Y, S, M, and A, Potato Ocuba Mosaic Virus (PAMV), Potato Mop Top Virus (PMTV), Potato Leaf Roll Virus (PLRV), Alfalfa Mosaic Virus (AMV), Cucumber Mosaic Virus (Cucumber Mosaic Virus), Tobacco Spike Virus (TSV ... The virus may be effective against diseases caused by plant viruses such as Cucumber green mottle mosaic virus (CMV), Cucumber green mottle mosaic virus (CGMMV), Cucumber yellows virus (CuYV), Watermelon mosaic virus (WMV), Tomato spotted wilt virus (TSWV), Tomato ringspot virus (TomRSV), Sugarcane mosaic virus (SCMV), Rice dwarf virus, Rice stripe virus, Rice black stripe virus, Strawberry mottle virus (SMoV), Strawberry vein banding virus (SVBV), Strawberry mild yellow edge virus (SMYEV), Strawberry crinkle virus (SCrV), Broad bean wilt virus (BBWV), and Melon necrotic spot virus (MNSV).
[0379] The present invention also relates to a method for controlling undesirable microorganisms, such as undesirable fungi, oomycetes, and bacteria on plants, comprising the step of applying at least one compound of formula (I) or at least one composition of the present invention to the microorganisms and / or their habitat (plants, plant parts, seeds, fruits, or the soil in which the plants grow).
[0380] Typically, when the compounds of formula (I) and compositions of the present invention are used in a curative or protective method to control phytopathogenic fungi and / or phytopathogenic oomycetes, an effective and plant-compatible amount is applied to plants, plant parts, fruits, seeds, or the soil or substrate on which the plants grow. Suitable substrates that can be used to cultivate plants include inorganic-based substrates such as mineral wool, especially stone wool, perlite, sand, or gravel; organic substrates such as peat, pine bark, and sawdust; and petroleum-based substrates such as polymer foam or plastic beads. A plant-compatible effective amount is an amount sufficient to control or destroy fungi that may be present or appear in agricultural soil without causing noticeable symptoms of phytotoxicity to the crop. Such amounts may vary within wide ranges depending on the fungi to be controlled, the type of crop, the stage of crop development, climatic conditions, and the respective compounds or compositions of the present invention used. This amount can be determined by systematic field testing, which is within the capabilities of those skilled in the art.
[0381] Plants and plant parts The compounds of formula (I) and compositions of the present invention may be applied to any plant or plant part.
[0382] Plants means all plants and plant populations, such as desirable and undesirable wild plants or crop plants (including naturally occurring crop plants). Crops are plants that can be obtained by conventional breeding and optimization methods, or by biotechnology and genetic engineering methods, or a combination of these methods, and include genetically modified plants (GMOs or transgenic plants), and plant varieties that can and cannot be protected by plant breeders' rights.
[0383] Plant varieties are understood to mean plants having new properties ("traits") and obtained by conventional breeding, mutagenesis or recombinant DNA techniques. They may be cultivars, varieties, biotypes or genotypes.
[0384] Plant parts are understood to mean all parts and organs of a plant, above and below ground, such as shoots, leaves, needles, stalks, stems, flowers, fruiting bodies, fruits, seeds, roots, tubers, rhizomes, etc. Plant parts also include harvested material, plant material and reproductive propagation material, such as cuttings, tubers, rhizomes, slips and seeds.
[0385] Plants that can be treated according to the method of the present invention include cotton, flax, grapes, fruits, vegetables, such as Rosaceae sp. (e.g., pome fruits such as apples and pears, but also stone fruits such as apricots, cherries, almonds and peaches, and soft fruits such as strawberries), Ribesioidae sp., Juglandaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae species (e.g., banana trees and plantations), Rubiaceae species (e.g., coffee), Theaceae species, Sterculiceae species, Rutaceae species (e.g., lemons, oranges, and grapefruit); Solanaceae species (e.g., tomatoes), Liliaceae species, Asteraceae species (e.g., lettuce), Umbelliferae species, Cruciferae species, Chenopodiaceae species, Cucurbitaceae species (e.g., cucumber), Alliaceae species sp.) (e.g., chives, onions), Papilionaceae sp. (e.g., peas); major crops, e.g., Gramineae sp. (e.g., maize, grass, cereals such as wheat, rye, rice, barley, oats, millet and triticale), Asteraceae sp. (e.g., sunflowers), Brassicaceae sp.) (e.g., white cabbage, red cabbage, broccoli, cauliflower, Brussels sprouts, bok choy, turnip cabbage, radish, and rapeseed, mustard, horseradish, and watercress), Fabacae sp. (e.g., kidney beans, peanuts), Papilionaceae sp. (e.g., soybeans), Solanaceae sp. (e.g., potatoes), Chenopodiaceae sp. (e.g., sugar beet, fodder beet, Swiss chard, beetroot); useful and ornamental plants for gardens and woodlands; and genetically modified varieties of each of these plants.
[0386] Plants and plant cultivars that may be treated by the disclosed methods include plants and plant cultivars that are tolerant to one or more biotic stresses, i.e., that exhibit better defense against animal and microbial pests, such as nematodes, insects, mites, plant pathogenic fungi, bacterial viruses and / or viroids.
[0387] Plants and plant cultivars that can be treated by the disclosed methods include plants that are tolerant to one or more abiotic stresses. Abiotic stress conditions can include, for example, drought, low temperature exposure, heat exposure, osmotic stress, flooding, increased soil salinity, increased mineral exposure, ozone exposure, high light exposure, limited availability of nitrogen nutrients, limited availability of phosphorus nutrients, and shade avoidance.
[0388] Plants and plant varieties that can be treated by the methods disclosed above include plants characterized by improved yield characteristics. Increased yield in such plants can be the result of improved plant physiology, growth, and development, such as improved water use efficiency, water retention efficiency, improved nitrogen utilization, improved carbon assimilation, improved photosynthesis, improved germination efficiency, and accelerated maturation. Furthermore, yield can be affected by improved plant architecture (under stress and non-stress conditions), including, but not limited to, early flowering, flowering control for hybrid seed production, seedling vigor, plant size, internode number and distance, root growth, seed size, fruit size, pod size, number of pods or panicles, number of seeds per pod or panicle, seed mass, enhanced seed filling, reduced seed dispersal, reduced pod dehiscence and lodging resistance. Additional yield characteristics include seed composition, such as carbohydrate content and composition (e.g., cotton or starch), protein content, oil content and composition, nutritional value, reduced antinutritional compounds, improved processability, and better storage stability.
[0389] Plants and plant cultivars that can be treated by the methods disclosed above include hybrid plants that already express characteristics of hybrid vigor or hybrid vigor that generally result in higher yield, vigor, health, and resistance to biotic and abiotic stresses.
[0390] Transgenic plants, seed treatments, and integration events The compounds of formula (I) can be advantageously used to treat transgenic plants, plant cultivars, or plant parts that have received genetic material that confers advantageous and / or useful properties (traits) to these plants, plant cultivars, or plant parts. It is therefore contemplated that the present invention can be combined with one or more recombinant traits, transgenic events, or combinations thereof. For purposes of this application, a transgenic event is created by the insertion of a specific recombinant DNA molecule into a specific location (locus) within a chromosome of the plant genome. The insertion creates a novel DNA sequence, referred to as an "event," characterized by the inserted recombinant DNA molecule and a certain amount of genomic DNA immediately adjacent to / flanking both ends of the inserted DNA. Such traits or transgenic events include, but are not limited to, pest resistance, water use efficiency, yield performance, drought tolerance, seed quality, improved nutritional quality, hybrid seed production, and herbicide tolerance. Specific examples of such advantageous and useful properties (traits) are better plant growth, vigor, stress tolerance, stability, lodging resistance, nutrient uptake, plant nutrition, and / or yield, in particular improved growth, increased tolerance to high or low temperatures, increased tolerance to drought or water or soil salinity levels, improved flowering performance, easier harvesting, accelerated ripening, increased yield, higher quality and / or nutritional value of the harvested product, improved storage life and / or processability of the harvested product, and increased resistance to animal and microbial pests such as insects, arachnids, nematodes, mites, slugs, snails, etc.
[0391] Among the DNA sequences encoding proteins that confer resistance to such animal and microbial pests, especially insects, mention may be made in particular of the genetic material from Bacillus thuringiensis that encodes the Bt proteins, which are widely described in the literature and well known to those skilled in the art, as well as proteins extracted from bacteria such as Photorhabdus (WO 97 / 17432 and WO 98 / 08932).In particular, CrylA, CryIAb, CryIAc, CryIIA, CryIIIA, CryIIIB2, Cry9c Cry2Ab, Cry3Bb and CryIF proteins or toxic fragments thereof, as well as hybrids or combinations thereof, in particular CrylF protein or hybrids derived from CrylF protein (e.g. hybrid CrylA-CrylF protein or toxic fragment thereof), CrylA-type proteins or toxic fragments thereof, preferably CrylAc protein or hybrids derived from CrylAc protein (e.g. hybrid CrylAb CrylAc protein) or CrylAb or Bt2 protein or toxic fragment thereof, Cry2Ae, Cry2Af or Cry2Ag protein or toxic fragment thereof, CrylA.105 protein or toxic fragment thereof, VIP3Aa19 protein, VIP3Aa20 protein, VIP3A protein produced in COT202 or COT203 cotton events, Estruch et al. (1996), Proc Natl Acad Sci USA 28;93(11):5389-94, or a toxic fragment thereof, a Cry protein as described in WO 2001 / 47952, or an insecticidal protein from Xenorhabdus (described in WO 98 / 50427), Serratia (particularly from S. entomophila), or Photorhabdus species strains, such as the Tc-protein from Photorhabdus described in WO 98 / 08932. Also included herein are variants or mutants of any one of these proteins that differ from any of the above sequences, particularly from the sequences of their toxic fragments, by a few amino acids (1-10, preferably 1-5), or that are fused to a transport peptide, such as a plastid transport peptide or another protein or peptide.
[0392] Another particularly highlighted example of such a trait is the conferring of resistance to one or more herbicides, such as imidazolinones, sulfonylureas, glyphosate, or phosphinothricin. Among DNA sequences encoding proteins that confer the trait of herbicide resistance to transformed plant cells and plants, mention may be made in particular of the bar or PAT genes or Streptomyces coelicolor genes described in WO 2009 / 152359, which confer resistance to the herbicide glufosinate, as well as genes encoding suitable EPSPS (5-enolpyruvylshikimat-3-phosphatase) enzymes, genes encoding glyphosate-N-acetyltransferase, or genes encoding glyphosate oxidoreductase, which confer resistance to EPSPS-targeting herbicides, particularly glyphosate and its salts. Further suitable herbicide tolerance traits include at least one ALS (acetolactate synthase) inhibitor (e.g., WO 2007 / 024782), a mutant Arabidopsis ALS / AHAS gene (e.g., U.S. Pat. No. 6,855,533), a gene encoding a 2,4-D-monooxygenase that confers tolerance to 2,4-D (2,4-dichlorophenoxyacetic acid), or a gene encoding a dicamba monooxygenase that confers tolerance to dicamba (3,6-dichloro-2-methoxybenzoic acid).
[0393] Another example of such a trait is resistance to one or more plant pathogenic fungi, such as Asian soybean rust. Among DNA sequences encoding proteins that confer such disease resistance traits, reference is made in particular to genetic material from Glycine tomentella, such as any of the publicly available accessions (PI441001, PI483224, PI583970, PI446958, PI499939, PI505220, PI499933, PI441008, PI505256, or PI446961) described in WO 2019 / 103918.
[0394] More particularly highlighted examples of such properties are, for example, systemic acquired resistance (SAR), increased resistance to bacteria and / or viruses due to systemins, phytoalexins, elicitors, and resistance genes and correspondingly expressed proteins and toxins.
[0395] Particularly useful transgenic events in transgenic plants or plant cultivars that can be preferably treated according to the invention include: event 531 / PV-GHBK04 (cotton, insect control, described in WO 2002 / 040677), event 1143-14A (cotton, insect control, not deposited, described in WO 2006 / 128569); event 1143-51B (cotton, insect control, deposited Event 1445 (cotton, herbicide-tolerant, not deposited, described in U.S. Patent Application Publication No. 2002 / 120964 or WO 2002 / 034946); Event 17053 (rice, herbicide-tolerant, deposited as PTA-9843, described in WO 2010 / 117737); Event 17314 (rice, herbicide-tolerant, deposited as PTA-9844) Event 281-24-236 (cotton, insect control - herbicide tolerance, deposited as PTA-6233, described in WO 2005 / 103266 or U.S. Patent Application Publication No. 2005-216969); Event 3006-210-23 (cotton, insect control - herbicide tolerance, deposited as PTA-6233, described in U.S. Patent Application Publication No. 2007-143876 or WO 2007-143876); 2005 / 103266); Event 3272 (corn, quality traits, deposited as PTA-9972, described in WO 2006 / 098952 or U.S. Patent Application Publication No. 2006 / 230473); Event 33391 (wheat, herbicide tolerance, deposited as PTA-2347, described in WO 2002 / 027004), Event 40416 (corn, insect control - herbicide tolerance, ATCC Event 43A47 (maize, insect control - herbicide resistance, deposited as ATCC PTA-11509, described in WO 2011 / 075595); Event 5307 (maize, insect control, deposited as ATCC PTA-9561, described in WO 2010 / 077816);Event ASR-368 (bentgrass, herbicide resistance, deposited as ATCC PTA-4816, described in U.S. Patent Application Publication No. 2006-162007 or WO 2004 / 053062); Event B16 (corn, herbicide resistance, not deposited, described in U.S. Patent Application Publication No. 2003-126634); Event BPS-CV127-9 (soybean, herbicide resistance, deposited as NCIMB No. 41603, described in WO 2010 / 080829); Event BLR1 (rapeseed, restoration of male sterility, deposited as NCIMB 41193, described in WO 2005 / 074671); Event CE43-67B (cotton, insect control, DSM Event CE44-69D (cotton, insect control, not deposited, described in U.S. Patent Application Publication No. 2009 / 217423 or WO 2006 / 128573); Event CE44-69D (cotton, insect control, not deposited, described in U.S. Patent Application Publication No. 2010 / 0024077); Event CE44-69D (cotton, insect control, not deposited, described in WO 2006 / 128571); Event CE46-02A (cotton, insect control, not deposited, described in WO 2006 / 128572); Event COT102 (cotton, insect control, not deposited, described in U.S. Patent Application Publication No. 006 / 130175 or WO 2004 / 039986); Event COT202 (cotton, insect control, not deposited, described in U.S. Patent Application Publication No. 2007 / 067868 or WO 2005 / 054479); Event COT203 (cotton, insect control, not deposited, described in WO 2005 / 054480); Event DAS21606-3 / 1606 (soybean, herbicide resistance, deposited as PTA-11028, described in WO 2012 / 033794), Event DAS40278 (corn, herbicide resistance, deposited as ATCC PTA-10244, described in WO 2011 / 022469);Event DAS-44406-6 / pDAB8264.44.06.1 (soybean, herbicide-resistant, deposited as PTA-11336, described in WO 2012 / 075426), Event DAS-14536-7 / pDAB8291.45.36.2 (soybean, herbicide-resistant, deposited as PTA-11335, described in WO 2012 / 075429), Event DAS-59122-7 (maize, insect control - herbicide-resistant, ATCC PTA11384, described in U.S. Patent Application Publication No. 2006 / 070139); Event DAS-59132 (corn, insect control - herbicide resistant, not deposited, described in WO 2009 / 100188); Event DAS68416 (soybean, herbicide resistant, deposited as ATCC PTA-10442, described in WO 2011 / 066384 or WO 2011 / 066360); Event DP-098140-6 (corn, herbicide resistant, ATCC PTA-8296, described in U.S. Patent Application Publication No. 2009-137395 or WO 08 / 112019); Event DP-305423-1 (soybean, quality traits, not deposited, described in U.S. Patent Application Publication No. 2008-312082 or WO 2008 / 054747); Event DP-32138-1 (maize, hybridization system, deposited as ATCC PTA-9158, described in U.S. Patent Application Publication No. 2009 / 0210970 or WO 2009 / 103049); Event DP-356043-5 (soybean, herbicide tolerance, ATCC PTA-8287, described in U.S. Patent Application Publication No. 2010 / 0184079 or WO 2008 / 002872); Event EE-I (eggplant, insect control, not deposited, described in WO 07 / 091277); Event Fil17 (corn, herbicide resistance, deposited as ATCC209031, described in U.S. Patent Application Publication No. 2006-059581 or WO 98 / 044140);Event FG72 (soybean, herbicide-resistant, deposited as PTA-11041, described in WO 2011 / 063413), event GA21 (corn, herbicide-resistant, deposited as ATCC 209033, described in U.S. Patent Application Publication No. 2005-086719 or WO 98 / 044140); event GG25 (corn, herbicide-resistant, deposited as ATCC 209032, described in U.S. Patent Application Publication No. 2005 / 188434 or WO 98 / 044140); event GHB119 (cotton, insect control-herbicide-resistant, deposited as ATCC PTA-8398, described in WO 2008 / 151780); event GHB614 (cotton, herbicide-resistant, deposited as ATCC PTA-6878, described in U.S. Patent Application Publication No. 2010-050282 or WO 2007 / 017186); Event GJ11 (corn, herbicide resistant, described in U.S. Patent Application Publication No. 2005 / 188434 or WO 98 / 044140, deposited as ATCC 209030); Event GM Event RZ13 (sugar beet, virus resistant, deposited as NCIMB-41601, described in WO 2010 / 076212); Event H7-l (sugar beet, herbicide resistant, deposited as NCIMB 41158 or NCIMB 41159, described in U.S. Patent Application Publication No. 2004 / 172669 or WO 2004 / 074492); Event JOPLINl (wheat, disease resistant, not deposited, U.S. Patent Application Publication No. 2008 / 0640 32); event LL27 (soybean, herbicide-tolerant, deposited as NCIMB41658, described in WO 2006 / 108674 or U.S. Patent Application Publication No. 2008-320616); event LL55 (soybean, herbicide-tolerant, deposited as NCIMB41660, described in WO 2006 / 108675 or U.S. Patent Application Publication No. 2008-196127); event LLcotton25 (cotton, herbicide-tolerant, deposited as ATCC PTA-3343, described in WO 2003 / 013224 or U.S. Patent Application Publication No. 2003 / 097687);Event LLRICE06 (rice, herbicide tolerance, deposited as ATCC 203353, described in U.S. Pat. No. 6,468,747 or WO 2000 / 026345); event LLRice62 (rice, herbicide tolerance, deposited as ATCC 203352, described in WO 2000 / 026345); event LLRICE601 (rice, herbicide tolerance, deposited as ATCC PTA-2600, described in U.S. Pat. App. Pub. No. 2008 / 2289060 or WO 2000 / 026356); event LY038 (maize, quality traits, ATCC PTA-5623, described in U.S. Patent Application Publication No. 2007 / 028322 or WO 2005 / 061720); Event MIR162 (corn, insect control, deposited as PTA-8166, described in U.S. Patent Application Publication No. 2009 / 300784 or WO 2007 / 142840); Event MIR604 (corn, insect control, not deposited, described in U.S. Patent Application Publication No. 2008-167456 or WO 2005 / 103301); Event MON15985 (cotton, insect control, ATCC Event MON810 (corn, insect control, not deposited, described in U.S. Patent Application Publication No. 2002 / 102582); Event MON863 (corn, insect control, deposited as ATCC PTA-2605, described in WO 2004 / 011601 or U.S. Patent Application Publication No. 2006 / 095986); Event MON87427 (corn, pollination control, deposited as ATCC PTA-7899, described in WO 2011 / 062904); Event MON87460 (corn, stress tolerance, deposited as ATCC PTA-8910, as described in WO 2009 / 111263 or U.S. Patent Application Publication No. 2011 / 0138504);Event MON87701 (soybean, insect control, deposited as ATCC PTA-8194, described in U.S. Patent Application Publication No. 2009 / 130071 or WO 2009 / 064652); Event MON87705 (soybean, quality traits - herbicide tolerance, deposited as ATCC PTA-9241, described in U.S. Patent Application Publication No. 2010 / 0080887 or WO 2010 / 037016); Event MON87708 (soybean, herbicide tolerance, deposited as ATCC PTA-9670, described in WO 2011 / 034704); Event MON87712 (soybean, yield, deposited as PTA-10296, described in WO 2012 / 051199), Event MON87754 (soybean, quality traits, ATCC PTA-9385, described in WO 2010 / 024976); Event MON87769 (soybean, quality traits, deposited as ATCC PTA-8911, described in U.S. Patent Application Publication No. 2011 / 0067141 or International; Publication No. 2009 / 102873); Event MON88017 (corn, insect control - herbicide resistance, deposited as ATCC PTA-5582, described in U.S. Patent Application Publication No. 2008 / 028482 or WO 2005 / 059103); Event MON88913 (cotton, herbicide resistance, deposited as ATCC PTA-4854, described in WO 2004 / 072235 or U.S. Patent Application Publication No. 2006 / 059590); event MON88302 (rapeseed, herbicide-resistant, deposited as PTA-10955, described in WO 2011 / 153186); event MON88701 (cotton, herbicide-resistant, deposited as PTA-11754, described in WO 2012 / 134808); event MON89034 (corn, insect control, deposited as ATCC PTA-7455, described in WO 07 / 140256 or U.S. Patent Application Publication No. 2008 / 260932); event MON89788 (soybean, herbicide-resistant, deposited as ATCC PTA-6708, described in U.S. Patent Application Publication No. 2006 / 282915 or WO 2006 / 130436); Event MS1 1 (rapeseed, pollination control—herbicide tolerance, deposited as ATCC PTA-850 or PTA-2485, described in WO 2001 / 031042); Event MS8 (rapeseed, pollination control—herbicide tolerance, deposited as ATCC PTA-730, described in WO 2001 / 041558 or U.S. Patent Application Publication No. 2003 / 188347); Event NK603 (maize, herbicide tolerance, deposited as ATCC PTA-2478, described in U.S. Patent Application Publication No. 2007 / 292854); Event PE-7 (rice, insect control, not deposited, described in WO 2008 / 114282); Event RF3 (rapeseed, pollination control - herbicide tolerance, deposited as ATCC PTA-730, described in WO 2001 / 041558 or U.S. Patent Application Publication No. 2003 / 188347); Event RT73 (rapeseed, herbicide tolerance, not deposited,Events include: Event SYHT0H2 / SYN-000H2-5 (soybean, herbicide-resistant, deposited as PTA-11226, described in WO 2012 / 082548); Event T227-1 (sugar beet, herbicide-resistant, not deposited, described in WO 2002 / 44407 or U.S. Patent Application Publication No. 2009 / 265817); Event T25 (corn, herbicide-resistant, not deposited, described in U.S. Patent Application Publication No. 2001 / 029014 or WO 2001 / 051654); Event T304-40 (cotton, insect control—herbicide-resistant, ATCC PTA-8171, described in U.S. Patent Application Publication No. 2010-077501 or WO 2008 / 122406); Event T342-142 (cotton, insect control, not deposited, described in WO 2006 / 128568); Event TC1507 (corn, insect control - herbicide resistance, not deposited, described in U.S. Patent Application Publication No. 2005 / 039226 or WO 2004 / 099447); Event VIP1034 (corn, insect control - herbicide resistance, ATCC Event 32316 (maize, insect control - herbicide resistance, deposited as PTA-11507, described in WO 2011 / 084632), Event 4114 (maize, insect control - herbicide resistance, deposited as PTA-11506, described in WO 2011 / 084621), Event EE-GM3 / FG72 (soybean, herbicide resistance, ATCC Accession No. PTA-11041) Events may be stacked with Event EE-GM1 / LL27 or Event EE-GM2 / LL55 (WO 2011 / 063413(A2)), Event DAS-68416-4 (soybean, herbicide tolerance, ATCC Accession No. PTA-10442, WO 2011 / 066360(A1)), Event DAS-68416-4 (soybean, herbicide tolerance, ATCC Accession No. PTA-10442, WO 2011 / 066384(A1)), Event DP-040416-8 (maize, insect control,ATCC Accession No. PTA-11508, WO 2011 / 075593(A1)), Event DP-043A47-3 (maize, insect control, ATCC Accession No. PTA-11509, WO 2011 / 075595(A1)), Event DP-004114-3 (maize, insect control, ATCC Accession No. PTA-11506, WO 2011 / 084621(A1)), Event DP-032316-8 (maize, insect control, ATCC Accession No. PTA-11507, WO 2011 / 084632(A1)) , Event MON-88302-9 (rapeseed, herbicide tolerance, ATCC Accession No. PTA10955, WO 2011 / 153186(A1)), Event DAS-21606-3 (soybean, herbicide tolerance, ATCC Accession No. PTA-11028, WO 2012 / 033794(A2)), Event MON-87712-4 (soybean, quality traits, ATCC Accession No. PTA-10296, WO 2012 / 051199(A2)), Event DAS-44406-6 (soybean, stacked herbicide tolerance, ATCC Accession No. PTA-11336 , WO 2012 / 075426(A1)), event DAS-14536-7 (soybean, stacked herbicide resistance, ATCC accession number PTA-11335, WO 2012 / 075429(A1)), event SYN-000H2-5 (soybean, herbicide resistance, ATCC accession number PTA-11226, WO 2012 / 082548(A2)), event DP-061061-7 (rapeseed, herbicide resistance, no accession number available, WO 2012 / 071039(A1)), event DP-073496-4 (rapeseed, herbicide Resistance, no accession number available, U.S. Patent Application Publication No. 2012 / 131692), Event 8264.44.06.1 (soybean, stacked herbicide resistance, Accession No. PTA-11336, WO 2012 / 075426(A2)), Event 8291.45.36.2 (soybean, stacked herbicide resistance, Accession No. PTA-11335, WO 2012 / 075429(A2)), Event SYHT0H2 (soybean, ATCC Accession No. PTA-11226, WO 2012 / 082548(A2)), Event MON88701 (cotton,ATCC Accession No. PTA-11754, International Publication No. 2012 / 134808(A1)), Event KK179-2 (Alfalfa, ATCC Accession No. PTA-11833, International Publication No. 2013 / 003558(A1)), Event pDAB8264.42.32.1 (Soybean, stack herbicide resistance, ATCC Accession No. PTA-11993, International Publication No. 2013 / 010094(A1)), Event MZDT09Y (Maize, ATCC Accession No. PTA-13025, International Publication No. 2013 / 012775(A1)).
[0396] Additionally, a list of such transgenic events is provided by the Animal and Plant Health Inspection Service (APHIS) of the United States Department of Agriculture (USDA) and can be found on the World Wide Web at its website at aphis.usda.gov. The status of such list as is / was relevant to this application as of the filing date of this application.
[0397] The genes / events that confer the desired traits of interest may also be present in combination with each other in transgenic plants. Examples of transgenic plants that may be mentioned are important crop plants, including cereals (wheat, rice, triticale, barley, rye, oats), corn, soybeans, potatoes, sugar beets, sugarcane, tomatoes, peas, other vegetables, cotton, tobacco, rapeseed, and fruit trees (including apples, pears, citrus fruits, and grapes), with particular emphasis on corn, soybeans, wheat, rice, potatoes, cotton, sugarcane, tobacco, and rapeseed. Particularly emphasized traits include increased plant resistance to insects, arachnids, nematodes, slugs, and snails, and increased plant resistance to one or more herbicides.
[0398] Commercially available examples of such plants, plant parts, or plant seeds that may be preferentially treated in accordance with the present invention include commercial products such as plant seeds sold or distributed under the trade names (GENUITY®, DROUGHTGARD®, SMARTSTAX®, RIB COMPLETE®, ROUNDUP READY®, VT DOUBLE PRO®, VT TRIPLE PRO®, BOLLGARD II®, ROUNDUP READY 2 YIELD®, YIELDGARD®, ROUNDUP READY® 2 XTEND™, INTACTA RR2 PRO®, VISTIVE GOLD®, and / or XTENDFLEX™).
[0399] pathogen Non-limiting examples of fungal disease pathogens that can be treated according to the present invention include: diseases caused by powdery mildew pathogens, for example Blumeria species, such as Blumeria graminis, Podosphaera species, such as Podosphaera leucotricha, Sphaerotheca species, such as Sphaerotheca fuliginea, Uncinula species, such as Uncinula necator; Rust pathogens, such as Gymnosporangium species (e.g., Gymnosporangium sabinae), Hemileia species (e.g., Hemileia vastatrix), Phakopsora species (e.g., Phakopsora pachyrhizi or Phakopsora meibomiae), Puccinia species (e.g., Puccinia recondita, Puccinia graminis, or Puccinia striiformis), striiformis), diseases caused by Uromyces species (e.g., Uromyces appendiculatus); For example, Albugo species (e.g., Albugo candida), Bremia species (e.g., Bremia lactucae), Peronospora species (e.g., Peronospora pisi or P. brassicae), Phytophthora species (e.g., Phytophthora infestans), Plasmopara species (e.g., Plasmopara viticola), Pseudoperonospora species (e.g., Pseudoperonospora humuli or P. humuli), Diseases caused by pathogens of the oomycete group, such as Pseudoperonospora cubensis, Pythium species (e.g., Pythium ultimum); For example, Alternaria species, such as Alternaria solani; Cercospora species, such as Cercospora beticola; Cladiosporium species, such as Cladiosporium cucumerinum; Cochliobolus species, such as Cochliobolus sativus (conidiophora: Drechslera, syn: Helminthosporium) or Cochliobolus miyabeanus; Colletotrichum species, such as Colletotrichum lindemtanium. lindemuthanium; Corynespora species, for example, Corynespora cassiicola; Cycloconium species, for example, Cycloconium oleaginum; Diaporthe species, for example, Diaporthe citri; Elsinoe species, for example, Elsinoe fawcettii; Gloeosporium species, for example, Gloeosporium laeticolor; Gloemerella species, for example, Gloemerella cingulata; Guignardia species, for example, Guignardia bidwelli bidwelli); Leptosphaeria species, for example, Leptosphaeria maculans; Magnaporthe species, for example, Magnaporthe grisea;Microdochium species, for example, Microdochium nivale; Mycosphaerella species, for example, Mycosphaerella graminicola, Mycosphaerella arachidicola or Mycosphaerella fijiensis; Phaeosphaeria species, for example, Phaeosphaeria nodorum; Pyrenophora species, for example, Pyrenophora teres or Pyrenophora tritici repentis; Ramularia species, for example, Ramularia collo-cygni or Ramularia areola; Rhynchosporium species, for example, Rhynchosporium secalis; Septoria species, for example, Septoria apii or Septoria lycopersici; Stagonospora species, for example, Stagonospora nodorum; Typhula species, for example, Typhula incarnata; Leaf blight and leaf wilt caused by Venturia species, for example, Venturia inaequalis; For example, Corticium species, such as Corticium graminearum; Fusarium species, such as Fusarium oxysporum; Gaeumannomyces species, such as Gaeumannomyces graminis; Plasmodiophora species, such as Plasmodiophora brassicae; Rhizoctonia species, such as Rhizoctonia solani; Sarocladium species, such as Sarocladium oryzae; Sclerotium species, such as Sclerotium oryzae. oryzae; Tapesia species, e.g., Tapesia acuformis; Root and stem diseases caused by Thielaviopsis species, e.g., Thielaviopsis basicola; For example, Alternaria species, such as Alternaria spp.; Aspergillus species, such as Aspergillus flavus; Cladosporium species, such as Cladosporium cladosporioides; Claviceps species, such as Claviceps purpurea; Fusarium species, such as Fusarium culmorum; Gibberella species, such as Gibberella zeae; Monographella species, such as Monographella nivalis. nivalis); diseases of ears and panicles (including corn cobs) caused by Stagnospora species, e.g., Stagnospora nodorum; diseases caused by smut fungi, for example Sphacelotheca species, for example Sphacelotheca reiliana; Tilletia species, for example Tilletia caries or Tilletia controversa; Urocystis species, for example Urocystis occulta; Ustilago species, for example Ustilago nuda; For example, Aspergillus species, such as Aspergillus flavus; Botrytis species, such as Botrytis cinerea; Monilinia species, such as Monilinia laxa; Penicillium species, such as Penicillium expansum or Penicillium purpurogenum; Rhizopus species, such as Rhizopus stolonifer; Sclerotinia species, such as Sclerotinia sclerotiorum; Verticilium species, such as Verticilium alboatorum. alboatrum); fruit rot caused by For example, Alternaria species, such as Alternaria brassicicola; Aphanomyces species, such as Aphanomyces euteiches; Ascochyta species, such as Ascochyta lentis; Aspergillus species, such as Aspergillus flavus; Cladosporium species, such as Cladosporium herbarum; Cochliobolus species, such as Cochliobolus sativus (conidiophores: Drechslera, bipolar Syn: Helminthosporium; Colletotrichum spp., for example, Colletotrichum coccodes; Fusarium spp., for example, Fusarium culmorum; Gibberella spp., for example, Gibberella zeae; Macrophomina spp., for example, Macrophomina phaseolina; Microdochium spp., for example, Microdochium nivale; Monographella spp., for example, Monographella nivalis; Penicillium spp., for example, Penicillium expansum expansum); Phoma species, for example, Phoma lingam; Phomopsis species, for example, Phomopsis sojae; Phytophthora species, for example, Phytophthora cactorum;Pyrenophora species, for example, Pyrenophora graminea; Pyricularia species, for example, Pyricularia oryzae; Pythium species, for example, Pythium ultimum; Rhizoctonia species, for example, Rhizoctonia solani; Rhizopus species, for example, Rhizopus oryzae; Sclerotium species, for example, Sclerotium rolfsii; Septoria species, for example, Septoria nodorum nodorum; Typhula species, for example, Typhula incarnata; seed and soil-borne rot and root blight caused by Verticillium species, for example, Verticillium dahliae, as well as diseases of seedlings; For example, cancer, galls and witches' broom caused by Nectria species, such as Nectria galligena; For example, Verticillium species, such as Verticillium longisporum; Fusarium species, such as Fusarium oxysporum, causing chestnut blight; For example, deformation of leaves, flowers and fruits caused by Exobasidium species, such as Exobasidium vexans; Taphrina species, such as Taphrina deformans; For example, degenerative diseases in woody plants caused by Esca species, such as Phaeomoniella chlamydospora, Phaeoacremonium aleophilum or Fomitiporia mediterranea; Ganoderma species, such as Ganoderma boninense; For example, tuber diseases caused by Rhizoctonia species, such as Rhizoctonia solani; Helminthosporium species, such as Helminthosporium solani; Bacterial pathogens, such as Xanthomonas species, e.g., Xanthomonas campestris pv. oryzae; Pseudomonas species, e.g., Pseudomonas syringae pv. lachrymans; Erwinia species, e.g., Erwinia amylovora; Liberibacter species, e.g., Liberibacter asiaticus; Xyella species, e.g., Xylella fastidiosa; Ralstonia species, e.g., Ralstonia solanacearum; solanacearum; Dickeya spp., for example, Dickeya solani; Clavibacter spp., for example, Clavibacter michiganensis; Diseases caused by Streptomyces spp., for example, Streptomyces scabies.
[0400] Soybean diseases: For example, Alternaria leaf spot (Alternaria spec. atrans tenuissima), anthracnose (Colletotrichum gloeosporoides dematium var. truncatum), brown spot (Septoria glycines), Cercospora leaf spot and blight (Cercospora kikuchii), Choanephora leaf blight (Choanephora infundibulifera trispora) (Syn.), Dactuliophora leaf spot (Dactuliophora glycines), Downy mildew (Peronospora manshurica), Drexlera canker (Drechslera glycini), Leaf ring spot (Cercospora sojina), Leptosphaerulina leaf spot (Leptosphaerulin...
Claims
1. Formula (I): 【Chemistry 1】 The compound of formula (I) A 2 is O, S, C(=O), S(=O), S(=O) 2 , N.R. 1 , or C.R. 2A R R2B and R 1 is hydrogen, C 1 ~C 6 Alkyl, C 3 ~C 8 cycloalkyl or formyl, C 1 ~C 6 Alkyl is halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxycarbonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, And C 3 ~C 8 Cycloalkyl is halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, R 2A and R 2B is hydrogen, C 1 ~C 6 Alkyl or C 3 ~C 8 is cycloalkyl, C 1 ~C 6 Alkyl is halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxycarbonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, And C 3 ~C 8 Cycloalkyl is halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, or R 2A and R 2B are independently, together with the carbon atom to which they are attached, C 3 ~C 8 forming a cycloalkyl ring or a 3- to 7-membered heterocyclyl ring; m is 0, 1, or 2; R 3 and R 4 are independently hydrogen, halogen, cyano, hydroxyl, formyl, carboxyl, C 1 ~C 6 Alkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Alkylcarbonyl, C 1 ~C 6 Alkylcarbonyloxy, C 1 ~C 6 Alkoxycarbonyl, C 2 ~C 6 Alkenyl, C 2 ~C 6 Alkynyl, C 3 ~C 8 Cycloalkyl, C 6 ~C 14 Aryl, 5- to 14-membered heteroaryl, 3- to 14-membered heterocyclyl or —O—Si(C 1 ~C 6 Alkyl) 3 and C 1 ~C 6 Alkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Alkylcarbonyl, C 1 ~C 6 Alkylcarbonyloxy, C 1 ~C 6 Alkoxycarbonyl, C 2 ~C 6 Alkenyl, C 2 ~C 6 Alkynyl and —O—Si(C 1 ~C 6 Alkyl) 3 is halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxycarbonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, And C 3 ~C 8 Cycloalkyl, C 6 ~C 14 Aryl, 5- to 14-membered heteroaryl, and 3- to 14-membered heterocyclyl are halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, or R 3 and R 4 together with the carbon atom to which they are attached form carbonyl, methylidene, C 3 ~C 8 forming a cycloalkyl ring or a 3- to 7-membered heterocyclyl ring; C 3 ~C 8 Cycloalkyl rings and 3- to 7-membered heterocyclyl rings are selected from halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, R 5 is hydrogen, hydroxyl, C 1 ~C 6 Alkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Alkylcarbonyloxy, C 1 ~C 6 Alkylsulfanyl, C 1 ~C 6 Alkylsulfinyl, C 1 ~C 6 Alkylsulfonyl, C 3 ~C 8 Cycloalkyl or -O-Si(C 1 ~C 6 Alkyl) 3 and C 1 ~C 6 Alkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Alkylcarbonyloxy, C 1 ~C 6 Alkylsulfanyl, C 1 ~C 6 Alkylsulfinyl, C 1 ~C 6 Alkylsulfonyl and —O—Si(C 1 ~C 6 Alkyl) 3 is halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxycarbonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, And C 3 ~C 8 Cycloalkyl is halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, or R 3 and R 5 Or R 4 and R 5 together with the carbon atom to which they are attached, 3 ~C 8 forming a cycloalkyl ring, T is hydrogen, hydroxyl, C 1 ~C 6 Alkyl, C 1 ~C 6 Alkoxy, -C(=O)R 9 , -C(=O)(OR 10 ), -C(=O)N(R 11 ) 2 , -S(=O)R 12 , -S(=O) 2 R 13 Or -S(=O) 2 N (R 14 ) 2 and R 9 and R 10 is independently 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 3 ~C 8 Cycloalkyl or C 2 ~C 6 alkenyl, R 11 , R 12 , R 13 and R 14 are independently hydrogen, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 3 ~C 8 Cycloalkyl or C 2 ~C 6 alkenyl, L is a direct bond, carbonyl, C 1 ~C 6 Alkylene, C 2 ~C 6 Alkenylene, C 2 ~C 6 Alkynylene, -C(=O)-C 1 ~C 6 Alkylene, -C 1 ~C 6 Alkylene -C(=O)-, -NR L1 --, --NR L2 (C=O)-, -C(=O)NR L3 --, --NR L4 S (=O) 2 -, -S(=O) 2 N.R. L5 -, -C(=NOR L6 )-,-C(=N-N(R L7 ) 2 ) -, -C(=NR L8 ) -or the formula: 【Chemistry 2】 Based on Said C 1 ~C 6 Alkylene, C 2 ~C 6 Alkenylene, C 2 ~C 6 Alkynylene, -C(=O)-C 1 ~C 6 Alkylene and -C 1 ~C 6 Alkylene-C(=O)- is one to three substituents L SA and optionally substituted by ## is the point of attachment to the heterocyclyl moiety, #### is R 6 It is the connection point with L 1 is a direct bond or C 1 ~C 6 is alkylene, L 2 is a direct bond or C 1 ~C 6 is alkylene, E is C 3 ~C 8 Cycloalkyl, C 3 ~C 8 cycloalkenyl or 3- to 7-membered heterocyclyl; Said C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Cycloalkenyl and 3- to 7-membered heterocyclyl are then each selected from 1 to 3 substituents L SC and optionally substituted by And R L1 , R L2 , R L3 , and R L4 are independently hydrogen or C 1 ~C 6 is alkyl, R L5 , R L6 , R L7 and R L8 are independently hydrogen, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 3 ~C 8 Cycloalkyl or C 2 ~C 6 alkenyl, L SA are independently halogen, cyano, hydroxyl, carboxyl, methylidene, halomethylidene, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, C 1 ~C 6 Alkoxycarbonyl, —O—Si(C 1 ~C 6 Alkyl) 3 or 3- to 7-membered heterocyclyl; and / or Two substituents L attached to the same carbon atom SA together with the carbon atom to which they are attached, 3 ~C 8 forming a cycloalkyl ring or a 3- to 7-membered heterocyclyl ring; L SC are independently halogen, cyano, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, and / or Two L's SC The substituents, together with the carbon atom to which they are attached, are C 3 ~C 8 forming a cycloalkyl ring, R 6 is C 3 ~C 12 Carbocyclyl, C 6 ~C 14 Aryl, 3- to 14-membered heterocyclyl, 5- to 14-membered heteroaryl, C 3 ~C 12 Carbocyclyloxy, C 6 ~C 14 Aryloxy, 5- to 14-membered heteroaryloxy, 3- to 14-membered heterocyclyloxy, C 3 ~C 12 Carbocyclylsulfanyl, C 6 ~C 14 arylsulfanyl, 5- to 14-membered heteroarylsulfanyl, 3- to 14-membered heterocyclylsulfanyl, C 3 ~C 12 Carbocyclylsulfinyl, C 6 ~C 14 Arylsulfinyl, 5- to 14-membered heteroarylsulfinyl, 3- to 14-membered heterocyclylsulfinyl, C 3 ~C 12 Carbocyclylsulfonyl, C 6 ~C 14 Arylsulfonyl, 5- to 14-membered heteroarylsulfonyl, 3- to 14-membered heterocyclylsulfonyl, C 1 ~C 3 Alkoxy, C 1 ~C 3 Haloalkoxy, C 1 ~C 3 Alkylsulfanyl, C 1 ~C 3 Alkylsulfinyl or C 1 ~C 3 is alkylsulfonyl, C 1 ~C 3 Alkoxy, C 1 ~C 3 Haloalkoxy, C 1 ~C 3 Alkylsulfanyl, C 1 ~C 3 Alkylsulfinyl and C 1 ~C 3 Alkylsulfonyl is C 3 ~C 12 Carbocyclyl, C 6 ~C 14 substituted by one substituent selected from the group consisting of aryl, 3- to 14-membered heterocyclyl, and 5- to 14-membered heteroaryl; Said C 3 ~C 12 Carbocyclyl, C 6 ~C 14 Aryl, 3- to 14-membered heterocyclyl and 5- to 14-membered heteroaryl are then 1 to 4R 6S may be substituted by a substituent, C 3 ~C 12 Carbocyclyl, C 6 ~C 14 Aryl, 3- to 14-membered heterocyclyl, 5- to 14-membered heteroaryl, C 3 ~C 12 Carbocyclyloxy, C 6 ~C 14 Aryloxy, 5- to 14-membered heteroaryloxy, 3- to 14-membered heterocyclyloxy, C 3 ~C 12 Carbocyclylsulfanyl, C 6 ~C 14 arylsulfanyl, 5- to 14-membered heteroarylsulfanyl, 3- to 14-membered heterocyclylsulfanyl, C 3 ~C 12 Carbocyclylsulfinyl, C 6 ~C 14 Arylsulfinyl, 5- to 14-membered heteroarylsulfinyl, 3- to 14-membered heterocyclylsulfinyl, C 3 ~C 12 Carbocyclylsulfonyl, C 6 ~C 14 Arylsulfonyl, 5- to 14-membered heteroarylsulfonyl, and 3- to 14-membered heterocyclylsulfonyl are each independently selected from the group consisting of 1 to 4R 6S may be substituted by a substituent, R 6S is halogen, cyano, isocyano, nitro, hydroxyl, mercapto, pentafluorosulfanyl, oxo, methylidene, halomethylidene, formyl, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 2 ~C 6 Haloalkenyl, C 2 ~C 6 Alkynyl, C 2 ~C 6 Haloalkynyl, C 2 ~C 6 Alkenyloxy, C 2 ~C 6 Haloalkenyloxy, C 2 ~C 6 Alkynyloxy, C 2 ~C 6 Haloalkynyloxy, C 1 ~C 6 Alkylsulfanyl, C 1 ~C 6 Haloalkylsulfanyl, C 3 ~C 8 Cycloalkylsulfanyl, C 1 ~C 6 Alkylsulfinyl, C 1 ~C 6 Haloalkylsulfinyl, C 3 ~C 8 Cycloalkylsulfinyl, C 1 ~C 6 Alkylsulfonyl, C 1 ~C 6 Haloalkylsulfonyl, C 3 ~C 8 Cycloalkylsulfonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Cycloalkyloxy, C 3 ~C 8 Cycloalkenyl, C 6 ~C 14 Aryl, 5- or 6-membered heteroaryl, 3- to 7-membered heterocyclyl, -N(R 15 ) 2 , -O(C=O)R 16 , -C(=O)R 16 , -C(=O)(OR 17 ), -C(=O)N(R 18 ) 2 , -S(=O) 2 N (R 19 ) 2 , —O—Si(C 1 ~C 6 Alkyl) 3 and -Si(C 1 ~C 6 Alkyl) 3 are independently selected from the group consisting of: C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 2 ~C 6 Haloalkenyl, C 2 ~C 6 Alkynyl, C 2 ~C 6 Haloalkynyl, C 2 ~C 6 Alkenyloxy, C 2 ~C 6 Haloalkenyloxy, C 2 ~C 6 Alkynyloxy, C 2 ~C 6 Haloalkynyloxy, C 1 ~C 6 Alkylsulfanyl, C 1 ~C 6 Haloalkylsulfanyl, C 1 ~C 6 Alkylsulfinyl, C 1 ~C 6 Haloalkylsulfinyl, C 1 ~C 6 Alkylsulfonyl, C 1 ~C 6 Haloalkylsulfonyl, —O—Si(C 1 ~C 6 Alkyl) 3 and -Si(C 1 ~C 6 Alkyl) 3 is cyano, hydroxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, —O—Si(C 1 ~C 6 Alkyl) 3 , -Si(C 1 ~C 6 Alkyl) 3 , C 3 ~C 8 Cycloalkyl, C 3 ~C 8 may be further substituted with 1 to 3 substituents independently selected from the group consisting of halocycloalkyl and 3- to 7-membered heterocyclyl; or Two substituents C attached to the same carbon atom 1 ~C 6 Alkyl groups, together with the carbon atom to which they are attached, are C 3 ~C 8 forming a cycloalkyl ring, And C 3 ~C 8 Cycloalkylsulfanyl, C 3 ~C 8 Cycloalkylsulfinyl, C 3 ~C 8 Cycloalkylsulfonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Cycloalkyloxy, C 3 ~C 8 Cycloalkenyl, C 6 ~C 14 Aryl, 5- or 6-membered heteroaryl and 3- to 7-membered heterocyclyl are selected from halogen, cyano, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxycarbonyl, C 1 ~C 6 Haloalkoxycarbonyl, C 2 ~C 6 Alkenyl, C 3 ~C 8 Cycloalkenyl and C 3 ~C 8 and optionally further substituted with 1 to 4 substituents independently selected from the group consisting of halocycloalkyl; And R 15 are independently hydrogen, C 1 ~C 6 Alkyl or C 3 ~C 8 is cycloalkyl, Said C 1 ~C 6 Alkyl can then be converted to halogen, cyano, hydroxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, —O—Si(C 1 ~C 6 Alkyl) 3 , -Si(C 1 ~C 6 Alkyl) 3 , C 3 ~C 8 Cycloalkyl, C 3 ~C 8 optionally substituted with 1 to 3 substituents independently selected from the group consisting of halocycloalkyl and 3- to 7-membered heterocyclyl; And Said C 3 ~C 8 Cycloalkyl can then be selected from halogen, cyano, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxycarbonyl, C 1 ~C 6 Haloalkoxycarbonyl, C 2 ~C 6 Alkenyl, C 3 ~C 8 Cycloalkyl and C 3 ~C 8 and optionally substituted with 1 to 4 substituents independently selected from the group consisting of halocycloalkyl; R 16 , R 17 , R 18 and R 19 are independently hydrogen, C 1 ~C 6 Alkyl or C 1 ~C 6 is cycloalkyl, Said C 1 ~C 6 Alkyl and C 1 ~C 6 Haloalkyl is then cyano, hydroxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, —O—Si(C 1 ~C 6 Alkyl) 3 , -Si(C 1 ~C 6 Alkyl) 3 , C 3 ~C 8 Cycloalkyl, C 3 ~C 8 optionally substituted with 1 to 3 substituents independently selected from the group consisting of halocycloalkyl and 3- to 7-membered heterocyclyl; Ring Y has the formula (II-a), (II-b), (II-c), (II-d), (II-e), (II-f), (II-g), (II-h), (II-i), (II-j), (II-k), (II-l), (II-m), (II-n), (II- o), (II-p), (II-q), (II-r), (II-s), (II-t), (II-u), (II-v), (II-w), (II-x), (II-y), (II-z), (II-aa), (II-ab) or (II-ac): 【Chemistry 3】 【change】 is a group of the formula * is the group -S(O) p - is the point of attachment to Q, # is the point of attachment to another heterocycle, A 1 is CR 8 or N, R 8 is hydrogen, halogen, cyano or C 1 ~C 4 is alkyl, G is O, S or NR 7L and R 7L is hydrogen, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl or C 3 ~C 8 is cycloalkyl, q is 0, 1, 2, 3, or 4; x 1 is 1 or 2, x 2 is 0, 1 or 2, R 7A , R 7B , R 7C , R 7D , R 7E , R 7F and R 7G are independently hydrogen, hydroxyl, halogen, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy or C 3 ~C 8 is cycloalkyl, R 7H is hydrogen, C 1 ~C 4 Alkyl or C 1 ~C 4 is haloalkyl, R 7K is methylidene, halomethylidene, halogen, hydroxyl, oxo, C 1 ~C 4 Alkyl, C 1 ~C 6 Haloalkyl or C 3 ~C 6 is cycloalkyl, or 2 substituent R 7K together with the carbon atom to which they are attached, 3 ~C 8 forming a cycloalkyl ring, R 7L is hydrogen, halogen, cyano, isocyano, hydroxyl, mercapto, nitro, amino, formyl, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Hydroxyalkyl, C 1 ~C 6 Alkylcarbonyl, C 1 ~C 6 Haloalkylcarbonyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 2 ~C 6 Haloalkenyl, C 2 ~C 6 Alkynyl, C 2 ~C 6 Haloalkynyl, C 2 ~C 6 Alkenyloxy, C 2 ~C 6 Haloalkenyloxy, C 2 ~C 6 Alkynyloxy, C 2 ~C 6 Haloalkynyloxy, C 1 ~C 6 Alkylsulfanyl, C 1 ~C 6 Haloalkylsulfanyl, C 3 ~C 8 Cycloalkylsulfanyl, C 1 ~C 6 Alkylsulfinyl, C 1 ~C 6 Haloalkylsulfinyl, C 3 ~C 8 Cycloalkylsulfinyl, C 1 ~C 6 Alkylsulfonyl, C 1 ~C 6 Haloalkylsulfonyl, C 3 ~C 8 Cycloalkylsulfonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 6 Cycloalkenyl, C 6 ~C 14 Aryl, 5- or 6-membered heteroaryl, 3- to 7-membered heterocyclyl, C 3 ~C 8 Cycloalkoxy, C 6 ~C 14 Aryloxy, 5- or 6-membered heteroaryloxy, 3- to 7-membered heterocyclyloxy, —O—Si(C 1 ~C 6 Alkyl) 3 , -Si(C 1 ~C 6 Alkyl) 3 , -N(R 20 ) 2 , -C(=NR 21 ) R 22 , -NR 23 C(=O)R 24 , -C(=O)(OR 25 ), -C(=O)N(R 26 ) 2 , -S(=O) 2 N (R 27 ) 2 Or -S(=O)(=NR 28 ) R 29 and C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Hydroxyalkyl, C 1 ~C 6 Alkylcarbonyl, C 1 ~C 6 Haloalkylcarbonyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 2 ~C 6 Haloalkenyl, C 2 ~C 6 Alkynyl, C 2 ~C 6 Haloalkynyl, C 2 ~C 6 Alkenyloxy, C 2 ~C 6 Haloalkenyloxy, C 2 ~C 6 Alkynyloxy, C 2 ~C 6 Haloalkynyloxy, C 1 ~C 6 Alkylsulfanyl, C 1 ~C 6 Haloalkylsulfanyl, C 1 ~C 6 Alkylsulfinyl, C 1 ~C 6 Haloalkylsulfinyl, C 1 ~C 6 Alkylsulfonyl and C 1 ~C 6 Haloalkylsulfonyl is 1 to 3R 7Sa may be substituted by a substituent, C 3 ~C 8 Cycloalkylsulfanyl, C 3 ~C 8 Cycloalkylsulfinyl, C 3 ~C 8 Cycloalkylsulfonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 6 Cycloalkenyl, C 6 ~C 14 Aryl, 5- or 6-membered heteroaryl, 3- to 7-membered heterocyclyl, C 3 ~C 8 Cycloalkoxy, C 6 ~C 14 Aryloxy, 5- or 6-membered heteroaryloxy and 3- to 7-membered heterocyclyloxy are each independently 1 to 3R 7Sc may be substituted by a substituent, And R 20 is hydrogen, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 2 ~C 6 Alkenyl, C 2 ~C 6 Haloalkenyl, C 2 ~C 6 Alkynyl, C 2 ~C 6 Haloalkynyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, C 6 ~C 14 aryl, 5- or 6-membered heteroaryl, or 3- to 7-membered heterocyclyl; C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 2 ~C 6 Alkenyl, C 2 ~C 6 Haloalkenyl, C 2 ~C 6 Alkynyl and C 2 ~C 6 Haloalkynyl is a group consisting of 1 to 3 substituents R 7Sa and optionally substituted by And C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, C 6 ~C 14 Aryl, 5- or 6-membered heteroaryl and 3- to 7-membered heterocyclyl are each independently selected from 1 to 3 substituents R 7Sc and optionally substituted by R 21 and R 22 are independently hydrogen, hydroxyl, amino, cyano, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, mono(C 1 ~C 6 alkyl)amino or di(C 1 ~C 6 alkyl)amino, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, mono(C 1 ~C 6 alkyl)amino or di(C 1 ~C 6 Alkyl)amino is 1 to 3R 7Sa may be substituted by a substituent, R 23 , R 24 , R 25 , R 26 , R 27 , R 28 and R 29 are independently hydrogen, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl and C 3 ~C 8 is cycloalkyl, C 1 ~C 6 Alkyl and C 1 ~C 6 Haloalkyl is 1 to 3R 7Sa may be substituted by a substituent, And C 3 ~C 8 Cycloalkyl is 1 to 3R 7Sc may be substituted by a substituent, R 7Sa are independently cyano, hydroxyl, carboxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, C 1 ~C 6 Alkoxycarbonyl, —O—Si(C 1 ~C 6 Alkyl) 3 , -Si(C 1 ~C 6 Alkyl) 3 , C 6 ~C 14 aryl or 3- to 7-membered heterocyclyl; R 7Sc are independently halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, halomethylidene, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 or 3- to 7-membered heterocyclyl; or 2R bonded to the same carbon atom 7Sc Substituent C 1 ~C 6 Alkyl groups together form C 3 ~C 8 Forming a cycloalkyl, R 7M is hydrogen, halogen, cyano, isocyano, amino, nitro, hydroxyl, mercapto, carboxyl, C 1 ~C 6 Alkoxycarbonyl, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Hydroxyalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 2 ~C 6 Haloalkenyl, C 2 ~C 6 Alkynyl, C 2 ~C 6 Haloalkynyl, C 2 ~C 6 Alkenyloxy, C 2 ~C 6 Haloalkenyloxy, C 2 ~C 6 Alkynyloxy, C 2 ~C 6 Haloalkynyloxy, C 1 ~C 6 Alkylsulfanyl, C 1 ~C 6 Haloalkylsulfanyl, C 1 ~C 6 Alkylsulfinyl, C 1 ~C 6 Haloalkylsulfinyl, C 1 ~C 6 Alkylsulfonyl, C 1 ~C 6 Haloalkylsulfonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Cycloalkenyl, C 6 ~C 14 Aryl, 3- to 14-membered heterocyclyl, 5- to 14-membered heteroaryl, C 3 ~C 8 Cycloalkoxy, C 6 ~C 14 Aryloxy, 3- to 14-membered heterocyclyloxy, 5- to 14-membered heteroaryloxy, —O—Si(C 1 ~C 6 Alkyl) 3 , -Si(C 1 ~C 6 Alkyl) 3 , -N(R 30 ) 2 , -SR 31 , -S(=O)R 31 Or -S(=O) 2 R 31 and Said C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Hydroxyalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 2 ~C 6 Haloalkenyl, C 2 ~C 6 Alkynyl, C 2 ~C 6 Haloalkynyl, C 2 ~C 6 Alkenyloxy, C 2 ~C 6 Haloalkenyloxy, C 2 ~C 6 Alkynyloxy, C 2 ~C 6 Haloalkynyloxy, C 1 ~C 6 Alkylsulfanyl, C 1 ~C 6 Haloalkylsulfanyl, C 1 ~C 6 Alkylsulfinyl, C 1 ~C 6 Haloalkylsulfinyl, C 1 ~C 6 Alkylsulfonyl, C 1 ~C 6 Haloalkylsulfonyl, —O—Si(C 1 ~C 6 Alkyl) 3 and -Si(C 1 ~C 6 Alkyl) 3 1st to 3rd round 8Sa may be substituted by a substituent, Said C 3 ~C 8 Cycloalkyl, C 3 ~C 6 Cycloalkenyl, C 6 ~C 14 Aryl, 3- to 14-membered heterocyclyl, 5- to 14-membered heteroaryl, C 3 ~C 8 Cycloalkoxy, C 6 ~C 14 Aryloxy and 3- to 14-membered heterocyclyloxy and 5- to 14-membered heteroaryloxy are 1 to 3R 8Sc may be substituted by a substituent, And R 30 are independently hydrogen, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 2 ~C 6 Alkenyl, C 2 ~C 6 Haloalkenyl, C 2 ~C 6 Alkynyl, C 2 ~C 6 Haloalkynyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, C 6 ~C 14 aryl, 5- to 14-membered heteroaryl, or 3- to 7-membered heterocyclyl; Said C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 2 ~C 6 Alkenyl, C 2 ~C 6 Haloalkenyl, C 2 ~C 6 Alkynyl and C 2 ~C 6 Haloalkynyl is then 1 to 3R 8Sa may be substituted by a substituent, Said C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, C 6 ~C 14 Aryl, 5- to 14-membered heteroaryl and 3- to 7-membered heterocyclyl are then 1 to 3R 8Sc may be substituted by a substituent, R 31 is C 2 ~C 6 Alkenyl, C 2 ~C 6 Haloalkenyl, C 2 ~C 6 Alkynyl, C 2 ~C 6 Haloalkynyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, C 6 ~C 14 aryl, 5- to 14-membered heteroaryl, or 3- to 7-membered heterocyclyl; Said C 2 ~C 6 Alkenyl, C 2 ~C 6 Haloalkenyl, C 2 ~C 6 Alkynyl and C 2 ~C 6 Haloalkynyl is then 1 to 3R 8Sa may be substituted by a substituent, Said C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, C 6 ~C 14 Aryl, 5- to 14-membered heteroaryl and 3- to 7-membered heterocyclyl are then 1 to 3R 8Sc may be substituted by a substituent, And R 8Sa are independently cyano, amino, nitro, hydroxyl, formyl, carboxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxy-C 1 ~C 6 Alkoxy, C 1 ~C 6 Alkoxycarbonyl, C 1 ~C 6 Haloalkoxycarbonyl, C 1 ~C 6 Alkylcarbonyl, C 1 ~C 6 Haloalkylcarbonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, C 1 ~C 6 Alkylsulfanyl, C 1 ~C 6 Haloalkylsulfanyl, C 1 ~C 6 Alkylsulfinyl, C 1 ~C 6 Haloalkylsulfinyl, C 1 ~C 6 Alkylsulfonyl, C 1 ~C 6 Haloalkylsulfonyl, —O—Si(C 1 ~C 6 Alkyl) 3 , -Si(C 1 ~C 6 Alkyl) 3 , 3- to 7-membered heterocyclyl and -N(R 32 ) 2 are independently selected from the group consisting of The 3- to 7-membered heterocyclyl is then represented by group C 1 ~C 6 optionally substituted with 1 to 3 substituents independently selected from alkyl; R 32 are independently hydrogen, formyl, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 3 ~C 8 Cycloalkyl or C 1 ~C 6 is an alkylcarbonyl; R 8Sc is halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxycarbonyl, C 1 ~C 6 Haloalkoxycarbonyl, C 2 ~C 6 Alkenyl, C 1 ~C 6 Alkylsulfanyl, C 1 ~C 6 Alkylsulfinyl, C 1 ~C 6 Alkylsulfonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl; The 3- to 7-membered heterocyclyl is then represented by group C 1 ~C 6 optionally substituted with 1 to 3 substituents independently selected from alkyl; or 2R 8Sc The substituents, together with the carbon atom to which they are attached, are C 3 ~C 8 may form a cycloalkyl ring or a 3- to 7-membered heterocyclyl ring; The 3- to 7-membered heterocyclyl ring is then represented by group C 1 ~C 6 optionally substituted with 1 to 3 substituents independently selected from alkyl; p is 0, 1 or 2; Q is C 6 ~C 14 Aryl, C 3 ~C 12 carbocyclyl, 3- to 14-membered heterocyclyl, or 5- to 14-membered heteroaryl; C 6 ~C 14 Aryl, C 3 ~C 12 Carbocyclyl, 3- to 14-membered heterocyclyl or 5- to 14-membered heteroaryl is substituted with 1 to 5 substituents Q S and optionally substituted by Q S is halogen, cyano, isocyano, nitro, hydroxyl, mercapto, formyl, carboxyl, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkylcarbonyl, C 1 ~C 6 Haloalkylcarbonyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxycarbonyl, C 1 ~C 6 Haloalkoxycarbonyl, C 2 ~C 6 Alkenyl, C 2 ~C 6 Haloalkenyl, C 2 ~C 6 Alkynyl, C 2 ~C 6 Haloalkynyl, C 2 ~C 6 Alkenyloxy, C 2 ~C 6 Haloalkenyloxy, C 1 ~C 6 Alkylsulfanyl, C 1 ~C 6 Haloalkylsulfanyl, C 1 ~C 6 Alkylsulfinyl, C 1 ~C 6 Haloalkylsulfinyl, C 1 ~C 6 Alkylsulfonyl, C 1 ~C 6 Haloalkylsulfonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Cycloalkyloxy, C 3 ~C 6 Cycloalkenyl, 3- to 7-membered heterocyclyl, C 6 ~C 14 Aryl, 5- to 14-membered heteroaryl, —O—Si(C 1 ~C 6 Alkyl) 3 , -Si(C 1 ~C 6 Alkyl) 3 , -OC(=O)R 33 , -NR 34 C(=O)R 35 , -C(=O)N(R 36 ) 2 , C(=S)R 37 , -C(=S)N(R 38 ) 2 , -C(=NR 39 ) R 40 , -C(=NOR 41 ) R 42 and -N(R 43 ) 2 are independently selected from the group consisting of: Said C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkylcarbonyl, C 1 ~C 6 Haloalkylcarbonyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxy-C 1 ~C 6 Alkyl, C 1 ~C 6 Alkoxycarbonyl, C 1 ~C 6 Haloalkoxycarbonyl, C 2 ~C 6 Alkenyl, C 2 ~C 6 Haloalkenyl, C 2 ~C 6 Alkynyl, C 2 ~C 6 Haloalkynyl, C 2 ~C 6 Alkenyloxy, C 2 ~C 6 Haloalkenyloxy, C 1 ~C 6 Alkylsulfanyl, C 1 ~C 6 Haloalkylsulfanyl, C 1 ~C 6 Alkylsulfinyl, C 1 ~C 6 Haloalkylsulfinyl, C 1 ~C 6 Alkylsulfonyl, C 1 ~C 6 Haloalkylsulfonyl, —O—Si(C 1 ~C 6 Alkyl) 3 and -Si(C 1 ~C 6 Alkyl) 3 Next, cyano, amino, nitro, hydroxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxycarbonyl, C 1 ~C 6 Haloalkoxycarbonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, And Said C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Cycloalkoxy, C 3 ~C 6 Cycloalkenyl, 3- to 7-membered heterocyclyl and 5- to 14-membered heteroaryl are then halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxycarbonyl, C 1 ~C 6 Haloalkoxycarbonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, C 2 ~C 6 optionally substituted by 1 to 3 substituents independently selected from the group consisting of alkenyl and 3- to 7-membered heterocyclyl; Said C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl and 3- to 7-membered heterocyclyl, together with the carbon atom to which they are attached, can further be represented by C 3 ~C 8 optionally substituted with two substituents forming a cycloalkyl; And R 33 , R 34 , R 35 , R 36 , R 37 , R 38 , R 39 , R 40 , R 41 and R 42 are independently hydrogen, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl or C 1 ~C 6 is an alkoxy; Said C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl and C 1 ~C 6 Alkoxy is then cyano, amino, nitro, hydroxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxycarbonyl, C 1 ~C 6 Haloalkoxycarbonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl; And R 43 is hydrogen, hydroxyl, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 2 ~C 6 Alkenyl, C 2 ~C 6 Haloalkenyl or C 3 ~C 8 is cycloalkyl, Said C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 2 ~C 6 Alkenyl and C 2 ~C 6 Haloalkenyl is then cyano, amino, nitro, hydroxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxycarbonyl, C 1 ~C 6 Haloalkoxycarbonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl; And Said C 3 ~C 8 Cycloalkyl can then be selected from halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxycarbonyl, C 1 ~C 6 Haloalkoxycarbonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, C 2 ~C 6 optionally substituted by 1 to 3 substituents independently selected from the group consisting of alkenyl and 3- to 7-membered heterocyclyl; Said C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl and 3- to 7-membered heterocyclyl, together with the carbon atom to which they are attached, can further be represented by C 3 ~C 8 optionally substituted with two substituents forming a cycloalkyl; or 2Q bonded to the same carbon atom S The substituents, together with the carbon atom to which they are attached, are independently C 3 ~C 8 forming a cycloalkyl ring, Compounds, as well as N-oxides, salts, hydrates, and hydrates of the salts and N-oxides thereof.
2. A 2 is O, C(=O), NR 1 Or CR 2A R R2B and R 1 is hydrogen, C 1 ~C 4 alkyl or formyl; R 2A and R 2B are independently hydrogen, C 1 ~C 4 Alkyl or C 3 ~C 6 is cycloalkyl, m is 0, 1, or 2; R 3 and R 4 are independently hydrogen, fluoro, chloro, C 1 ~C 4 Alkyl, C 1 ~C 4 Alkylcarbonyl, C 1 ~C 4 Alkylcarbonyloxy, C 2 ~C 4 Alkenyl, C 2 ~C 4 Alkynyl or C 3 ~C 4 is cycloalkyl, C 1 ~C 4 Alkyl, C 1 ~C 4 Alkylcarbonyl, C 1 ~C 4 Alkylcarbonyloxy, C 2 ~C 4 Alkenyl and C 2 ~C 4 Alkynyl is fluoro, chloro, hydroxyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 3 ~C 6 Cycloalkyl and C 3 ~C 6 and optionally substituted with 1 or 2 substituents independently selected from the group consisting of halocycloalkyl; And C 3 ~C 6 Cycloalkyl is fluoro, chloro, hydroxyl, oxo, methylidene, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 2 ~C 4 Alkenyl, C 3 ~C 6 Cycloalkyl and C 3 ~C 6 and optionally substituted with 1 or 2 substituents independently selected from the group consisting of halocycloalkyl; R 5 is hydrogen or C 1 ~C 4 is alkyl, T is hydrogen or C 1 ~C 4 is alkyl, L is a direct bond, C 1 ~C 6 Alkylene, or of the formula: 【Chemistry 4】 Based on During the ceremony, Said C 1 ~C 6 Alkylene is a group consisting of 1 to 3 substituents L SA and optionally substituted by ## is the point of attachment to the heterocyclyl moiety, #### is R 6 It is the connection point with L 1 is a direct bond or C 1 ~C 6 is alkylene, L 2 is a direct bond or C 1 ~C 6 is alkylene, E is C 3 ~C 8 cycloalkyl or 3- to 7-membered heterocyclyl; Said C 3 ~C 8 Cycloalkyl and 3- to 7-membered heterocyclyl are then each represented by 1 to 3 substituents L SC and optionally substituted by And L SA are independently fluoro, chloro, hydroxyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 3 ~C 6 Cycloalkyl or C 3 ~C 6 halocycloalkyl, or Two substituents L attached to the same carbon atom SA together with the carbon atom to which they are attached, 3 ~C 6 forming a cycloalkyl ring or a 3- to 7-membered heterocyclyl ring; L SC are independently fluoro, chloro, hydroxyl, oxo, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 2 ~C 4 Alkenyl, C 3 ~C 6 Cycloalkyl and C 3 ~C 6 halocycloalkyl, R 6 is C 5 ~C 10 carbocyclyl, phenyl, naphthyl, 5- to 10-membered heterocyclyl, 5- to 10-membered heteroaryl, C 5 ~C 10 carbocyclyloxy, phenoxy, naphthyloxy, 5- to 10-membered heteroaryloxy, 5- to 10-membered heterocyclyloxy, C 5 ~C 10 Carbocyclylsulfanyl, phenylsulfanyl, naphthylsulfanyl, 5- to 10-membered heteroarylsulfanyl, 5- to 10-membered heterocyclylsulfanyl, C 1 ~C 3 Alkoxy or C 1 ~C 3 is haloalkoxy; C 1 ~C 3 Alkoxy and C 1 ~C 3 Haloalkoxy is C 5 ~C 10 substituted by one substituent selected from the group consisting of carbocyclyl, phenyl, naphthyl, 5- to 10-membered heterocyclyl, and 5- to 10-membered heteroaryl; Said C 5 ~C 10 Carbocyclyl, phenyl, naphthyl, 5- to 10-membered heterocyclyl and 5- to 10-membered heteroaryl are then 1 to 3R 6S may be substituted by a substituent, C 5 ~C 10 carbocyclyl, phenyl, naphthyl, 5- to 10-membered heterocyclyl, 5- to 10-membered heteroaryl, C 5 ~C 10 carbocyclyloxy, phenoxy, naphthyloxy, 5- to 10-membered heteroaryloxy, 5- to 10-membered heterocyclyloxy, C 5 ~C 10 Carbocyclylsulfanyl, phenylsulfanyl, naphthylsulfanyl, 5- to 10-membered heteroarylsulfanyl and 5- to 10-membered heterocyclylsulfanyl are each independently selected from the group consisting of 1-3R 6S may be substituted by a substituent, R 6S is halogen, cyano, hydroxyl, mercapto, pentafluorosulfanyl, oxo, methylidene, halomethylidene, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 2 ~C 4 Alkenyl, C 2 ~C 4 Haloalkenyl, C 2 ~C 4 Alkynyl, C 2 ~C 4 Haloalkynyl, C 1 ~C 4 Alkylsulfanyl, C 1 ~C 4 Haloalkylsulfanyl, C 3 ~C 6 Cycloalkylsulfanyl, C 3 ~C 6 Cycloalkyl, C 3 ~C 6 Cycloalkyloxy, phenyl, 5- or 6-membered heteroaryl, 3- to 7-membered heterocyclyl, -C(=O)R 16 , -C(=O)(OR 17 ) and -C(=O)N(R 18 ) 2 are independently selected from the group consisting of: C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 2 ~C 4 Alkenyl, C 2 ~C 4 Haloalkenyl, C 2 ~C 4 Alkynyl, C 2 ~C 4 Haloalkynyl, C 1 ~C 4 Alkylsulfanyl and C 1 ~C 4 Haloalkylsulfanyl is hydroxyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, -Si(C 1 ~C 6 Alkyl) 3 , C 3 ~C 6 Cycloalkyl and C 3 ~C 6 and optionally further substituted with 1 to 3 substituents independently selected from the group consisting of halocycloalkyl; And C 3 ~C 6 Cycloalkylsulfanyl, C 3 ~C 6 Cycloalkyl, C 3 ~C 6 Cycloalkyloxy, phenyl, 5- or 6-membered heteroaryl and 3- to 7-membered heterocyclyl are fluoro, chloro, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy and C 1 ~C 4 and optionally further substituted with 1 to 4 substituents independently selected from the group consisting of haloalkoxy; And R 16 , R 17 and R 18 are independently hydrogen, C 1 ~C 4 Alkyl or C 1 ~C 4 is haloalkyl, Said C 1 ~C 4 Alkyl and C 1 ~C 4 Haloalkyl then hydroxyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 3 ~C 6 Cycloalkyl and C 3 ~C 6 and optionally substituted with 1 to 3 substituents independently selected from the group consisting of halocycloalkyl; Ring Y is represented by the formula (II-a), (II-b), (II-g), (II-h), (II-i), (II-r), (II-s), (II-u), (II-v), (II-ab) or (II-ac): 【Chemistry 5】 is a group of the formula * is the group -S(O) p - is the point of attachment to Q, # is the point of attachment to another heterocycle, A 1 is CR 8 or N, R 8 is hydrogen or methyl, G is O, S or NR 7L and R 7L is hydrogen, q is 0, 1 or 2; x 1 is 1 or 2, x 2 is 0, 1 or 2, R 7A is hydrogen, R 7B is hydrogen, fluoro, methyl or methoxy; R 7C is hydrogen, fluoro, methyl or methoxy; R 7D is hydrogen, R 7E is hydrogen, R 7F is hydrogen, R 7K is hydroxyl or methyl, R 7L is hydrogen, halogen, cyano, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Hydroxyalkyl, C 1 ~C 4 Alkylcarbonyl, C 1 ~C 4 Haloalkylcarbonyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 2 ~C 4 Alkenyl, C 2 ~C 4 Haloalkenyl, C 2 ~C 4 Alkynyl, C 2 ~C 4 Haloalkynyl, C 1 ~C 4 Alkylsulfanyl, C 1 ~C 4 Haloalkylsulfanyl, C 1 ~C 4 Alkylsulfinyl, C 1 ~C 4 Haloalkylsulfinyl, C 1 ~C 4 Alkylsulfonyl, C 1 ~C 4 Haloalkylsulfonyl, C 3 ~C 6 Cycloalkyl, phenyl, 5- or 6-membered heteroaryl, 3- to 7-membered heterocyclyl, -N(R 20 ) 2 , -C(=NR 21 ) R 22 , -C(=O)(OR 25 ) or -C(=O)N(R 26 ) 2 and C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Hydroxyalkyl, C 1 ~C 4 Alkylcarbonyl, C 1 ~C 4 Haloalkylcarbonyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 2 ~C 4 Alkenyl, C 2 ~C 4 Haloalkenyl, C 2 ~C 4 Alkynyl, C 2 ~C 4 Haloalkynyl, C 1 ~C 4 Alkylsulfanyl, C 1 ~C 4 Haloalkylsulfanyl, C 1 ~C 4 Alkylsulfinyl, C 1 ~C 4 Haloalkylsulfinyl, C 1 ~C 4 Alkylsulfonyl and C 1 ~C 4 Haloalkylsulfonyl is 1 to 3R 7Sa may be substituted by a substituent, C 3 ~C 6 Cycloalkyl, phenyl, 5- or 6-membered heteroaryl and 3- to 7-membered heterocyclyl are each 1 to 3R 7Sc may be substituted by a substituent, And R 20 are independently hydrogen, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl or C 3 ~C 6 is cycloalkyl, C 3 ~C 6 Cycloalkyl is selected from halogen and C 1 ~C 4 and optionally substituted with 1 or 2 substituents independently selected from the group consisting of alkyl, R 21 is hydroxyl, C 1 ~C 4 Alkyl or C 1 ~C 4 is an alkoxy; R 22 is hydrogen, C 1 ~C 4 Alkyl or C 1 ~C 4 is haloalkyl, R 25 , and R 26 are independently hydrogen or C 1 ~C 4 is alkyl, And R 7Sa are independently cyano, hydroxyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 3 ~C 6 Cycloalkyl, C 1 ~C 4 Alkoxycarbonyl, —O—Si(C 1 ~C 4 Alkyl) 3 or phenyl, R 7Sc are independently halogen, hydroxyl, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy or C 1 ~C 4 is haloalkoxy; R 7M is hydrogen, halogen, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 2 ~C 4 Alkenyl, C 2 ~C 4 Haloalkenyl, C 2 ~C 4 Alkynyl, C 2 ~C 4 Haloalkynyl, C 1 ~C 4 Alkylsulfanyl, C 1 ~C 4 Haloalkylsulfanyl, C 1 ~C 4 Alkylsulfinyl, C 1 ~C 4 Haloalkylsulfinyl, C 1 ~C 4 Alkylsulfonyl, C 1 ~C 4 Haloalkylsulfonyl, C 3 ~C 4 Cycloalkyl, phenyl, 3- to 7-membered heterocyclyl, 5- or 6-membered heteroaryl, C 3 ~C 6 Cycloalkoxy, phenoxy, 3- to 7-membered heterocyclyloxy, 5- or 6-membered heteroaryloxy or -N(R 30 ) 2 and Said C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 2 ~C 4 Alkenyl, C 2 ~C 4 Haloalkenyl, C 2 ~C 4 Alkynyl, C 2 ~C 4 Haloalkynyl, C 1 ~C 4 Alkylsulfanyl, C 1 ~C 4 Haloalkylsulfanyl, C 1 ~C 4 Alkylsulfinyl, C 1 ~C 4 Haloalkylsulfinyl, C 1 ~C 4 Alkylsulfonyl and C 1 ~C 4 Haloalkylsulfonyl is 1 to 3R 8Sa may be substituted by a substituent, Said C 3 ~C 6 Cycloalkyl, phenyl, 3- to 7-membered heterocyclyl, 5- or 6-membered heteroaryl, C 3 ~C 6 Cycloalkoxy, phenoxy, 3- to 7-membered heterocyclyloxy and 5- or 6-membered heteroaryloxy are each independently 1 to 3R 8Sc may be substituted by a substituent, And R 30 are independently hydrogen, C 1 ~C 4 Alkyl, C 2 ~C 4 Alkenyl, C 2 ~C 4 Haloalkenyl and C 3 ~C 6 is cycloalkyl, Said C 1 ~C 4 Alkyl, C 2 ~C 4 Alkenyl and C 2 ~C 4 Haloalkenyl is then 1 or 2R 8Sa may be substituted by a substituent, Said C 3 ~C 6 Cycloalkyl and phenyl are then 1 or 2R 8Sc may be substituted by a substituent, And R 8Sa is hydroxyl, carboxyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 1 ~C 4 Alkoxy-C 1 ~C 4 Alkoxy, C 1 ~C 4 Alkoxycarbonyl, C 3 ~C 6 Cycloalkyl, C 1 ~C 4 Alkylsulfanyl, —O—Si(C 1 ~C 6 Alkyl) 3 , -Si(C 1 ~C 6 Alkyl) 3 , 3- to 7-membered heterocyclyl and -N(R 32 ) 2 are independently selected from the group consisting of The 3- to 7-membered heterocyclyl is then represented by group C 1 ~C 6 may be substituted by 1 or 2 substituents independently selected from alkyl; R 32 are independently hydrogen, formyl, C 1 ~C 4 Alkyl and C 1 ~C 4 is an alkylcarbonyl; R 8Sc is halogen, cyano, hydroxyl, oxo, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Alkoxycarbonyl, C 3 ~C 6 independently selected from the group consisting of cycloalkyl and 3- to 7-membered heterocyclyl; The 3- to 7-membered heterocyclyl is then represented by group C 1 ~C 4 may be substituted by 1 or 2 substituents independently selected from alkyl; or 2R 8Sc The substituents, together with the carbon atoms to which they are attached, may form a 3- to 7-membered heterocyclyl ring; p is 0, 1 or 2; Q is phenyl, naphthyl, bicyclo[4.2.0]octa-1(6)2,4-trienyl, indanyl, tetrahydronaphthalenyl, indenyl, dihydronaphthalenyl, dihydrobenzofuranyl, dihydroisobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, dihydro-1,4-benzodioxinyl, [1,3]dioxolo[4,5-b]pyridinyl, tetrahydroquinolinyl, dihydro-5H-cyclopenta[b]pyridinyl, pyrrolyl, furanyl, thienyl, imidazolyl, triazolyl, oxazolyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinolinyl, furopyridinyl, thienothiophenyl or thienothiazolyl; Phenyl, naphthyl, bicyclo[4.2.0]octa-1(6)2,4-trienyl, indanyl, tetrahydronaphthalenyl, indenyl, dihydronaphthalenyl, dihydrobenzofuranyl, dihydroisobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, dihydro-1,4-benzodioxinyl, [1,3]dioxolo[4,5-b]pyridinyl, tetrahydroquinolinyl, dihydro-5H-cyclopenta[b]pyridinyl, pyrrolyl, furanyl, thienyl, imidazolyl, triazolyl, oxazolyl, thiazolyl, pyridinyl, pyridazinyl, pyrimidinyl, indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinolinyl, furopyridinyl, thienothiophenyl and thienothiazolyl are 1 to 3 substituents Q S and optionally substituted by Q S is halogen, cyano, nitro, hydroxyl, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkylcarbonyl, C 1 ~C 4 Haloalkylcarbonyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 1 ~C 4 Alkoxy-C 1 ~C 4 Alkyl, C 2 ~C 4 Alkenyl, C 2 ~C 4 Haloalkenyl, C 2 ~C 4 Alkynyl, C 2 ~C 4 Haloalkynyl, C 1 ~C 4 Alkylsulfanyl, C 1 ~C 4 Haloalkylsulfanyl, C 3 ~C 6 Cycloalkyl, oxetanyl and -N(R 43 ) 2 are independently selected from the group consisting of Said C 3 ~C 6 Cycloalkyl is halogen, C 1 ~C 4 Alkyl and C 1 ~C 4 and optionally substituted with 1 or 2 substituents independently selected from the group consisting of haloalkyl; And R 43 are independently hydrogen or C 1 ~C 4 is alkyl, 2. The compound of formula (I) according to claim 1, as well as the N-oxides, salts, hydrates and hydrates of the salts and N-oxides thereof.
3. A 2 is O, m is 1, R 3 and R 4 are independently hydrogen, fluoro or methyl; R 5 is hydrogen, T is hydrogen; L is a direct bond or methylene; R 6 is phenyl or thienyl, Phenyl and thienyl have 1 to 3 substituents R 6S and optionally substituted by R 6S is halogen, C 1 ~C 4 independently selected from the group consisting of alkyl, difluoromethyl and trifluoromethyl; Ring Y is represented by formula (II-a), (II-ab) or (II-ac-1): 【Chemistry 6】 is a group of the formula * is the group -S(O) p - is the point of attachment to Q, # is the point of attachment to another heterocycle, A 1 is CR 8 or N, R 8 is hydrogen or methyl, R 7A is hydrogen, R 7B is hydrogen, R 7C is hydrogen, R 7D is hydrogen, R 7L is hydrogen, chloro or methyl; R 7M is hydrogen or methyl, p is 0 or 2; Q is phenyl, naphthyl or pyridinyl; Phenyl, naphthyl and pyridinyl are each independently selected from the group consisting of one or two substituents Q S and optionally substituted by Q S is halogen, nitro, (C 1 ~C 4 )-independently selected from the group consisting of alkyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, difluoromethoxy and trifluoromethoxy; 3. Compounds of formula (I) according to claim 1 or 2, as well as salts, hydrates and hydrates of the salts thereof.
4. Ring Y is represented by formula (II-a), (II-ab-1) or (II-ac-1): 【Chemistry 7】 During the ceremony, * is the group -S(O) p - is the point of attachment to Q, # is the point of attachment to another heterocycle, A 1 is CR 8 or N, R 8 is hydrogen or methyl, R 7A is hydrogen, R 7B is hydrogen, R 7C is hydrogen, R 7D is hydrogen, R 7L is hydrogen, chloro or methyl; R 7M is hydrogen or methyl; The compound of formula (I) according to any one of claims 1 to 3, which is a group
5. A 2 is O, m is 1, T is hydrogen; And R 3 , R 4 and R 5 each of is hydrogen; A compound of formula (I) according to any one of claims 1 to 4.
6. A composition for controlling phytopathogenic harmful fungi, comprising at least one compound of formula (I) according to any one of claims 1 to 5 and at least one carrier and / or surfactant.
7. A method for controlling harmful microorganisms in crop protection and material protection, characterized in that at least one compound of formula (I) as defined in any one of claims 1 to 5 and / or a composition as defined in claim 6 is applied to the harmful microorganisms and / or their habitat.
8. Use of one or more compounds of formula (I) as claimed in any one of claims 1 to 5 and / or compositions as claimed in claim 6 for controlling harmful microorganisms in crop protection and material protection.
9. Formula (I-a-1): 【Chemistry 8】 In the formula (I-a-1), Q, Y, A 1 , L, R 3 , R 4 , R 5 and R 6 is as defined in any one of claims 1 to 5, A 2 is O, T is hydrogen; m is 1 or 2; p is 1 or 2; The compound is represented by formula (I-a-2): 【Chemistry 9】 In the formula (I-a-2), m, T, Q, Y, A 1 , A 2 , L, R 3 , R 4 , R 5 and R 6 is as previously defined, may be prepared by reacting the compound with an oxidizing agent, A process for preparing a compound of formula (Ia-1).
10. Formula (I-a-2): 【Chemistry 10】 In the formula (I-a-2), Q, Y, A 1 , L, R 3 , R 4 , R 5 and R 6 is as defined in any one of claims 1 to 5, A 2 is O, T is hydrogen; m is 1 or 2; p is 0; The compound, [A] Formula (4): 【Chemistry 11】 In the formula (4), m, p, T, Q, Y, A 1 , A 2 , L, R 3 , R 4 , R 5 and R 6 is as previously defined, When W is hydrogen, Treatment with a dehydrating agent, optionally in the presence of a base, gives the compound of formula (I-a-1) directly, or or When W is an amino protecting group, preferably tert-butoxycarbonyl, benzyl, allyl or (4-methoxyphenyl)methyl, The compound of formula (4) is treated with a dehydrating agent, optionally in the presence of a base, followed by a deprotection step to obtain a compound of formula (I-a-2). or [B] Formula (5): 【Chemistry 12】 In the formula (5), m, Y, T, A 1 , L, R 3 , R 4 , R 5 and R 6 is as previously defined, X 1 is halogen, preferably bromo, trifluoromethylsulfonate or p-toluenesulfonate; The compound of formula (5) is reacted with a compound of formula (6): 【Chemistry 13】 wherein Q is defined as above. may be prepared by reacting a compound of formula (6) in the presence of a base (e.g. an organic or inorganic base) and, optionally, in the presence of a suitable copper salt or complex, A process for preparing a compound of formula (Ia-2).
11. Formula (3) or Formula (4): 【Chemistry 14】 In the formula (3) or (4), p, L, Q, T, Y, R 3 , R 4 , R 5 and R 6 is as defined in any one of claims 1 to 5, m is 1 or 2; A 1 is CH or N, A 2 is O, compound.
12. Formula (10): 【Chemistry 15】 In the formula (10), p, L, Q, T, Y, R 3 , R 4 and R 6 is as defined in any one of claims 1 to 5, A 1 is CH or N, m is 1 or 2; compound.
13. Formula (12) or Formula (14) 【Chemistry 16】 In the formula (12) or (14), p, L, Q, T, Y, R 3 , R 4 , R 5 and R 6 is as defined in any one of claims 1 to 5, m is 1 or 2; A 1 is CH or N, E 1 is hydroxyl or halogen, E 2 is hydroxyl, W is hydrogen or an amino protecting group, preferably tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl; compound.
14. Formula (16) or Formula (18): 【Chemistry 17】 In the formula (16) or (18), p, Q, T, Y, R 3 , R 4 , R 5 and R 6 is as defined in any one of claims 1 to 5, A 1 is CH or N; compound.
15. Formula (27) 【Chemistry 18】 In the formula (27), Y is as defined in any one of claims 1 to 5, m is 1, A 1 is CH or N, X 1 is a halogen, R 3 and R 4 are independently hydrogen, halogen, cyano, hydroxyl, formyl, carboxyl, C 1 ~C 6 Alkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Alkylcarbonyl, C 1 ~C 6 Alkoxycarbonyl, C 2 ~C 6 Alkenyl, C 2 ~C 6 Alkynyl, C 3 ~C 8 Cycloalkyl, C 6 ~C 14 Aryl, 5- to 14-membered heteroaryl, 3- to 14-membered heterocyclyl or —O—Si(C 1 ~C 6 Alkyl) 3 and C 1 ~C 6 Alkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Alkylcarbonyl, C 1 ~C 6 Alkoxycarbonyl, C 2 ~C 6 Alkenyl, C 2 ~C 6 Alkynyl and —O—Si(C 1 ~C 6 Alkyl) 3 is halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxycarbonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, And C 3 ~C 8 Cycloalkyl, C 6 ~C 14 Aryl, 5- to 14-membered heteroaryl and 3- to 14-membered heterocyclyl are selected from halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, or R 3 and R 4 together with the carbon atom to which they are attached form carbonyl, methylidene, C 3 ~C 8 forming a cycloalkyl ring or a 3- to 7-membered heterocyclyl ring; C 3 ~C 8 Cycloalkyl and 3- to 7-membered heterocyclyl are halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, R 5 is hydrogen, hydroxyl, C 1 ~C 6 Alkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Alkylcarbonyloxy, C 1 ~C 6 Alkylsulfanyl, C 1 ~C 6 Alkylsulfinyl, C 1 ~C 6 Alkylsulfonyl, C 3 ~C 8 Cycloalkyl or -O-Si(C 1 ~C 6 Alkyl) 3 and C 1 ~C 6 Alkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Alkylcarbonyloxy, C 1 ~C 6 Alkylsulfanyl, C 1 ~C 6 Alkylsulfinyl, C 1 ~C 6 Alkylsulfonyl and —O—Si(C 1 ~C 6 Alkyl) 3 is halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 1 ~C 6 Alkoxycarbonyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, And C 3 ~C 8 Cycloalkyl is halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 2 ~C 6 Alkenyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Halocycloalkyl, —O—Si(C 1 ~C 6 Alkyl) 3 and 3- to 7-membered heterocyclyl, compound.
16. Formula (29): 【Chemistry 19】 In the formula (29), Y is as defined in any one of claims 1 to 5, A 1 is CH or N, X 1 is a halogen, However, the compound of formula (29) is 1937347-23-3 3-fluoro-N'-hydroxypyridine-4-carboximidamide 1824883-82-0 3-Bromo-N'-hydroxypyridine-4-carboximidamide 411222-41-8 3-chloro-N'-hydroxypyridine-4-carboximidamide 2387453-83-8 5-bromo-2-chloro-N'-hydroxypyridine-4-carboximidamide 2387409-08-5 2-Bromo-5-fluoro-N'-hydroxypyridine-4-carboximidamide No, compound.
Citation Information
Patent Citations
Heterocyclyl pyridazine as fungicidal compounds
WO2020127780A1
Methods of treating epilepsy using the same
WO2021046183A1
